<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135354</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>24</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-7544</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neuroscience</Title>
                <ISOAbbreviation>Neuroscience</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Phosphorylation enhances recombinant HSP27 neuroprotection against focal cerebral ischemia in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0306-4522(14)00650-2</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.neuroscience.2014.07.073</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Heat shock protein 27 (HSP27) exerts cytoprotection against many cellular insults including cerebral ischemia. We previously indicated that intravenous injection of HSP27 purified from human lymphocytes (hHSP27) significantly reduced infarct volume following cerebral ischemia-reperfusion injury, while recombinant HSP27 (rHSP27) was less effective. Phosphorylation is important for HSP27 function, and hHSP27 was more highly phosphorylated than rHSP27. We hypothesized that MAPKAP kinase 2 in vitro-phosphorylated rHSP27 (prHSP27) might increase its brain protection. Mice underwent transient 1-h middle cerebral artery occlusion (MCAO), and then received tail-vein injections of one of the following 1h after reperfusion: hHSP27 as positive control, rHSP27, prHSP27, or bovine serum albumin (BSA) as control. We measured infarct volume, neurological deficits, neurological severity, physiological parameters, cell-death, oxidative stress, and inflammatory response. Compared with BSA controls (30.7??3.1mm(3), n=5), infarct volume was reduced by 67% in the hHSP27 positive-control group (10.1??4.6mm(3), P&lt;0.001, n=5), 17% following rHSP27 (25.4??3.6mm(3), P&lt;0.05, n=5), and 46% following prHSP27 (16.5??4.0mm(3), P&lt;0.001, n=9). Compared to the rHSP27 and BSA-treated groups, prHSP27 also reduced functional deficits, and significantly suppressed apoptosis, oxidative stress, and inflammatory responses. Here, we showed the superior neuroprotective effects of phosphorylated HSP27 by administering prHSP27. prHSP27 may be a useful therapeutic agent to protect against acute cerebral ischemic stroke.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Shimada</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tanaka</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan. Electronic address: r_tanaka@juntendo.ac.jp.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shimura</LastName>
                    <ForeName>H</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan; Institute for Environment and Gender Specific Medicine, Juntendo University School of Medicine, Chiba, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yamshiro</LastName>
                    <ForeName>K</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Urabe</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hattori</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neuroscience</MedlineTA>
            <NlmUniqueID>7605074</NlmUniqueID>
            <ISSNLinking>0306-4522</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">HSP27</Keyword>
            <Keyword MajorTopicYN="N">MAPKAP kinase 2</Keyword>
            <Keyword MajorTopicYN="N">focal ischemia</Keyword>
            <Keyword MajorTopicYN="N">neuroprotection</Keyword>
            <Keyword MajorTopicYN="N">phosphorylation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25135354</ArticleId>
            <ArticleId IdType="pii">S0306-4522(14)00650-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2014.07.073</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135349</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1473-1150</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The pharmacogenomics journal</Title>
                <ISOAbbreviation>Pharmacogenomics J.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The synaptoneurosome transcriptome: a model for profiling the emolecular effects of alcohol.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/tpj.2014.43</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Chronic alcohol consumption changes gene expression, likely causing persistent remodeling of synaptic structures via altered translation of mRNAs within synaptic compartments of the cell. We profiled the transcriptome from synaptoneurosomes (SNs) and paired total homogenates (THs) from mouse amygdala following chronic voluntary alcohol consumption. In SN, both the number of alcohol-responsive mRNAs and the magnitude of fold-change were greater than in THs, including many GABA-related mRNAs upregulated in SNs. Furthermore, SN gene co-expression analysis revealed a highly connected network, demonstrating coordinated patterns of gene expression and highlighting alcohol-responsive biological pathways, such as long-term potentiation, long-term depression, glutamate signaling, RNA processing and upregulation of alcohol-responsive genes within neuroimmune modules. Alterations in these pathways have also been observed in the amygdala of human alcoholics. SNs offer an ideal model for detecting intricate networks of coordinated synaptic gene expression and may provide a unique system for investigating therapeutic targets for the treatment of alcoholism.The Pharmacogenomics Journal advance online publication, 19 August 2014; doi:10.1038/tpj.2014.43.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Most</LastName>
                    <ForeName>D</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>1] Waggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, TX, USA [2] The Institute for Neuroscience (INS), University of Texas at Austin, Austin, TX, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ferguson</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>1] Waggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, TX, USA [2] The Institute for Neuroscience (INS), University of Texas at Austin, Austin, TX, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Blednov</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Waggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, TX, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mayfield</LastName>
                    <ForeName>R D</ForeName>
                    <Initials>RD</Initials>
                    <Affiliation>Waggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, TX, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Harris</LastName>
                    <ForeName>R A</ForeName>
                    <Initials>RA</Initials>
                    <Affiliation>Waggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, TX, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Pharmacogenomics J</MedlineTA>
            <NlmUniqueID>101083949</NlmUniqueID>
            <ISSNLinking>1470-269X</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">tpj201443</ArticleId>
            <ArticleId IdType="doi">10.1038/tpj.2014.43</ArticleId>
            <ArticleId IdType="pubmed">25135349</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135302</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-0832</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Mycopathologia</Title>
                <ISOAbbreviation>Mycopathologia</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Paracoccidioidomycosis is a systemic granulomatous disease caused by Paracoccidioides spp. A peptide from the major diagnostic antigen gp43, named P10, induces a T-CD4(+)??helper-1 immune response in mice and protects against intratracheal challenge with virulent P. brasiliensis. Previously, we evaluated the efficacy of the P10 peptide alone or combined with antifungal drugs in mice immunosuppressed and infected with virulent isolate of P. brasiliensis. In the present work, our data suggest that P10 immunization leads to an effective cellular immune response associated with an enhanced T cell proliferative response. P10-stimulated splenocytes increased nitric oxide (NO) production and induced high levels of IFN-??, IL-1?? and IL-12. Furthermore, significantly increased concentrations of pro-inflammatory cytokines were also observed in lung homogenates of immunized mice. P10 immunization was followed by minimal fibrosis in response to infection. Combined with antifungal drugs, P10 immunization most significantly improved survival of anergic infected mice. Administration of either itraconazole or sulfamethoxazole/trimethoprim together with P10 immunization resulted in 100??% survival up to 200??days post-infection, whereas untreated mice died within 80??days. Hence, our data show that P10 immunization promotes a strong specific immune response even in immunocompromised hosts and thus P10 treatment represents a powerful adjuvant therapy to chemotherapy.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Mu??oz</LastName>
                    <ForeName>Juli??n E</ForeName>
                    <Initials>JE</Initials>
                    <Affiliation>Department of Microbiology, Institute of Biomedical Sciences, University of S??o Paulo, Av. Prof. Lineu Prestes, 1374, S??o Paulo, SP, 05008-900, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Luft</LastName>
                    <ForeName>Vinicius D</ForeName>
                    <Initials>VD</Initials>
                </Author>
                <Author>
                    <LastName>Amorim</LastName>
                    <ForeName>Juliana</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Magalh??es</LastName>
                    <ForeName>Adriana</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Thomaz</LastName>
                    <ForeName>Luciana</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Nosanchuk</LastName>
                    <ForeName>Joshua D</ForeName>
                    <Initials>JD</Initials>
                </Author>
                <Author>
                    <LastName>Travassos</LastName>
                    <ForeName>Luiz R</ForeName>
                    <Initials>LR</Initials>
                </Author>
                <Author>
                    <LastName>Taborda</LastName>
                    <ForeName>Carlos P</ForeName>
                    <Initials>CP</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Mycopathologia</MedlineTA>
            <NlmUniqueID>7505689</NlmUniqueID>
            <ISSNLinking>0301-486X</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>9</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11046-014-9801-1</ArticleId>
            <ArticleId IdType="pubmed">25135302</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135299</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1540-9538</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of experimental medicine</Title>
                <ISOAbbreviation>J. Exp. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Classical Flt3L-dependent dendritic cells control immunity to protein vaccine.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">jem.20131397</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">DCs are critical for initiating immunity. The current paradigm in vaccine biology is that DCs migrating from peripheral tissue and classical lymphoid-resident DCs (cDCs) cooperate in the draining LNs to initiate priming and proliferation of T cells. Here, we observe subcutaneous immunity is Fms-like tyrosine kinase 3 ligand (Flt3L) dependent. Flt3L is rapidly secreted after immunization; Flt3 deletion reduces T cell responses by 50%. Flt3L enhances global T cell and humoral immunity as well as both the numbers and antigen capture capacity of migratory DCs (migDCs) and LN-resident cDCs. Surprisingly, however, we find immunity is controlled by cDCs and actively tempered in vivo by migDCs. Deletion of Langerin(+) DC or blockade of DC migration improves immunity. Consistent with an immune-regulatory role, transcriptomic analyses reveals different skin migDC subsets in both mouse and human cluster together, and share immune-suppressing gene expression and regulatory pathways. These data reveal that protective immunity to protein vaccines is controlled by Flt3L-dependent, LN-resident cDCs.</AbstractText>
                <CopyrightInformation>?? 2014 Anandasabapathy et al.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Anandasabapathy</LastName>
                    <ForeName>Niroshana</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065 Department of Dermatology/Harvard Skin Disease Research Center, Brigham and Women's Hospital, Boston, MA 02115 nanandasabapathy@partners.org.</Affiliation>
                </Author>
                <Author>
                    <LastName>Feder</LastName>
                    <ForeName>Rachel</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mollah</LastName>
                    <ForeName>Shamim</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tse</LastName>
                    <ForeName>Sze-Wah</ForeName>
                    <Initials>SW</Initials>
                    <Affiliation>Department of Dermatology/Harvard Skin Disease Research Center, Brigham and Women's Hospital, Boston, MA 02115.</Affiliation>
                </Author>
                <Author>
                    <LastName>Longhi</LastName>
                    <ForeName>Maria Paula</ForeName>
                    <Initials>MP</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mehandru</LastName>
                    <ForeName>Saurabh</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Matos</LastName>
                    <ForeName>Ines</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cheong</LastName>
                    <ForeName>Cheolho</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ruane</LastName>
                    <ForeName>Darren</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Brane</LastName>
                    <ForeName>Lucas</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Teixeira</LastName>
                    <ForeName>Angela</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dobrin</LastName>
                    <ForeName>Joseph</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mizenina</LastName>
                    <ForeName>Olga</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Chae Gyu</ForeName>
                    <Initials>CG</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Meredith</LastName>
                    <ForeName>Matthew</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Clausen</LastName>
                    <ForeName>Bj??rn E</ForeName>
                    <Initials>BE</Initials>
                    <Affiliation>Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, D-55131 Mainz, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nussenzweig</LastName>
                    <ForeName>Michel C</ForeName>
                    <Initials>MC</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
                <Author>
                    <LastName>Steinman</LastName>
                    <ForeName>Ralph M</ForeName>
                    <Initials>RM</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065Laboratory of Cellular Physiology and Immunology, Christopher H. Browne Center for Immunology and Immune Diseases, Hospital Informatics, and Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Exp Med</MedlineTA>
            <NlmUniqueID>2985109R</NlmUniqueID>
            <ISSNLinking>0022-1007</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">jem.20131397</ArticleId>
            <ArticleId IdType="doi">10.1084/jem.20131397</ArticleId>
            <ArticleId IdType="pubmed">25135299</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135298</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1540-9538</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of experimental medicine</Title>
                <ISOAbbreviation>J. Exp. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>RUNX1-dependent RAG1 deposition instigates human TCR-?? locus rearrangement.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">jem.20132585</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">V(D)J recombination of TCR loci is regulated by chromatin accessibility to RAG1/2 proteins, rendering RAG1/2 targeting a potentially important regulator of lymphoid differentiation. We show that within the human TCR-??/?? locus, D??2-D??3 rearrangements occur at a very immature thymic, CD34(+)/CD1a(-)/CD7(+dim) stage, before D??2(D??3)-J??1 rearrangements. These strictly ordered rearrangements are regulated by mechanisms acting beyond chromatin accessibility. Importantly, direct D??2-J??1 rearrangements are prohibited by a B12/23 restriction and ordered human TCR-?? gene assembly requires RUNX1 protein, which binds to the D??2-23RSS, interacts with RAG1, and enhances RAG1 deposition at this site. This RUNX1-mediated V(D)J recombinase targeting imposes the use of two D?? gene segments in human TCR-?? chains. Absence of this RUNX1 binding site in the homologous mouse D??1-23RSS provides a molecular explanation for the lack of ordered TCR-?? gene assembly in mice and may underlie differences in early lymphoid differentiation between these species.</AbstractText>
                <CopyrightInformation>?? 2014 Cieslak et al.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Cieslak</LastName>
                    <ForeName>Agata</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Universit?? Paris Descartes Sorbonne Cit??, Institut Necker-Enfants Malades (INEM), Institut national de recherche m??dicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-H??pitaux de Paris (AP-HP), H??pital Necker Enfants-Malades, 75015 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Le Noir</LastName>
                    <ForeName>Sandrine</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Universit?? Paris Descartes Sorbonne Cit??, Institut Necker-Enfants Malades (INEM), Institut national de recherche m??dicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-H??pitaux de Paris (AP-HP), H??pital Necker Enfants-Malades, 75015 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Trinquand</LastName>
                    <ForeName>Am??lie</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Universit?? Paris Descartes Sorbonne Cit??, Institut Necker-Enfants Malades (INEM), Institut national de recherche m??dicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-H??pitaux de Paris (AP-HP), H??pital Necker Enfants-Malades, 75015 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lhermitte</LastName>
                    <ForeName>Ludovic</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Universit?? Paris Descartes Sorbonne Cit??, Institut Necker-Enfants Malades (INEM), Institut national de recherche m??dicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-H??pitaux de Paris (AP-HP), H??pital Necker Enfants-Malades, 75015 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Franchini</LastName>
                    <ForeName>Don-Marc</ForeName>
                    <Initials>DM</Initials>
                    <Affiliation>CNRS-Pierre Fabre USR3388, Epigenetic Targeting of Cancer (ETaC), and INSERM UMR1037, Cancer Research Center of Toulouse (CRCT), 31035 Toulouse, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Villarese</LastName>
                    <ForeName>Patrick</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Universit?? Paris Descartes Sorbonne Cit??, Institut Necker-Enfants Malades (INEM), Institut national de recherche m??dicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-H??pitaux de Paris (AP-HP), H??pital Necker Enfants-Malades, 75015 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gon</LastName>
                    <ForeName>St??phanie</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Centre d'Immunologie de Marseille-Luminy (CIML), Aix-Marseille Universit?? UM 2, INSERM UMR 1104, CNRS UMR 7280, 13288 Marseille, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bond</LastName>
                    <ForeName>Jonathan</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Universit?? Paris Descartes Sorbonne Cit??, Institut Necker-Enfants Malades (INEM), Institut national de recherche m??dicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-H??pitaux de Paris (AP-HP), H??pital Necker Enfants-Malades, 75015 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Simonin</LastName>
                    <ForeName>Mathieu</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Universit?? Paris Descartes Sorbonne Cit??, Institut Necker-Enfants Malades (INEM), Institut national de recherche m??dicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-H??pitaux de Paris (AP-HP), H??pital Necker Enfants-Malades, 75015 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Vanhile</LastName>
                    <ForeName>Laurent</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Technological Advances for Genomics and Clinics (TAGC), INSERM U1090, Universit?? de la M??diterran??e, 13288 Marseille, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Reimann</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Universit?? Paris-Descartes, Facult?? de M??decine Ren?? Descartes, IFR94 and INSERM, U768, F-75015 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Verhoeyen</LastName>
                    <ForeName>Els</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>CIRI, International center for Infectiology Research, EVIR team, Universit?? de Lyon, INSERM U1111, Lyon, France and Centre M??diterran??en de M??decine Mol??culaire (C3M), team &quot;contr??le m??tabolique des morts cellulaires&quot; Inserm, U1065, 06204 Nice, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Larghero</LastName>
                    <ForeName>Jerome</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Assistance Publique-H??pitaux de Paris (AP-HP), H??pital Saint-Louis, Unit?? de Th??rapie Cellulaire, Universit?? Paris Diderot, Sorbonne Paris Cit??, Inserm CICBT501 et UMR1160, Institut Universitaire d'H??matologie, 75010 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Six</LastName>
                    <ForeName>Emmanuelle</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Universit?? Paris-Descartes, Facult?? de M??decine Ren?? Descartes, IFR94 and INSERM, U768, F-75015 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Spicuglia</LastName>
                    <ForeName>Salvatore</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Technological Advances for Genomics and Clinics (TAGC), INSERM U1090, Universit?? de la M??diterran??e, 13288 Marseille, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Andr??-Schmutz</LastName>
                    <ForeName>Isabelle</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Universit?? Paris-Descartes, Facult?? de M??decine Ren?? Descartes, IFR94 and INSERM, U768, F-75015 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Langerak</LastName>
                    <ForeName>Anton</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Immunology, Erasmus MC, University Medical Center, 3016 Rotterdam, Netherlands.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nadel</LastName>
                    <ForeName>Bertrand</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Centre d'Immunologie de Marseille-Luminy (CIML), Aix-Marseille Universit?? UM 2, INSERM UMR 1104, CNRS UMR 7280, 13288 Marseille, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Macintyre</LastName>
                    <ForeName>Elizabeth</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Universit?? Paris Descartes Sorbonne Cit??, Institut Necker-Enfants Malades (INEM), Institut national de recherche m??dicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-H??pitaux de Paris (AP-HP), H??pital Necker Enfants-Malades, 75015 Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Payet-Bornet</LastName>
                    <ForeName>Dominique</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Centre d'Immunologie de Marseille-Luminy (CIML), Aix-Marseille Universit?? UM 2, INSERM UMR 1104, CNRS UMR 7280, 13288 Marseille, France vahid.asnafi@nck.aphp.fr payet@ciml.univ-mrs.fr.</Affiliation>
                </Author>
                <Author>
                    <LastName>Asnafi</LastName>
                    <ForeName>Vahid</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Universit?? Paris Descartes Sorbonne Cit??, Institut Necker-Enfants Malades (INEM), Institut national de recherche m??dicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-H??pitaux de Paris (AP-HP), H??pital Necker Enfants-Malades, 75015 Paris, France vahid.asnafi@nck.aphp.fr payet@ciml.univ-mrs.fr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Exp Med</MedlineTA>
            <NlmUniqueID>2985109R</NlmUniqueID>
            <ISSNLinking>0022-1007</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">jem.20132585</ArticleId>
            <ArticleId IdType="doi">10.1084/jem.20132585</ArticleId>
            <ArticleId IdType="pubmed">25135298</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135278</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-0261</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                        <Day>29</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular oncology</Title>
                <ISOAbbreviation>Mol Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11???miRNA-541???androgen receptor (AR)???MMP9 signaling.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1574-7891(14)00168-9</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.molonc.2014.07.013</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Early clinical studies suggested infiltrating T cells might be associated with poor outcomes in prostate cancer (PCa) patients. The detailed mechanisms how T cells contribute to PCa progression, however, remained unclear. Here, we found PCa cells have a better capacity to recruit more CD4(+) T cells than the surrounding normal prostate cells via secreting more chemokines-CXCL9. The consequences of more recruited CD4(+) T cells to PCa might then lead to enhance PCa cell invasion. Mechanism dissection revealed that infiltrating CD4(+) T cells might function through the modulation of FGF11???miRNA-541 signals to suppress PCa androgen receptor (AR) signals. The suppressed AR signals might then alter the MMP9 signals to promote the PCa cell invasion. Importantly, suppressed AR signals via AR-siRNA or anti-androgen Enzalutamide in PCa cells also enhanced the recruitment of T cells and the consequences of this positive feed back regulation could then enhance the PCa cell invasion. Targeting these newly identified signals via FGF11-siRNA, miRNA-541 inhibitor or MMP9 inhibitor all led to partially reverse the enhanced PCa cell invasion. Results from in??vivo mouse models also confirmed the in??vitro cell lines in co-culture studies. Together, these results concluded that infiltrating CD4(+) T cells could promote PCa metastasis via modulation of FGF11???miRNA-541???AR???MMP9 signaling. Targeting these newly identified signals may provide us a new potential therapeutic approach to better battle PCa metastasis.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Hu</LastName>
                    <ForeName>Shuai</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Urology, Peking University First Hospital, Beijing, China; George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology, and The Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology, and The Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yeh</LastName>
                    <ForeName>Shuyuan</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology, and The Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cui</LastName>
                    <ForeName>Yun</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Urology, Peking University First Hospital, Beijing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Xin</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Urology, Peking University First Hospital, Beijing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chang</LastName>
                    <ForeName>Hong-Chiang</ForeName>
                    <Initials>HC</Initials>
                    <Affiliation>George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology, and The Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jin</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Urology, Peking University First Hospital, Beijing, China. Electronic address: jinjie@vip.163.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chang</LastName>
                    <ForeName>Chawnshang</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>George Whipple Lab for Cancer Research, Departments of Pathology, Urology, Radiation Oncology, and The Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA; Sex Hormone Research Center, China Medical University/Hospital, Taichung, Taiwan. Electronic address: chang@urmc.rochester.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Mol Oncol</MedlineTA>
            <NlmUniqueID>101308230</NlmUniqueID>
            <ISSNLinking>1574-7891</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Androgen receptor</Keyword>
            <Keyword MajorTopicYN="N">Prostate cancer</Keyword>
            <Keyword MajorTopicYN="N">T cells</Keyword>
            <Keyword MajorTopicYN="N">Tumor metastasis</Keyword>
            <Keyword MajorTopicYN="N">Tumor microenvironment</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1574-7891(14)00168-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.molonc.2014.07.013</ArticleId>
            <ArticleId IdType="pubmed">25135278</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135254</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1468-2060</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of the rheumatic diseases</Title>
                <ISOAbbreviation>Ann. Rheum. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-?? receptor signalling.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">annrheumdis-2014-205496</ELocationID>
            <ELocationID EIdType="doi">10.1136/annrheumdis-2014-205496</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The NLRP3/ASC inflammasome drives host defence and autoinflammatory disorders by activating caspase-1 to trigger the secretion of mature interleukin (IL)-1??/IL-18, but its potential role in autoimmunity is speculative.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We generated and phenotyped Nlrp3-deficient, Asc-deficient, Il-1r-deficient and Il-18-deficient C57BL/6-lpr/lpr mice, the latter being a mild model of spontaneous lupus-like autoimmunity.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">While lack of IL-1R or IL-18 did not affect the C57BL/6-lpr/lpr phenotype, lack of NLRP3 or ASC triggered massive lymphoproliferation, lung T cell infiltrates and severe proliferative lupus nephritis within 6???months, which were all absent in age-matched C57BL/6-lpr/lpr controls. Lack of NLRP3 or ASC increased dendritic cell and macrophage activation, the expression of numerous proinflammatory mediators, lymphocyte necrosis and the expansion of most T cell and B cell subsets. In contrast, plasma cells and autoantibody production were hardly affected. This unexpected immunosuppressive effect of NLRP3 and ASC may relate to their known role in SMAD2/3 phosphorylation during tumour growth factor (TGF)-?? receptor signalling, for example, Nlrp3-deficiency and Asc-deficiency significantly suppressed the expression of numerous TGF-?? target genes in C57BL/6-lpr/lpr mice and partially recapitulated the known autoimmune phenotype of Tgf-??1-deficient mice.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These data identify a novel non-canonical immunoregulatory function of NLRP3 and ASC in autoimmunity.</AbstractText>
                <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lech</LastName>
                    <ForeName>Maciej</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universit??t, M??nchen-Innenstadt, Munich, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lorenz</LastName>
                    <ForeName>Georg</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universit??t, M??nchen-Innenstadt, Munich, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kulkarni</LastName>
                    <ForeName>Onkar P</ForeName>
                    <Initials>OP</Initials>
                    <Affiliation>Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universit??t, M??nchen-Innenstadt, Munich, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Grosser</LastName>
                    <ForeName>Marian O O</ForeName>
                    <Initials>MO</Initials>
                    <Affiliation>Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universit??t, M??nchen-Innenstadt, Munich, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Stigrot</LastName>
                    <ForeName>Nora</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universit??t, M??nchen-Innenstadt, Munich, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Darisipudi</LastName>
                    <ForeName>Murthy N</ForeName>
                    <Initials>MN</Initials>
                    <Affiliation>Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universit??t, M??nchen-Innenstadt, Munich, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>G??nthner</LastName>
                    <ForeName>Roman</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universit??t, M??nchen-Innenstadt, Munich, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wintergerst</LastName>
                    <ForeName>Maximilian W M</ForeName>
                    <Initials>MW</Initials>
                    <Affiliation>Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universit??t, M??nchen-Innenstadt, Munich, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Anz</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universit??t, M??nchen-Innenstadt, Munich, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Susanti</LastName>
                    <ForeName>Heni Eka</ForeName>
                    <Initials>HE</Initials>
                    <Affiliation>Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universit??t, M??nchen-Innenstadt, Munich, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Anders</LastName>
                    <ForeName>Hans-Joachim</ForeName>
                    <Initials>HJ</Initials>
                    <Affiliation>Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universit??t, M??nchen-Innenstadt, Munich, Germany.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Ann Rheum Dis</MedlineTA>
            <NlmUniqueID>0372355</NlmUniqueID>
            <ISSNLinking>0003-4967</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Inflammation</Keyword>
            <Keyword MajorTopicYN="N">Lupus Nephritis</Keyword>
            <Keyword MajorTopicYN="N">Systemic Lupus Erythematosus</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">annrheumdis-2014-205496</ArticleId>
            <ArticleId IdType="doi">10.1136/annrheumdis-2014-205496</ArticleId>
            <ArticleId IdType="pubmed">25135254</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135253</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1468-2060</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of the rheumatic diseases</Title>
                <ISOAbbreviation>Ann. Rheum. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A homeostatic function of CXCR2 signalling in articular cartilage.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">annrheumdis-2014-205546</ELocationID>
            <ELocationID EIdType="doi">10.1136/annrheumdis-2014-205546</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">ELR+ CXC chemokines are heparin-binding cytokines signalling through the CXCR1 and CXCR2 receptors. ELR+ CXC chemokines have been associated with inflammatory arthritis due to their capacity to attract inflammatory cells. Here, we describe an unsuspected physiological function of these molecules in articular cartilage homeostasis.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Chemokine receptors and ligands were detected by immunohistochemistry, western blotting and RT-PCR. Osteoarthritis was induced in wild-type and CXCR2(-/-) mice by destabilisation of the medial meniscus (DMM). CXCR1/2 signalling was inhibited in vitro using blocking antibodies or siRNA. Chondrocyte phenotype was analysed using Alcian blue staining, RT-PCR and western blotting. AKT phosphorylation and SOX9 expression were upregulated using constitutively active AKT or SOX9 plasmids. Apoptosis was detected by terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">CXCL6 was expressed in healthy cartilage and was retained through binding to heparan sulfate proteoglycans. CXCR2(-/-) mice developed more severe osteoarthritis than wild types following DMM, with increased chondrocyte apoptosis. Disruption of CXCR1/2 in human and CXCR2 signalling in mouse chondrocytes led to a decrease in extracellular matrix production, reduced expression of chondrocyte differentiation markers and increased chondrocyte apoptosis. CXCR2-dependent chondrocyte homeostasis was mediated by AKT signalling since forced expression of constitutively active AKT rescued the expression of phenotypic markers and the apoptosis induced by CXCR2 blockade.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study demonstrates an important physiological role for CXCR1/2 signalling in maintaining cartilage homeostasis and suggests that the loss of ELR+ CXC chemokines during cartilage breakdown in osteoarthritis contributes to the characteristic loss of chondrocyte phenotypic stability.</AbstractText>
                <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Sherwood</LastName>
                    <ForeName>Joanna</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bertrand</LastName>
                    <ForeName>Jessica</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nalesso</LastName>
                    <ForeName>Giovanna</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Poulet</LastName>
                    <ForeName>Blandine</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Division of Medicine, Centre for Rheumatology and Connective Tissue Disease, UCL, London, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pitsillides</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Veterinary Basic Sciences, Royal Veterinary College, University of London, Royal College Street, London, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Brandolini</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Domp?? S.P.A., L'Aquila, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Karystinou</LastName>
                    <ForeName>Alexandra</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Institute of Medical Sciences, University of Aberdeen, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>De Bari</LastName>
                    <ForeName>Cosimo</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Institute of Medical Sciences, University of Aberdeen, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Luyten</LastName>
                    <ForeName>Frank P</ForeName>
                    <Initials>FP</Initials>
                    <Affiliation>Skeletal Biology and Engineering Research Center, KU Leuven, Belgium.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pitzalis</LastName>
                    <ForeName>Costantino</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pap</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dell'Accio</LastName>
                    <ForeName>Francesco</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Ann Rheum Dis</MedlineTA>
            <NlmUniqueID>0372355</NlmUniqueID>
            <ISSNLinking>0003-4967</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chemokines</Keyword>
            <Keyword MajorTopicYN="N">Chondrocytes</Keyword>
            <Keyword MajorTopicYN="N">Osteoarthritis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">annrheumdis-2014-205546</ArticleId>
            <ArticleId IdType="doi">10.1136/annrheumdis-2014-205546</ArticleId>
            <ArticleId IdType="pubmed">25135253</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135252</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1468-2060</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of the rheumatic diseases</Title>
                <ISOAbbreviation>Ann. Rheum. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Disease-modifying effects of TD-198946 on progressed osteoarthritis in a mouse model.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">annrheumdis-2014-205672</ELocationID>
            <ELocationID EIdType="doi">10.1136/annrheumdis-2014-205672</ELocationID>
            <AuthorList>
                <Author>
                    <LastName>Yano</LastName>
                    <ForeName>Fumiko</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Center for Disease Biology and Integrative Medicine, University of Tokyo, Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ohba</LastName>
                    <ForeName>Shinsuke</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Bioengineering, The University of Tokyo, Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hosaka</LastName>
                    <ForeName>Yoko</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Sensory and Motor System Medicine, The University of Tokyo, Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Saito</LastName>
                    <ForeName>Taku</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Sensory and Motor System Medicine, The University of Tokyo, Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chung</LastName>
                    <ForeName>Ung-Il</ForeName>
                    <Initials>UI</Initials>
                    <Affiliation>Center for Disease Biology and Integrative Medicine, University of Tokyo, Tokyo, Japan Department of Bioengineering, The University of Tokyo, Tokyo, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>LETTER</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Ann Rheum Dis</MedlineTA>
            <NlmUniqueID>0372355</NlmUniqueID>
            <ISSNLinking>0003-4967</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chondrocytes</Keyword>
            <Keyword MajorTopicYN="N">Knee Osteoarthritis</Keyword>
            <Keyword MajorTopicYN="N">Osteoarthritis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">annrheumdis-2014-205672</ArticleId>
            <ArticleId IdType="doi">10.1136/annrheumdis-2014-205672</ArticleId>
            <ArticleId IdType="pubmed">25135252</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25135196</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-Print">
            <Journal>
                <ISSN IssnType="Electronic">1549-5485</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>21</Volume>
                    <Issue>9</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Learning &amp; memory (Cold Spring Harbor, N.Y.)</Title>
                <ISOAbbreviation>Learn. Mem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Protein degradation by ubiquitin-proteasome system in formation and labilization of contextual conditioning memory.</ArticleTitle>
            <Pagination>
                <MedlinePgn>478-87</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1101/lm.035998.114</ELocationID>
            <Abstract>
                <AbstractText>The ubiquitin-proteasome system (UPS) of protein degradation has been evaluated in different forms of neural plasticity and memory. The role of UPS in such processes is controversial. Several results support the idea that the activation of this system in memory consolidation is necessary to overcome negative constrains for plasticity. In this case, the inhibition of the UPS during consolidation impairs memory. Similar results were reported for memory reconsolidation. However, in other cases, the inhibition of UPS had no effect on memory consolidation and reconsolidation but impedes the amnesic action of protein synthesis inhibition after retrieval. The last finding suggests a specific action of the UPS inhibitor on memory labilization. However, another interpretation is possible in terms of the synthesis/degradation balance of positive and negative elements in neural plasticity, as was found in the case of long-term potentiation. To evaluate these alternative interpretations, other reconsolidation-interfering drugs than translation inhibitors should be tested. Here we analyzed initially the UPS inhibitor effect in contextual conditioning in crabs. We found that UPS inhibition during consolidation impaired long-term memory. In contrast, UPS inhibition did not affect memory reconsolidation after contextual retrieval but, in fact, impeded memory labilization, blocking the action of drugs that does not affect directly the protein synthesis. To extend these finding to vertebrates, we performed similar experiments in contextual fear memory in mice. We found that the UPS inhibitor in hippocampus affected memory consolidation and blocked memory labilization after retrieval. These findings exclude alternative interpretations to the requirement of UPS in memory labilization and give evidence of this mechanism in both vertebrates and invertebrates.</AbstractText>
                <CopyrightInformation>?? 2014 Sol Fusti??ana et al.; Published by Cold Spring Harbor Laboratory Press.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sol Fusti??ana</LastName>
                    <ForeName>Mar??a</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Laboratorio de Neurobiolog??a de la Memoria, Departamento de Fisiolog??a, Biolog??a Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, IFIByNE, CONICET, Ciudad Universitaria, 1428EHA, Buenos Aires, Argentina.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Federman</LastName>
                    <ForeName>Noel</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Laboratorio de Neurobiolog??a de la Memoria, Departamento de Fisiolog??a, Biolog??a Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, IFIByNE, CONICET, Ciudad Universitaria, 1428EHA, Buenos Aires, Argentina.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Freudenthal</LastName>
                    <ForeName>Ramiro</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Laboratorio de Neurobiolog??a de la Memoria, Departamento de Fisiolog??a, Biolog??a Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, IFIByNE, CONICET, Ciudad Universitaria, 1428EHA, Buenos Aires, Argentina.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Romano</LastName>
                    <ForeName>Arturo</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratorio de Neurobiolog??a de la Memoria, Departamento de Fisiolog??a, Biolog??a Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, IFIByNE, CONICET, Ciudad Universitaria, 1428EHA, Buenos Aires, Argentina aromano@fbmc.fcen.uba.ar.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Learn Mem</MedlineTA>
            <NlmUniqueID>9435678</NlmUniqueID>
            <ISSNLinking>1072-0502</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <OtherID Source="NLM">PMC4138359 [Available on 09/01/15]</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ppublish">
                <Year>2014</Year>
                <Month>9</Month>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2015</Year>
                <Month>9</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">21/9/478</ArticleId>
            <ArticleId IdType="doi">10.1101/lm.035998.114</ArticleId>
            <ArticleId IdType="pubmed">25135196</ArticleId>
            <ArticleId IdType="pmc">PMC4138359</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25135115</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-5177</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pharmacology, biochemistry, and behavior</Title>
                <ISOAbbreviation>Pharmacol. Biochem. Behav.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Serotonergic systems are implicated in antinociceptive effect of m-trifluoromethyl diphenyl diselenide in the mouse glutamate test.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0091-3057(14)00223-8</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.pbb.2014.08.002</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The organoselenium compound m-trifluoromethyl diphenyl diselenide (m-CF3-PhSe)2 has antinociceptive actions in several animal models, which are mediated by interaction with endogenous opioid systems. It also shows antidepressant-like action mediated by both opioid and serotonergic systems. Considering that serotonin (5-HT) plays an important role in the descending control of pain, this study further investigated the role of serotonergic systems in the antinociceptive action of (m-CF3-PhSe)2 in the glutamate-induced licking behavior model in mice. (m-CF3-PhSe)2 (1-50mg/kg, p.o.), morphine (2.5mg/kg, s.c.) or paroxetine (5mg/kg, i.p.) reduced glutamate-induced nociception. Selective 5-HT1A and 5-HT2A receptor antagonists, WAY100635 (0.7mg/kg, i.p.) and ketanserin (0.3mg/kg, i.p.), but not the selective 5-HT3 receptor antagonist, ondansetron (0.5mg/kg, i.p.), prevented the antinociceptive effect of (m-CF3-PhSe)2 (10mg/kg) in the glutamate test. In biochemical studies, (m-CF3-PhSe)2 (10 and 50mg/kg) decreased [(3)H]5-HT uptake in crude synaptosomes of mouse brains and slightly inhibited in vitro [(3)H]5-HT binding. In kinetic studies, the selenium (Se) distribution was determined at different time points after the administration of (m-CF3-PhSe)2 (500mg/kg, p.o.) to mice. After 30min, a high amount of Se was found in liver and kidneys, followed by the lung, red blood cells, serum and brain. A significant amount of Se accumulated in fat over the course of 8h. Urine was an important route of Se excretion originating from (m-CF3-PhSe)2. Collectively, results of this study indicate an involvement of the serotonergic systems in the antinociceptive effect of (m-CF3-PhSe)2 and a wide distribution of Se derived from this compound.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Br??ning</LastName>
                    <ForeName>C??sar Augusto</ForeName>
                    <Initials>CA</Initials>
                    <Affiliation>Laborat??rio de S??ntese, Reatividade e Avalia????o Farmacol??gica e Toxicol??gica de Organocalcog??nios, Centro de Ci??ncias Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900 RS, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gai</LastName>
                    <ForeName>Bibiana Mozzaquatro</ForeName>
                    <Initials>BM</Initials>
                    <Affiliation>Laborat??rio de S??ntese, Reatividade e Avalia????o Farmacol??gica e Toxicol??gica de Organocalcog??nios, Centro de Ci??ncias Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900 RS, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Soares</LastName>
                    <ForeName>Suelen Mendon??a</ForeName>
                    <Initials>SM</Initials>
                    <Affiliation>Laborat??rio de S??ntese, Reatividade e Avalia????o Farmacol??gica e Toxicol??gica de Organocalcog??nios, Centro de Ci??ncias Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900 RS, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Martini</LastName>
                    <ForeName>Franciele</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Laborat??rio de S??ntese, Reatividade e Avalia????o Farmacol??gica e Toxicol??gica de Organocalcog??nios, Centro de Ci??ncias Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900 RS, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nogueira</LastName>
                    <ForeName>Cristina Wayne</ForeName>
                    <Initials>CW</Initials>
                    <Affiliation>Laborat??rio de S??ntese, Reatividade e Avalia????o Farmacol??gica e Toxicol??gica de Organocalcog??nios, Centro de Ci??ncias Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900 RS, Brazil. Electronic address: criswn@quimica.ufsm.br.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Pharmacol Biochem Behav</MedlineTA>
            <NlmUniqueID>0367050</NlmUniqueID>
            <ISSNLinking>0091-3057</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antinociceptive</Keyword>
            <Keyword MajorTopicYN="N">Distribution</Keyword>
            <Keyword MajorTopicYN="N">Glutamate test</Keyword>
            <Keyword MajorTopicYN="N">Organoselenium</Keyword>
            <Keyword MajorTopicYN="N">Selenium</Keyword>
            <Keyword MajorTopicYN="N">Serotonergic systems</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25135115</ArticleId>
            <ArticleId IdType="pii">S0091-3057(14)00223-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.pbb.2014.08.002</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25134989</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-1723</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Nature communications</Title>
                <ISOAbbreviation>Nat Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Toll-like receptor 4 and MAIR-II/CLM-4/LMIR2 immunoreceptor regulate VLA-4-mediated inflammatory monocyte migration.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4710</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/ncomms5710</ELocationID>
            <Abstract>
                <AbstractText>Inflammatory monocytes play an important role in host defense against infections. However, the regulatory mechanisms of transmigration into infected tissue are not yet completely understood. Here we show that mice deficient in MAIR-II (also called CLM-4 or LMIR2) are more susceptible to caecal ligation and puncture (CLP)-induced peritonitis than wild-type (WT) mice. Adoptive transfer of inflammatory monocytes from WT mice, but not from MAIR-II, TLR4 or MyD88-deficient mice, significantly improves survival of MAIR-II-deficient mice after CLP. Migration of inflammatory monocytes into the peritoneal cavity after CLP, which is dependent on VLA-4, is impaired in above mutant and FcR?? chain-deficient mice. Lipopolysaccharide stimulation induces association of MAIR-II with FcR?? chain and Syk, leading to enhancement of VLA-4-mediated adhesion to VCAM-1. These results indicate that activation of MAIR-II/FcR?? chain by TLR4/MyD88-mediated signalling is essential for the transmigration of inflammatory monocytes from the blood to sites of infection mediated by VLA-4.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Totsuka</LastName>
                    <ForeName>Naoya</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>1] Department of Immunology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan [2] Department of Immunology, Fukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima 960-1295, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Yun-Gi</ForeName>
                    <Initials>YG</Initials>
                    <Affiliation>1] Department of Immunology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan [2] Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan [3] Department of Pathology and Comprehensive Cancer Center, University of Michigan Medical School, 1500 East Medical Center Dr-4111 CCGC, Ann Arbor, Michigan 48109, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kanemaru</LastName>
                    <ForeName>Kazumasa</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Immunology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Niizuma</LastName>
                    <ForeName>Kouta</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Immunology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Umemoto</LastName>
                    <ForeName>Eiji</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Laboratory of Immune Regulation, Department of Microbiology and Immunology, Osaka University, 1-1 Yamadaoka, Suita, Osaka 565-0871, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nagai</LastName>
                    <ForeName>Kei</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Immunology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tahara-Hanaoka</LastName>
                    <ForeName>Satoko</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>1] Department of Immunology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan [2] Life Science Center of Tsukuba Advanced Research Alliance (TARA), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakahasi-Oda</LastName>
                    <ForeName>Chigusa</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Immunology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Honda</LastName>
                    <ForeName>Shin-Ichiro</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>1] Department of Immunology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan [2] Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miyasaka</LastName>
                    <ForeName>Masayuki</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Interdisciplinary Program for Biomedical Sciences, Institute for Academic Initiatives, Osaka University, 1-1 Yamadaoka, Suita, Osaka 565-0871, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shibuya</LastName>
                    <ForeName>Kazuko</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Immunology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shibuya</LastName>
                    <ForeName>Akira</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>1] Department of Immunology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan [2] Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan [3] Life Science Center of Tsukuba Advanced Research Alliance (TARA), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Commun</MedlineTA>
            <NlmUniqueID>101528555</NlmUniqueID>
            <ISSNLinking>2041-1723</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ncomms5710</ArticleId>
            <ArticleId IdType="doi">10.1038/ncomms5710</ArticleId>
            <ArticleId IdType="pubmed">25134989</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25134987</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-1723</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Nature communications</Title>
                <ISOAbbreviation>Nat Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The deubiquitinating enzyme CYLD controls apical docking of basal bodies in ciliated epithelial cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4585</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/ncomms5585</ELocationID>
            <Abstract>
                <AbstractText>CYLD is a tumour suppressor gene mutated in familial cylindromatosis, a genetic disorder leading to the development of skin appendage tumours. It encodes a deubiquitinating enzyme that removes Lys63- or linear-linked ubiquitin chains. CYLD was shown to regulate cell proliferation, cell survival and inflammatory responses, through various signalling pathways. Here we show that CYLD localizes at centrosomes and basal bodies via interaction with the centrosomal protein CAP350 and demonstrate that CYLD must be both at the centrosome and catalytically active to promote ciliogenesis independently of NF-??B. In transgenic mice engineered to mimic the smallest truncation found in cylindromatosis patients, CYLD interaction with CAP350 is lost disrupting CYLD centrosome localization, which results in cilia formation defects due to impairment of basal body migration and docking. These results point to an undiscovered regulation of ciliogenesis by Lys63 ubiquitination and provide new perspectives regarding CYLD function that should be considered in the context of cylindromatosis.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Eguether</LastName>
                    <ForeName>Thibaut</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>1] Institut Curie/INSERM U759, Campus Universitaire, Bat 112, 91405 Orsay Cedex, France [2] Universit?? Pierre et Marie Curie, 75005 Paris, France [3].</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ermolaeva</LastName>
                    <ForeName>Maria A</ForeName>
                    <Initials>MA</Initials>
                    <Affiliation>Institute for Genetics, Center for Molecular Medicine (CMMC) and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Strasse 26, 50931 Cologne, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Yongge</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, Maryland 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bonnet</LastName>
                    <ForeName>Marion C</ForeName>
                    <Initials>MC</Initials>
                    <Affiliation>1] Institute for Genetics, Center for Molecular Medicine (CMMC) and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Strasse 26, 50931 Cologne, Germany [2] Excellence Research Chair, Universit?? Europ??enne de Bretagne, IRSET/INSERM UMR1085, Facult?? de Pharmacie, Universit?? de Rennes 1, 35000 Rennes, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jain</LastName>
                    <ForeName>Ashish</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, Maryland 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pasparakis</LastName>
                    <ForeName>Manolis</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute for Genetics, Center for Molecular Medicine (CMMC) and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Strasse 26, 50931 Cologne, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Courtois</LastName>
                    <ForeName>Gilles</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>1] Universit?? Grenoble Alpes, 38000 Grenoble, France [2] INSERM U1038/BGE/Institut de Recherches en Technologies et Sciences pour le Vivant, CEA, 38054 Grenoble, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tassin</LastName>
                    <ForeName>Anne-Marie</ForeName>
                    <Initials>AM</Initials>
                    <Affiliation>1] Institut Curie/INSERM U759, Campus Universitaire, Bat 112, 91405 Orsay Cedex, France [2] CNRS, Centre de G??n??tique Mol??culaire, UPR3404, Avenue de la Terrasse, F-91198 Gif-sur-Yvette, France.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Commun</MedlineTA>
            <NlmUniqueID>101528555</NlmUniqueID>
            <ISSNLinking>2041-1723</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ncomms5585</ArticleId>
            <ArticleId IdType="doi">10.1038/ncomms5585</ArticleId>
            <ArticleId IdType="pubmed">25134987</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134983</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1472-6750</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC biotechnology</Title>
                <ISOAbbreviation>BMC Biotechnol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cytotoxicity of purified listeriolysin O on mouse and human leukocytes and leukaemia cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>77</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Listeriolysin O (LLO) is the main virulence factor of Listeria monocytogenes and facilitates the intracellular survival of the pathogen. Some of its characteristics endorse the growing popularity of LLO for use in biotechnology, particularly in the development of novel vaccines. Here, we evaluate the use of LLO to eradicate leukaemia cells.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A purified LLO preparation was obtained by affinity chromatography. The LLO preparation procedure was optimized and purified LLO was tested for optimal conditions of storage including temperature, application of proteinase inhibitors and serum components. We demonstrated the possibility of regulating LLO activity by adjusting cell membrane cholesterol content. The LLO preparation had haemolytic activity and had a cytotoxic effect on the human T-leukaemia Jurkat cell line as well as mouse and human peripheral blood mononuclear cells.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">LLO has a very potent cytotoxic activity towards human leukocytes. Importantly, the cytotoxic activity was easily regulated in vitro and could be restricted to areas containing malignant cells, raising the possibility of future clinical application of LLO for leukaemia treatment.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Stachowiak</LastName>
                    <ForeName>Rados Aw</ForeName>
                    <Initials>RA</Initials>
                </Author>
                <Author>
                    <LastName>Y Niak</LastName>
                    <ForeName>Marcin</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Grabowska</LastName>
                    <ForeName>Maja</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Roeske</LastName>
                    <ForeName>Katarzyna</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Jagielski</LastName>
                    <ForeName>Tomasz</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Bielecki</LastName>
                    <ForeName>Jacek</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Budziszewska</LastName>
                    <ForeName>Bo Ena K</ForeName>
                    <Initials>BE</Initials>
                </Author>
                <Author>
                    <LastName>Hoser</LastName>
                    <ForeName>Gra Yna</ForeName>
                    <Initials>GY</Initials>
                </Author>
                <Author>
                    <LastName>Kawiak</LastName>
                    <ForeName>Jerzy</ForeName>
                    <Initials>J</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>BMC Biotechnol</MedlineTA>
            <NlmUniqueID>101088663</NlmUniqueID>
            <ISSNLinking>1472-6750</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1472-6750-14-77</ArticleId>
            <ArticleId IdType="doi">10.1186/1472-6750-14-77</ArticleId>
            <ArticleId IdType="pubmed">25134983</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134913</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1420-9071</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cellular and molecular life sciences : CMLS</Title>
                <ISOAbbreviation>Cell. Mol. Life Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Novel function of PITH domain-containing 1 as an activator of internal ribosomal entry site to enhance RUNX1 expression and promote megakaryocyte differentiation.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Altered gene expression coincides with leukemia development and may affect distinct features of leukemic cells. PITHD1 was significantly downregulated in leukemia and upregulated upon PMA induction in K562 cells undergoing megakaryocyte differentiation. We aimed to study the function of PITHD1 in megakaryocyte differentiation.</AbstractText>
                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">K562 cells and fetal liver cells were used for either overexpression or downregulation of PITHD1 by retroviral or lentiviral transduction. FACS was used to detect the expression of CD41 and CD42 to measure megakaryocyte differentiation in these cells. Western blot and quantitative RT-PCR were used to measure gene expression. Dual luciferase assay was used to detect promoter or internal ribosomal entry site (IRES) activity.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Ectopic expression of PITHD1 promoted megakaryocyte differentiation and increased RUNX1 expression while PITHD1 knockdown showed an opposite phenotype. Furthermore, PITHD1 efficiently induced endogenous RUNX1 expression and restored megakaryocyte differentiation suppressed by a dominant negative form of RUNX1. PITHD1 regulated RUNX1 expression at least through two distinct mechanisms: increasing transcription activity of proximal promoter and enhancing translation activity of an IRES element in exon 3. Finally, we confirmed the function of PITHD1 in regulating RUNX1 expression and megakaryopoiesis in mouse fetal liver cells.</AbstractText>
                <AbstractText Label="CONCLUSION AND SIGNIFICANCE" NlmCategory="CONCLUSIONS">PITHD1 was a novel activator of IRES and enhanced RUNX1 expression that subsequently promoted megakaryocyte differentiation. Our findings shed light on understanding the mechanisms underlying megakaryopoiesis or leukemogenesis.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lu</LastName>
                    <ForeName>Bin</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>College of Life Sciences, Wuhan University, Wuhan, 430072, Hubei, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sun</LastName>
                    <ForeName>Xueqin</ForeName>
                    <Initials>X</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Yuxuan</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Jin</LastName>
                    <ForeName>Qi</ForeName>
                    <Initials>Q</Initials>
                </Author>
                <Author>
                    <LastName>Liang</LastName>
                    <ForeName>Qin</ForeName>
                    <Initials>Q</Initials>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Shangqin</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Yamu</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Zhou</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Wenxin</ForeName>
                    <Initials>W</Initials>
                </Author>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Zan</ForeName>
                    <Initials>Z</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell Mol Life Sci</MedlineTA>
            <NlmUniqueID>9705402</NlmUniqueID>
            <ISSNLinking>1420-682X</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-014-1704-2</ArticleId>
            <ArticleId IdType="pubmed">25134913</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134824</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1742-7843</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Basic &amp; clinical pharmacology &amp; toxicology</Title>
                <ISOAbbreviation>Basic Clin. Pharmacol. Toxicol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Galla Chinensis Attenuates Cigarette Smoke-associated Lung Injury by Inhibiting Recruitment of Inflammatory Cells into the Lung.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/bcpt.12308</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Inflammation is a common feature in the pathogenesis of cigarette smoke (CS)-associated diseases. In this study, we investigated the effects of Galla Chinensis (GC) extract on pulmonary inflammatory responses in a CS-exposed mouse model. In vitro studies showed that GC extract reduced MCP-1 production in a dose-dependent manner. In addition, the recruitment of inflammatory cells into the lung was significantly inhibited in the bronchoalveolar lavage fluid (BALF) of the GC-treated mice after three weeks of daily CS exposure. GC treatment down-regulated TNF-??, IL-6 and MCP-1 mRNA expression levels in lung tissue. Finally, GC-treated mice showed less emphysematous change of alveolar compared to mice only exposed to CS. Our results show that GC extract reduces lung inflammation and emphysematous change by inhibiting the infiltration of inflammatory cells to the lung. These data indicate that GC extract is a therapeutic candidate for CS-induced lung injury. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Hyojung</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Oriental Physiology, College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yu</LastName>
                    <ForeName>Seung-Ryeol</ForeName>
                    <Initials>SR</Initials>
                </Author>
                <Author>
                    <LastName>Lim</LastName>
                    <ForeName>Dahae</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Hyejung</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Jin</LastName>
                    <ForeName>Eun-Young</ForeName>
                    <Initials>EY</Initials>
                </Author>
                <Author>
                    <LastName>Jang</LastName>
                    <ForeName>Young-Pyo</ForeName>
                    <Initials>YP</Initials>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Jinju</ForeName>
                    <Initials>J</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Basic Clin Pharmacol Toxicol</MedlineTA>
            <NlmUniqueID>101208422</NlmUniqueID>
            <ISSNLinking>1742-7835</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bcpt.12308</ArticleId>
            <ArticleId IdType="pubmed">25134824</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134818</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1543-706X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>In vitro cellular &amp; developmental biology. Animal</Title>
                <ISOAbbreviation>In Vitro Cell. Dev. Biol. Anim.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The expression of pluripotency genes and neuronal markers after neurodifferentiation in fibroblasts co-cultured with human umbilical cord blood mononuclear cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Human umbilical cord blood is an attractive source of stem cells; however, it has a heterogeneous cell population with few mesenchymal stem cells. Cell reprogramming induced by different methodologies can confer pluripotency to differentiated adult cells. The objective of this study was to evaluate the reprogramming of fibroblasts and their subsequent neural differentiation after co-culture with umbilical cord blood mononuclear cells. Cells were obtained from four human umbilical cords. The mononuclear cells were cultured for 7??d and subsequently co-cultured with mouse fibroblast NIH-3T3 cells for 6??d. The pluripotency of the cells was evaluated by RT-PCR using primers specific for pluripotency marker genes. The pluripotency was also confirmed by adipogenic and osteogenic differentiation. Neural differentiation of the reprogrammed cells was evaluated by immunofluorescence. All co-cultured cells showed adipogenic and osteogenic differentiation capacity. After co-cultivation, cells expressed the pluripotency gene KLF4. Statistically significant differences in cell area, diameter, optical density, and fractal dimension were observed by confocal microscopy in the neurally differentiated cells. Contact in the form of co-cultivation of fibroblasts with umbilical cord blood mononuclear fraction for 6??d promoted the reprogramming of these cells, allowing the later induction of neural differentiation.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Marinowic</LastName>
                    <ForeName>D R</ForeName>
                    <Initials>DR</Initials>
                    <Affiliation>Biomedical Research Institute, Pontif??cia Universidade Cat??lica do Rio Grande do Sul. Brazil, Porto Alegre, 90610-000, Brazil, dmarinowic@gmail.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Domingues</LastName>
                    <ForeName>M F</ForeName>
                    <Initials>MF</Initials>
                </Author>
                <Author>
                    <LastName>Machado</LastName>
                    <ForeName>D C</ForeName>
                    <Initials>DC</Initials>
                </Author>
                <Author>
                    <LastName>DaCosta</LastName>
                    <ForeName>J C</ForeName>
                    <Initials>JC</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>In Vitro Cell Dev Biol Anim</MedlineTA>
            <NlmUniqueID>9418515</NlmUniqueID>
            <ISSNLinking>1071-2690</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11626-014-9804-8</ArticleId>
            <ArticleId IdType="pubmed">25134818</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134817</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1543-706X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>In vitro cellular &amp; developmental biology. Animal</Title>
                <ISOAbbreviation>In Vitro Cell. Dev. Biol. Anim.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Concentration-dependent effects of spermine on apoptosis and consequent generation of multilayer myotube sheets from mouse embryoid bodies in vitro.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The concentration-dependent effect of spermine was investigated on the spermine-induced generation of multilayer myotube sheets (MMTS) from mouse embryoid bodies (EBs). During spermine treatment for 24??h, a monolayer cell sheet that had already grown radially from the periphery of an EB was exfoliated. The exfoliation was inhibited by z-VAD.fmk, indicating the occurrence of apoptosis, and inhibited also by aminoguanidine, indicating the involvement of amine oxidase. Following the exfoliation, the cell growth restarted from the fresh periphery of EB in a spermine-free medium and finally formed MMTS. To analyze the contribution of apoptosis to the cell death causing exfoliation, the numbers of apoptotic, necrotic, and 2nd apoptotic cells were counted by staining with Annexin V-Cyanine-3 (AVC3) and 7-aminoactinomycin (7AAC). AVC3-positive, 7AAC-positive, and AVC3/7AAC doubly positive cells were assigned as apoptotic, necrotic, and 2nd necrotic cells, respectively. The relative number of apoptotic and 2nd necrotic cells (N A???+???N A/7) to the total number of dying cells (N T) was 84?????????94%, which was independent of spermine concentration in the range from 0.1 to 2.0??mM. The MMTS generation rate at the final stage, however, was dependent on the spermine concentration. It was 60?????????80% in the range from 0.1 to 1.5??mM, while it decreased sharply to 1% at 2??mM. This suggests another role of spermine in the MMTS generation in addition to the induction of apoptosis. This 2nd role seems to be inhibited at a spermine concentration higher than a critical limit between 1.5 and 2.0??mM.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Saito</LastName>
                    <ForeName>Mikako</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16, Naka-cho, Koganei, Tokyo, 184-8588, Japan, mikako@cc.tuat.ac.jp.</Affiliation>
                </Author>
                <Author>
                    <LastName>Abe</LastName>
                    <ForeName>Natsuki</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Ishida</LastName>
                    <ForeName>Ayano</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Nakagawa</LastName>
                    <ForeName>Shota</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Matsuoka</LastName>
                    <ForeName>Hideaki</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>In Vitro Cell Dev Biol Anim</MedlineTA>
            <NlmUniqueID>9418515</NlmUniqueID>
            <ISSNLinking>1071-2690</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11626-014-9799-1</ArticleId>
            <ArticleId IdType="pubmed">25134817</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134787</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1468-3288</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Gut</Title>
                <ISOAbbreviation>Gut</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A pro-inflammatory role for Th22 cells in Helicobacter pylori-associated gastritis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">gutjnl-2014-307020</ELocationID>
            <ELocationID EIdType="doi">10.1136/gutjnl-2014-307020</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Helper T (Th) cell responses are critical for the pathogenesis of Helicobacter pylori-induced gastritis. Th22 cells represent a newly discovered Th cell subset, but their relevance to H. pylori-induced gastritis is unknown.</AbstractText>
                <AbstractText Label="DESIGN" NlmCategory="METHODS">Flow cytometry, real-time PCR and ELISA analyses were performed to examine cell, protein and transcript levels in gastric samples from patients and mice infected with H. pylori. Gastric tissues from interleukin (IL)-22-deficient and wild-type (control) mice were also examined. Tissue inflammation was determined for pro-inflammatory cell infiltration and pro-inflammatory protein production. Gastric epithelial cells and myeloid-derived suppressor cells (MDSC) were isolated, stimulated and/or cultured for Th22 cell function assays.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Th22 cells accumulated in gastric mucosa of both patients and mice infected with H. pylori. Th22 cell polarisation was promoted via the production of IL-23 by dendritic cells (DC) during H. pylori infection, and resulted in increased inflammation within the gastric mucosa. This inflammation was characterised by the CXCR2-dependent influx of MDSCs, whose migration was induced via the IL-22-dependent production of CXCL2 by gastric epithelial cells. Under the influence of IL-22, MDSCs, in turn, produced pro-inflammatory proteins, such as S100A8 and S100A9, and suppressed Th1 cell responses, thereby contributing to the development of H. pylori-associated gastritis.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study, therefore, identifies a novel regulatory network involving H. pylori, DCs, Th22 cells, gastric epithelial cells and MDSCs, which collectively exert a pro-inflammatory effect within the gastric microenvironment. Efforts to inhibit this Th22-dependent pathway may therefore prove a valuable strategy in the therapy of H. pylori-associated gastritis.</AbstractText>
                <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Zhuang</LastName>
                    <ForeName>Yuan</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cheng</LastName>
                    <ForeName>Ping</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Xiao-Fei</ForeName>
                    <Initials>XF</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China Department of Laboratory Medicine, General Hospital of Ji'nan Military Region of PLA, Ji'nan, Shandong, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Peng</LastName>
                    <ForeName>Liu-Sheng</ForeName>
                    <Initials>LS</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Bo-Sheng</ForeName>
                    <Initials>BS</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Ting-Ting</ForeName>
                    <Initials>TT</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Na</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Wen-Hua</ForeName>
                    <Initials>WH</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shi</LastName>
                    <ForeName>Yun</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Weisan</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>School of Molecular Science, La Trobe University, Bundoora, Victoria, Australia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pang</LastName>
                    <ForeName>Ken C</ForeName>
                    <Initials>KC</Initials>
                    <Affiliation>Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zeng</LastName>
                    <ForeName>Ming</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>National Institutes for Food and Drug Control, Beijing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mao</LastName>
                    <ForeName>Xu-Hu</ForeName>
                    <Initials>XH</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Shi-Ming</ForeName>
                    <Initials>SM</Initials>
                    <Affiliation>Department of Gastroenterology, XinQiao Hospital, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Guo</LastName>
                    <ForeName>Hong</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Gastroenterology, XinQiao Hospital, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Guo</LastName>
                    <ForeName>Gang</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Tao</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zuo</LastName>
                    <ForeName>Qian-Fei</ForeName>
                    <Initials>QF</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Hui-Jie</ForeName>
                    <Initials>HJ</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Liu-Yang</ForeName>
                    <Initials>LY</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mao</LastName>
                    <ForeName>Fang-Yuan</ForeName>
                    <Initials>FY</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lv</LastName>
                    <ForeName>Yi-Pin</ForeName>
                    <Initials>YP</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zou</LastName>
                    <ForeName>Quan-Ming</ForeName>
                    <Initials>QM</Initials>
                    <Affiliation>Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Gut</MedlineTA>
            <NlmUniqueID>2985108R</NlmUniqueID>
            <ISSNLinking>0017-5749</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">GASTRITIS</Keyword>
            <Keyword MajorTopicYN="N">HELICOBACTER PYLORI</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">gutjnl-2014-307020</ArticleId>
            <ArticleId IdType="doi">10.1136/gutjnl-2014-307020</ArticleId>
            <ArticleId IdType="pubmed">25134787</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25134760</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1525-2191</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>184</Volume>
                    <Issue>9</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The American journal of pathology</Title>
                <ISOAbbreviation>Am. J. Pathol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evidence that Meningeal Mast Cells Can Worsen Stroke Pathology in Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2493-504</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajpath.2014.06.003</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0002-9440(14)00324-1</ELocationID>
            <Abstract>
                <AbstractText>Stroke is the leading cause of adult disability and the fourth most common cause of death in the United States. Inflammation is thought to play an important role in stroke pathology, but the factors that promote inflammation in this setting remain to be fully defined. An understudied but important factor is the role of meningeal-located immune cells in modulating brain pathology. Although different immune cells traffic through meningeal vessels en route to the brain, mature mast cells do not circulate but are resident in the meninges. With the use of genetic and cell transfer approaches in mice, we identified evidence that meningeal mast cells can importantly contribute to the key features of stroke pathology, including infiltration of granulocytes and activated macrophages, brain swelling, and infarct size. We also obtained evidence that two mast cell-derived products, interleukin-6 and, to a lesser extent, chemokine (C-C motif) ligand 7, can contribute to stroke pathology. These findings indicate a novel role for mast cells in??the meninges, the membranes that envelop the brain, as potential gatekeepers for??modulating brain inflammation and pathology after stroke.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Arac</LastName>
                    <ForeName>Ahmet</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Neurosurgery, School of Medicine, Stanford University, Stanford, California; Stanford Stroke Center, School of Medicine, Stanford University, Stanford, California; Stanford Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford University, Stanford, California.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grimbaldeston</LastName>
                    <ForeName>Michele A</ForeName>
                    <Initials>MA</Initials>
                    <Affiliation>Stanford Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford University, Stanford, California; Division of Human Immunology, Center for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia; School of Molecular &amp; Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia. Electronic address: michele.grimbaldeston@unisa.edu.au.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nepomuceno</LastName>
                    <ForeName>Andrew R B</ForeName>
                    <Initials>AR</Initials>
                    <Affiliation>Department of Neurosurgery, School of Medicine, Stanford University, Stanford, California; Stanford Stroke Center, School of Medicine, Stanford University, Stanford, California; Stanford Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford University, Stanford, California.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Olayiwola</LastName>
                    <ForeName>Oluwatobi</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Department of Neurosurgery, School of Medicine, Stanford University, Stanford, California; Stanford Stroke Center, School of Medicine, Stanford University, Stanford, California; Stanford Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford University, Stanford, California.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pereira</LastName>
                    <ForeName>Marta P</ForeName>
                    <Initials>MP</Initials>
                    <Affiliation>Department of Neurosurgery, School of Medicine, Stanford University, Stanford, California; Stanford Stroke Center, School of Medicine, Stanford University, Stanford, California; Stanford Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford University, Stanford, California; Department of Molecular Biology and Center of Molecular Biology &quot;Severo Ochoa&quot;, Universidad Autonoma de Madrid, Madrid, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nishiyama</LastName>
                    <ForeName>Yasuhiro</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Neurosurgery, School of Medicine, Stanford University, Stanford, California; Stanford Stroke Center, School of Medicine, Stanford University, Stanford, California; Stanford Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford University, Stanford, California.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsykin</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Division of Human Immunology, Center for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia; School of Molecular &amp; Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goodall</LastName>
                    <ForeName>Gregory J</ForeName>
                    <Initials>GJ</Initials>
                    <Affiliation>Division of Human Immunology, Center for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia; School of Molecular &amp; Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schlecht</LastName>
                    <ForeName>Ulrich</ForeName>
                    <Initials>U</Initials>
                    <Affiliation>Department of Biochemistry, School of Medicine, Stanford University, Stanford, California.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vogel</LastName>
                    <ForeName>Hannes</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Stanford Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford University, Stanford, California; Department of Pathology, School of Medicine, Stanford University, Stanford, California.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsai</LastName>
                    <ForeName>Mindy</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Stanford Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford University, Stanford, California; Department of Pathology, School of Medicine, Stanford University, Stanford, California.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Galli</LastName>
                    <ForeName>Stephen J</ForeName>
                    <Initials>SJ</Initials>
                    <Affiliation>Stanford Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford University, Stanford, California; Department of Pathology, School of Medicine, Stanford University, Stanford, California; Department of Microbiology and Immunology, School of Medicine, Stanford University, Stanford, California. Electronic address: sgalli@stanford.edu.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bliss</LastName>
                    <ForeName>Tonya M</ForeName>
                    <Initials>TM</Initials>
                    <Affiliation>Department of Neurosurgery, School of Medicine, Stanford University, Stanford, California; Stanford Stroke Center, School of Medicine, Stanford University, Stanford, California; Stanford Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford University, Stanford, California. Electronic address: tbliss1@stanford.edu.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Steinberg</LastName>
                    <ForeName>Gary K</ForeName>
                    <Initials>GK</Initials>
                    <Affiliation>Department of Neurosurgery, School of Medicine, Stanford University, Stanford, California; Stanford Stroke Center, School of Medicine, Stanford University, Stanford, California; Stanford Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford University, Stanford, California. Electronic address: gsteinberg@stanford.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Pathol</MedlineTA>
            <NlmUniqueID>0370502</NlmUniqueID>
            <ISSNLinking>0002-9440</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0002-9440(14)00324-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ajpath.2014.06.003</ArticleId>
            <ArticleId IdType="pubmed">25134760</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134731</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1095-953X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurobiology of disease</Title>
                <ISOAbbreviation>Neurobiol. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0969-9961(14)00241-1</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.nbd.2014.08.010</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Approximately 20% of familial amyotrophic lateral sclerosis (FALS) cases are caused by mutant superoxide dismutase type 1 (mtSOD1). Although the mechanisms of mtSOD1-induced toxicity remain poorly understood, evidence suggests that accumulation of misfolded SOD1 is fundamental to its toxicity and the death of motor neurons. Misfolded mtSOD1 can accumulate inside the endoplasmic reticulum (ER), leading to ER stress, with activation of the unfolded protein response (UPR). We have previously carried out genetic studies focused on PERK (which is an eIF2?? kinase that is rapidly activated in response to ER stress and leads to a repression in translation) and GADD34 (which participates in the dephosphorylation of eIF2??). We reported that mtSOD1 transgenic mice that are haploinsufficient for PERK have a significantly accelerated ALS disease, while mtSOD1 mice that are haploinsufficient for GADD34 have a remarkably ameliorated disease. Guanabenz, a centrally acting oral drug approved for the treatment of hypertension, enhances the PERK pathway by selectively inhibiting GADD34-mediated dephosphorylation of eIF2??. We have now treated G93A mtSOD1 transgenic mice with guanabenz and found a significant amelioration of disease with a delay in the onset and prolongation of the early phase of disease and survival. Guanabenz-treated G93A mice have less accumulation of mtSOD1 and an enhanced phosphorylation of eIF2?? at endstage. This study further emphasizes the importance of the PERK pathway in the pathogenesis of FALS and as therapeutic targets in ALS, and identifies guanabenz as a candidate drug for the treatment of ALS patients.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Lijun</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Neurology/MC2030, The University of Chicago Pritzker School of Medicine, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Popko</LastName>
                    <ForeName>Brian</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Department of Neurology/MC2030, The University of Chicago Pritzker School of Medicine, 5841 S. Maryland Avenue, Chicago, IL 60637, USA; The University of Chicago Center for Peripheral Neuropathy, The University of Chicago Pritzker School of Medicine, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tixier</LastName>
                    <ForeName>Emily</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Department of Neurology/MC2030, The University of Chicago Pritzker School of Medicine, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Roos</LastName>
                    <ForeName>Raymond P</ForeName>
                    <Initials>RP</Initials>
                    <Affiliation>Department of Neurology/MC2030, The University of Chicago Pritzker School of Medicine, 5841 S. Maryland Avenue, Chicago, IL 60637, USA; The University of Chicago Center for Peripheral Neuropathy, The University of Chicago Pritzker School of Medicine, 5841 S. Maryland Avenue, Chicago, IL 60637, USA. Electronic address: rroos@neurology.bsd.uchicago.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>R01 NS034939</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neurobiol Dis</MedlineTA>
            <NlmUniqueID>9500169</NlmUniqueID>
            <ISSNLinking>0969-9961</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword>
            <Keyword MajorTopicYN="N">Superoxide dismutase type 1</Keyword>
            <Keyword MajorTopicYN="N">Unfolded protein response</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25134731</ArticleId>
            <ArticleId IdType="pii">S0969-9961(14)00241-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nbd.2014.08.010</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134730</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1095-953X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurobiology of disease</Title>
                <ISOAbbreviation>Neurobiol. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-?? agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0969-9961(14)00242-3</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.nbd.2014.08.011</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Neuroinflammatory changes play a pivotal role in the progression of Parkinson's disease (PD) pathogenesis. Recent findings have suggested that activated microglia may polarize similarly to peripheral macrophages in the central nervous system (CNS), assuming a pro-inflammatory M1 phenotype or the alternative anti-inflammatory M2 phenotype via cytokine production. A skewed M1 activation over M2 has been related to disease progression in Alzheimer disease, and modulation of microglia polarization may be a therapeutic target for neuroprotection. By using the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-probenecid (MPTPp) mouse model of progressive PD, we investigated dynamic changes in the production of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-?? and interleukin (IL)-1??, and anti-inflammatory cytokines, such as transforming growth factor (TGF)-?? and IL-10, within Iba-1-positive cells in the substantia nigra compacta (SNc). In addition, to further characterize changes in the M2 phenotype, we measured CD206 in microglia. Moreover, in order to target microglia polarization, we evaluated the effect of the peroxisome-proliferator-activated receptor (PPAR)-?? agonist rosiglitazone, which has been shown to exert neuroprotective effects on nigral dopaminergic neurons in PD models, and acts as a modulator of cytokine production and phenotype in peripheral macrophages. Chronic treatment with MPTPp induced a progressive degeneration of SNc neurons. The neurotoxin treatment was associated with a gradual increase in both TNF-?? and IL-1?? colocalization with Iba-1-positive cells, suggesting an increase in pro-inflammatory microglia. In contrast, TGF-?? colocalization was reduced by the neurotoxin treatment, while IL-10 was mostly unchanged. Administration of rosiglitazone during the full duration of MPTPp treatment reverted both TNF-?? and IL-1?? colocalization with Iba-1 to control levels. Moreover, rosiglitazone induced an increase in TGF-?? and IL-10 colocalization compared with the MPTPp treatment. CD206 was gradually reduced by the chronic MPTPp treatment, while rosiglitazone restored control levels, suggesting that M2 anti-inflammatory microglia were stimulated and inflammatory microglia were inhibited by the neuroprotective treatment. The results show that the dopaminergic degeneration was associated with a gradual microglia polarization to the inflammatory over the anti-inflammatory phenotype in a chronic mouse model of PD. Neuroprotective treatment with rosiglitazone modulated microglia polarization, boosting the M2 over the pro-inflammatory phenotype. PPAR-?? agonists may offer a novel approach to neuroprotection, acting as disease-modifying drugs through an immunomodulatory action in the CNS.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Pisanu</LastName>
                    <ForeName>Augusta</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>National Research Council, Institute of Neuroscience, via Ospedale 72, 09124 Cagliari, Italy. Electronic address: augustapisanu@tiscali.it.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lecca</LastName>
                    <ForeName>Daniela</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Biomedical Sciences, University of Cagliari, via Ospedale 72, 09124 Cagliari, Italy. Electronic address: d-lecca@yahoo.it.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mulas</LastName>
                    <ForeName>Giovanna</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Biomedical Sciences, University of Cagliari, via Ospedale 72, 09124 Cagliari, Italy. Electronic address: giovannamulas2@gmail.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wardas</LastName>
                    <ForeName>Jadwiga</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Neuropsychopharmacology, Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna St., 31-343 Krakow, Poland. Electronic address: wardas@if-pan.krakow.pl.</Affiliation>
                </Author>
                <Author>
                    <LastName>Simbula</LastName>
                    <ForeName>Gabriella</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Biomedical Sciences, University of Cagliari, via Ospedale 72, 09124 Cagliari, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Spiga</LastName>
                    <ForeName>Saturnino</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Life and Environmental Sciences, Via Fiorelli 1, 09126 Cagliari, Italy. Electronic address: sspiga@unica.it.</Affiliation>
                </Author>
                <Author>
                    <LastName>Carta</LastName>
                    <ForeName>Anna R</ForeName>
                    <Initials>AR</Initials>
                    <Affiliation>Department of Biomedical Sciences, University of Cagliari, via Ospedale 72, 09124 Cagliari, Italy. Electronic address: acarta@unica.it.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neurobiol Dis</MedlineTA>
            <NlmUniqueID>9500169</NlmUniqueID>
            <ISSNLinking>0969-9961</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cytokines</Keyword>
            <Keyword MajorTopicYN="N">MPTP</Keyword>
            <Keyword MajorTopicYN="N">Microglia</Keyword>
            <Keyword MajorTopicYN="N">Neuroprotection</Keyword>
            <Keyword MajorTopicYN="N">PPAR-??</Keyword>
            <Keyword MajorTopicYN="N">Parkinson's disease</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25134730</ArticleId>
            <ArticleId IdType="pii">S0969-9961(14)00242-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nbd.2014.08.011</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134728</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1095-953X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurobiology of disease</Title>
                <ISOAbbreviation>Neurobiol. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0969-9961(14)00240-X</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.nbd.2014.08.009</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Huntington's disease (HD) is caused by an expanded polyglutamine repeat in huntingtin protein that disrupts synaptic function in specific neuronal populations and results in characteristic motor, cognitive and affective deficits. Histopathological hallmarks observed in both HD patients and genetic mouse models include the reduced expression of synaptic proteins, reduced medium spiny neuron (MSN) dendritic spine density and decreased frequency of spontaneous excitatory post-synaptic currents (sEPSCs). Early down-regulation of cannabinoid CB1 receptor expression on MSN (CB1(MSN)) is thought to participate in HD pathogenesis. Here we present a cell-specific genetic rescue of CB1(MSN) in R6/2 mice and report that treatment prevents the reduction of excitatory synaptic markers in the striatum (synaptophysin, vGLUT1 and vGLUT2), of dendritic spine density on MSNs and of sEPSCs, but does not prevent motor impairment. We conclude that loss of excitatory striatal synapses in HD mice is controlled by CB1(MSN) and can be uncoupled from the motor phenotype.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Naydenov</LastName>
                    <ForeName>Alipi V</ForeName>
                    <Initials>AV</Initials>
                    <Affiliation>Medical Scientist Training Program, University of Washington, Seattle WA USA; Graduate Program in Neurobiology and Behavior, University of Washington, Seattle WA USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sepers</LastName>
                    <ForeName>Marja D</ForeName>
                    <Initials>MD</Initials>
                    <Affiliation>Department of Psychiatry, Brain Research Centre, University of British Columbia, Vancouver, BC, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Swinney</LastName>
                    <ForeName>Katie</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Pharmacology, University of Washington, Seattle WA USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Raymond</LastName>
                    <ForeName>Lynn A</ForeName>
                    <Initials>LA</Initials>
                    <Affiliation>Department of Psychiatry, Brain Research Centre, University of British Columbia, Vancouver, BC, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Palmiter</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Howard Hughes Medical Institute, Department of Biochemistry, University of Washington, Seattle WA USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Stella</LastName>
                    <ForeName>Nephi</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Pharmacology, University of Washington, Seattle WA USA. Electronic address: nstella@uw.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neurobiol Dis</MedlineTA>
            <NlmUniqueID>9500169</NlmUniqueID>
            <ISSNLinking>0969-9961</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CB1</Keyword>
            <Keyword MajorTopicYN="N">Huntington's disease</Keyword>
            <Keyword MajorTopicYN="N">R6/2 mice</Keyword>
            <Keyword MajorTopicYN="N">dendritic spines</Keyword>
            <Keyword MajorTopicYN="N">endocannabinoids</Keyword>
            <Keyword MajorTopicYN="N">synaptic loss</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0969-9961(14)00240-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nbd.2014.08.009</ArticleId>
            <ArticleId IdType="pubmed">25134728</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134718</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1756-0500</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC research notes</Title>
                <ISOAbbreviation>BMC Res Notes</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Analysis of high fat diet induced genes during mammary gland development: identifying role players in poor prognosis of breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>543</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Epidemiological studies have shown that consumption of a high-fat diet (HFD) increases the risk of developing breast cancer (BC). Studies in rodents have shown HFD causes changes in the genetic programming of the maturing mammary gland (MG) increasing the susceptibility of developing the disease. Less is known about how HFD induced genes impact BC development. HFD exposure two weeks before conception to six weeks of age was previously shown to dramatically change MG gene expression in 10 week old mice. Therefore, we investigated these differentially expressed HFD-induced genes for their expression in BC using the NKI 295 breast tumor dataset.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">To examine the potential role of HFD induced genes in BC, we first investigated whether these HFD-induced genes in mouse MGs were differentially expressed in different types of human BC. Of the 28 HFD induced genes that were differentially expressed between BC subtypes in the NKI set, 79% were significantly higher in basal-like BC. Next, we analyzed whether HFD induced genes were associated with BC prognosis utilizing gene expression and survival data for each HFD induced gene from the NKI data and constructed Kaplan Meier survival plots. Significantly, 93% of the prognosis associated genes (13/14) were associated with poor prognosis (P = 0.002). Kaplan Meier analysis with 249 non-basal-like BC found that all but one of the genes examined were still significantly associated with poor prognosis. Furthermore, gene set enrichment analysis (GSEA) with HFD microarray data revealed that invasive BC genes where enriched in HFD samples that also had lost expression of luminal genes.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">HFD exposed mouse MGs maintain differential expression of genes that are found highly expressed in basal-like breast cancer. These HFD-induced genes associate with poor survival in numerous BC subtypes, making them more likely to directly impact prognosis. Furthermore, HFD exposure leads to a loss in the expression of luminal genes and a gain in expression of mesenchymal and BC invasion genes in MGs. Collectively, our study suggests that HFD exposure during development induces genes associated with poor prognosis, thus identifying how HFD diet may regulate BC development.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Martinez-Chacin</LastName>
                    <ForeName>Raquel C</ForeName>
                    <Initials>RC</Initials>
                </Author>
                <Author>
                    <LastName>Keniry</LastName>
                    <ForeName>Megan</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Dearth</LastName>
                    <ForeName>Robert K</ForeName>
                    <Initials>RK</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>BMC Res Notes</MedlineTA>
            <NlmUniqueID>101462768</NlmUniqueID>
            <ISSNLinking>1756-0500</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1756-0500-7-543</ArticleId>
            <ArticleId IdType="doi">10.1186/1756-0500-7-543</ArticleId>
            <ArticleId IdType="pubmed">25134718</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25134715</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-1723</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Nature communications</Title>
                <ISOAbbreviation>Nat Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The MK2/3 cascade regulates AMPAR trafficking and cognitive flexibility.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4701</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/ncomms5701</ELocationID>
            <Abstract>
                <AbstractText>The interplay between long-term potentiation and long-term depression (LTD) is thought to be involved in learning and memory formation. One form of LTD expressed in the hippocampus is initiated by the activation of the group 1 metabotropic glutamate receptors (mGluRs). Importantly, mGluRs have been shown to be critical for acquisition of new memories and for reversal learning, processes that are thought to be crucial for cognitive flexibility. Here we provide evidence that MAPK-activated protein kinases 2 and 3 (MK2/3) regulate neuronal spine morphology, synaptic transmission and plasticity. Furthermore, mGluR-LTD is impaired in the hippocampus of MK2/3 double knockout (DKO) mice, an observation that is mirrored by deficits in endocytosis of GluA1 subunits. Consistent with compromised mGluR-LTD, MK2/3 DKO mice have distinctive deficits in hippocampal-dependent spatial reversal learning. These novel findings demonstrate that the MK2/3 cascade plays a strategic role in controlling synaptic plasticity and cognition.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Eales</LastName>
                    <ForeName>Katherine L</ForeName>
                    <Initials>KL</Initials>
                    <Affiliation>School of Life Sciences, University of Warwick, Coventry CV4 7AL, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Palygin</LastName>
                    <ForeName>Oleg</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>School of Life Sciences, University of Warwick, Coventry CV4 7AL, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Loughlin</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>School of Life Sciences, University of Warwick, Coventry CV4 7AL, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rasooli-Nejad</LastName>
                    <ForeName>Seyed</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>School of Life Sciences, University of Warwick, Coventry CV4 7AL, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gaestel</LastName>
                    <ForeName>Matthias</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute of Biochemistry, Hannover Medical University, 30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>M??ller</LastName>
                    <ForeName>J??rgen</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Collins</LastName>
                    <ForeName>Dawn R</ForeName>
                    <Initials>DR</Initials>
                    <Affiliation>Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pankratov</LastName>
                    <ForeName>Yuriy</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>School of Life Sciences, University of Warwick, Coventry CV4 7AL, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Corr??a</LastName>
                    <ForeName>Sonia A L</ForeName>
                    <Initials>SA</Initials>
                    <Affiliation>1] School of Life Sciences, University of Warwick, Coventry CV4 7AL, UK [2] School of Life Sciences, University of Bradford, Bradford BD7 1DP, UK.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Commun</MedlineTA>
            <NlmUniqueID>101528555</NlmUniqueID>
            <ISSNLinking>2041-1723</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ncomms5701</ArticleId>
            <ArticleId IdType="doi">10.1038/ncomms5701</ArticleId>
            <ArticleId IdType="pubmed">25134715</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134712</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1759-4766</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature reviews. Neurology</Title>
                <ISOAbbreviation>Nat Rev Neurol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Motor neuron disease: Suppression of microglial activation ameliorates symptoms in a mouse model of amyotrophic lateral sclerosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/nrneurol.2014.155</ELocationID>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Nat Rev Neurol</MedlineTA>
            <NlmUniqueID>101500072</NlmUniqueID>
            <ISSNLinking>1759-4758</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">nrneurol.2014.155</ArticleId>
            <ArticleId IdType="doi">10.1038/nrneurol.2014.155</ArticleId>
            <ArticleId IdType="pubmed">25134712</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134707</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1759-4766</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature reviews. Neurology</Title>
                <ISOAbbreviation>Nat Rev Neurol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Neuromuscular disease: Splicing modifiers alleviate spinal muscular atrophy in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/nrneurol.2014.151</ELocationID>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Nat Rev Neurol</MedlineTA>
            <NlmUniqueID>101500072</NlmUniqueID>
            <ISSNLinking>1759-4758</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">nrneurol.2014.151</ArticleId>
            <ArticleId IdType="doi">10.1038/nrneurol.2014.151</ArticleId>
            <ArticleId IdType="pubmed">25134707</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25134659</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCompleted>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1555-8932</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>9</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Genes &amp; nutrition</Title>
                <ISOAbbreviation>Genes Nutr</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The omega-3 fatty acid docosahexaenoic acid favorably modulates the inflammatory pathways and macrophage polarization within aorta of LDLR(-/-) mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>424</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12263-014-0424-4</ELocationID>
            <Abstract>
                <AbstractText>The omega-3 fatty acid docosahexaenoic acid (DHA) has potent anti-atherogenic properties but its mechanisms of action at the vascular level remain poorly explored. Knowing the broad range of molecular targets of omega-3 fatty acids, microarray analysis was used to open-mindedly evaluate the effects of DHA on aorta gene expression in LDLR(-/-) mice and better understand its local anti-atherogenic action. Mice were fed an atherogenic diet and received daily oral gavages with oils rich in oleic acid or DHA. Bioinformatics analysis of microarray data first identified inflammation and innate immunity as processes the most affected by DHA supplementation within aorta. More precisely, several down-regulated genes were associated with the inflammatory functions of macrophages (e.g., CCL5 and CCR7), cell movement (e.g., ICAM-2, SELP, and PECAM-1), and the major histocompatibility complex (e.g., HLA-DQA1 and HLA-DRB1). Interestingly, several genes were identified as specific biomarkers of macrophage polarization, and their changes suggested a preferential orientation toward a M2 reparative phenotype. This observation was supported by the upstream regulator analysis highlighting the involvement of three main regulators of macrophage polarization, namely PPAR?? (z-score??=??2.367, p??=??1.50??????10(-13)), INF?? (z-score??=??-2.797, p??=??2.81??????10(-14)), and NF??B (z-score??=??2.360, p??=??6.32??????10(-9)). Moreover, immunohistological analysis of aortic root revealed an increased abundance of Arg1 (+111??%, p??=??0.01), a specific biomarker of M2 macrophage. The present study showed for the first time that DHA supplementation during atherogenesis is associated with protective modulation of inflammation and innate immunity pathways within aorta putatively through the orientation of plaque macrophages toward a M2 reparative phenotype.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gladine</LastName>
                    <ForeName>C??cile</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>INRA, UMR1019, UNH, CRNH Auvergne, Clermont-Ferrand, France, cecile.gladine@clermont.inra.fr.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zmojdzian</LastName>
                    <ForeName>Monika</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joumard-Cubizolles</LastName>
                    <ForeName>Laurie</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Verny</LastName>
                    <ForeName>Marie-Anne</ForeName>
                    <Initials>MA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Comte</LastName>
                    <ForeName>Blandine</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mazur</LastName>
                    <ForeName>Andrzej</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Genes Nutr</MedlineTA>
            <NlmUniqueID>101280108</NlmUniqueID>
            <ISSNLinking>1555-8932</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12263-014-0424-4</ArticleId>
            <ArticleId IdType="pubmed">25134659</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134542</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1362-3095</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of radiation biology</Title>
                <ISOAbbreviation>Int. J. Radiat. Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cellular dosimetry calculations for Strontium-90 using Monte Carlo code PENELOPE.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-16</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Abstract Purpose: To improve risk assessments associated with chronic exposure to Strontium-90 (Sr-90), for both the environment and human health, it is necessary to know the energy distribution in specific cells or tissue. Monte Carlo (MC) simulations codes are extremely useful tools for calculating deposition energy. The present work is focused on the validation of the MC code PENetration and Energy LOss of Positrons and Electrons (PENELOPE) and the assessment of dose distribution to bone marrow cells from punctual Sr-90 source localized within the cortical bone part. Materials and methods: S-values (absorbed dose per unit cumulated activity) calculations using Monte Carlo simulations have been performed by using PENELOPE and Monte Carlo N-Particle eXtended (MCNPX). Cytoplasm, nucleus, cell surface, mouse femur bone and Sr-90 radiation source were simulated. Cells are assumed to be spherical with the radii of the cell and cell nucleus ranging from 2 to 10 ??m. The Sr-90 source is assumed to be uniformly distributed in cell nucleus, cytoplasm and Cell surface. Results: The comparison of S-values calculated with PENELOPE to MCNPX results and the Medical Internal Radiation Dose (MIRD) values agreed very well since the relative deviations are less than 4.5%. The dose distribution to mouse bone marrow cells shows that the cells localized near the cortical part received the maximum dose. Conclusion: The MC code PENELOPE may prove useful for cellular dosimetry involving radiation transport through materials other than water, or for complex distributions of radionuclides and geometries.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Hocine</LastName>
                    <ForeName>Nora</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Farlay</LastName>
                    <ForeName>Delphine</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Boivin</LastName>
                    <ForeName>Georges</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Franck</LastName>
                    <ForeName>Didier</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Agarande</LastName>
                    <ForeName>Michelle</ForeName>
                    <Initials>M</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Int J Radiat Biol</MedlineTA>
            <NlmUniqueID>8809243</NlmUniqueID>
            <ISSNLinking>0955-3002</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">MCNPX</Keyword>
            <Keyword MajorTopicYN="N">MIRD</Keyword>
            <Keyword MajorTopicYN="N">PENELOPE</Keyword>
            <Keyword MajorTopicYN="N">Sr-90</Keyword>
            <Keyword MajorTopicYN="N">cellular dosimetry</Keyword>
            <Keyword MajorTopicYN="N">validation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3109/09553002.2014.955144</ArticleId>
            <ArticleId IdType="pubmed">25134542</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134521</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1753-4267</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Innate immunity</Title>
                <ISOAbbreviation>Innate Immun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">1753425914542444</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Periodontal infections increase the risk of atherosclerotic vascular disease via partly unresolved mechanisms. Of the natural IgM Abs that recognize molecular mimicry on bacterial epitopes and modified lipid and protein structures, IgM directed against oxidized low-density lipoprotein (LDL) is associated with atheroprotective properties. Here, the effect of natural immune responses to malondialdehyde-modified LDL (MDA-LDL) in conferring protection against atherosclerosis, which was accelerated by the major periodontopathogen Porphyromonas gingivalis, was investigated. LDL receptor-deficient (LDLR(-/-)) mice were immunized with mouse MDA-LDL without adjuvant before topical application challenge with live P. gingivalis. Atherosclerosis was analyzed after a high-fat diet, and plasma IgG and IgM Ab levels were measured throughout the study, and the secretion of IL-5, IL-10 and IFN-?? in splenocytes stimulated with MDA-LDL was determined. LDLR(-/-) mice immunized with MDA-LDL had elevated IgM and IgG levels to MDA-LDL compared with saline-treated controls. MDA-LDL immunization diminished aortic lipid depositions after challenge with P. gingivalis compared with mice receiving only P. gingivalis challenge. Immunization of LDLR(-/-) mice with homologous MDA-LDL stimulated the production of IL-5, implicating general activation of B-1 cells. Immune responses to MDA-LDL protected from the P. gingivalis-accelerated atherosclerosis. Thus, the linkage between bacterial infectious burden and atherogenesis is suggested to be modulated via natural IgM directed against cross-reactive epitopes on bacteria and modified LDL.</AbstractText>
                <CopyrightInformation>?? The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Turunen</LastName>
                    <ForeName>S Pauliina</ForeName>
                    <Initials>SP</Initials>
                    <Affiliation>Department of Medical Microbiology and Immunology, Institute of Diagnostics, University of Oulu, Finland and Medical Research Center Oulu, Oulu, Finland NordLab Oulu, Oulu University Hospital, Oulu, Finland pauliina.turunen@helsinki.fi.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kummu</LastName>
                    <ForeName>Outi</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Department of Medical Microbiology and Immunology, Institute of Diagnostics, University of Oulu, Finland and Medical Research Center Oulu, Oulu, Finland NordLab Oulu, Oulu University Hospital, Oulu, Finland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Chunguang</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Medical Microbiology and Immunology, Institute of Diagnostics, University of Oulu, Finland and Medical Research Center Oulu, Oulu, Finland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Harila</LastName>
                    <ForeName>Kirsi</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Medical Microbiology and Immunology, Institute of Diagnostics, University of Oulu, Finland and Medical Research Center Oulu, Oulu, Finland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mattila</LastName>
                    <ForeName>Riikka</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Medical Microbiology and Immunology, Institute of Diagnostics, University of Oulu, Finland and Medical Research Center Oulu, Oulu, Finland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sahlman</LastName>
                    <ForeName>Marjo</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Medical Microbiology and Immunology, Institute of Diagnostics, University of Oulu, Finland and Medical Research Center Oulu, Oulu, Finland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pussinen</LastName>
                    <ForeName>Pirkko J</ForeName>
                    <Initials>PJ</Initials>
                    <Affiliation>Institute of Dentistry, University of Helsinki, Helsinki, Finland.</Affiliation>
                </Author>
                <Author>
                    <LastName>H??rkk??</LastName>
                    <ForeName>Sohvi</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Medical Microbiology and Immunology, Institute of Diagnostics, University of Oulu, Finland and Medical Research Center Oulu, Oulu, Finland NordLab Oulu, Oulu University Hospital, Oulu, Finland.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Innate Immun</MedlineTA>
            <NlmUniqueID>101469670</NlmUniqueID>
            <ISSNLinking>1753-4259</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Natural antibodies</Keyword>
            <Keyword MajorTopicYN="N">atherosclerosis</Keyword>
            <Keyword MajorTopicYN="N">innate immunity</Keyword>
            <Keyword MajorTopicYN="N">lipid peroxidation</Keyword>
            <Keyword MajorTopicYN="N">malondialdehyde</Keyword>
            <Keyword MajorTopicYN="N">periodontitis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1753425914542444</ArticleId>
            <ArticleId IdType="doi">10.1177/1753425914542444</ArticleId>
            <ArticleId IdType="pubmed">25134521</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25134515</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1744-4292</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular systems biology</Title>
                <ISOAbbreviation>Mol. Syst. Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Specificity, propagation, and memory of pericentric heterochromatin.</ArticleTitle>
            <Pagination>
                <MedlinePgn>746</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.15252/msb.20145377</ELocationID>
            <Abstract>
                <AbstractText>The cell establishes heritable patterns of active and silenced chromatin via interacting factors that set, remove, and read epigenetic marks. To understand how the underlying networks operate, we have dissected transcriptional silencing in pericentric heterochromatin (PCH) of mouse fibroblasts. We assembled a quantitative map for the abundance and interactions of 16 factors related to PCH in living cells and found that stably bound complexes of the histone methyltransferase SUV39H1/2 demarcate the PCH state. From the experimental data, we developed a predictive mathematical model that explains how chromatin-bound SUV39H1/2 complexes act as nucleation sites and propagate a spatially confined PCH domain with elevated histone H3 lysine 9 trimethylation levels via chromatin dynamics. This &quot;nucleation and looping&quot; mechanism is particularly robust toward transient perturbations and stably maintains the PCH state. These features make it an attractive model for establishing functional epigenetic domains throughout the genome based on the localized immobilization of chromatin-modifying enzymes.</AbstractText>
                <CopyrightInformation>?? 2014 The Authors. Published under the terms of the CC BY 4.0 license.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>M??ller-Ott</LastName>
                    <ForeName>Katharina</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Deutsches Krebsforschungszentrum (DKFZ) and BioQuant, Research Group Genome Organization &amp; Function, Heidelberg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Erdel</LastName>
                    <ForeName>Fabian</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Deutsches Krebsforschungszentrum (DKFZ) and BioQuant, Research Group Genome Organization &amp; Function, Heidelberg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matveeva</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Deutsches Krebsforschungszentrum (DKFZ) and BioQuant, Division Theoretical Systems Biology, Heidelberg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mallm</LastName>
                    <ForeName>Jan-Philipp</ForeName>
                    <Initials>JP</Initials>
                    <Affiliation>Deutsches Krebsforschungszentrum (DKFZ) and BioQuant, Research Group Genome Organization &amp; Function, Heidelberg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rademacher</LastName>
                    <ForeName>Anne</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Deutsches Krebsforschungszentrum (DKFZ) and BioQuant, Research Group Genome Organization &amp; Function, Heidelberg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hahn</LastName>
                    <ForeName>Matthias</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Munich Center for Integrated Protein Science and Adolf Butenandt Institute, Ludwig Maximilians University, Munich, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bauer</LastName>
                    <ForeName>Caroline</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Deutsches Krebsforschungszentrum (DKFZ) and BioQuant, Research Group Genome Organization &amp; Function, Heidelberg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Qin</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Deutsches Krebsforschungszentrum (DKFZ) and BioQuant, Division Theoretical Systems Biology, Heidelberg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaltofen</LastName>
                    <ForeName>Sabine</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Deutsches Krebsforschungszentrum (DKFZ) and BioQuant, Research Group Genome Organization &amp; Function, Heidelberg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schotta</LastName>
                    <ForeName>Gunnar</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Munich Center for Integrated Protein Science and Adolf Butenandt Institute, Ludwig Maximilians University, Munich, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>H??fer</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Deutsches Krebsforschungszentrum (DKFZ) and BioQuant, Division Theoretical Systems Biology, Heidelberg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rippe</LastName>
                    <ForeName>Karsten</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Deutsches Krebsforschungszentrum (DKFZ) and BioQuant, Research Group Genome Organization &amp; Function, Heidelberg, Germany karsten.rippe@dkfz.de.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Mol Syst Biol</MedlineTA>
            <NlmUniqueID>101235389</NlmUniqueID>
            <ISSNLinking>1744-4292</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">FRAP/FCS</Keyword>
            <Keyword MajorTopicYN="N">heterochromatin protein 1</Keyword>
            <Keyword MajorTopicYN="N">histone methylation</Keyword>
            <Keyword MajorTopicYN="N">pericentric heterochromatin</Keyword>
            <Keyword MajorTopicYN="N">protein network</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25134515</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134500</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-2072</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>20</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Psychopharmacology</Title>
                <ISOAbbreviation>Psychopharmacology (Berl.)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Differential effects of dopamine D1 and D 2/3 receptor antagonism on motor responses.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">The zebrafish dopaminergic system is thought to be evolutionarily conserved and may be amenable to pharmacological manipulation using drugs developed for mammalian receptors. However, only few studies have examined the role of specific receptor subtypes in behaviour of adult zebrafish.</AbstractText>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The objectives of this study are to determine the translational relevance of the zebrafish and examine the psychopharmacology of specific dopamine receptors in this species.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Using a behavioural pharmacological approach, we examine the effect of D1 and D2/3 receptor antagonisms on motor patterns of adult zebrafish during acute drug exposure and withdrawal.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Acute exposure to SCH-23390 (D1 receptor antagonist) decreased total distance travelled in a dose-dependent manner. Exposure to amisulpride (D2/3 receptor antagonist) induced a biphasic dose-response in total distance travelled and in angular velocity. The results provide support for the existence of structurally and functionally conserved postsynaptic D1 and D2 receptors, as well as presynaptic D2 autoreceptors in the zebrafish brain. The behavioural effects of the employed antagonists did not persist following 30??min of withdrawal.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results suggest that zebrafish, a cheaper and simpler model organism compared to the rat and the mouse, may be an efficient translationally relevant tool for the analysis of the psychopharmacology of receptors of the vertebrate dopaminergic system.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Tran</LastName>
                    <ForeName>Steven</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Cell and Systems Biology, University of Toronto Mississauga, 3359 Mississauga Road North, Rm 1022D, Mississauga, Ontario, L5L 1C6, Canada, stevenhuy.tran@mail.utoronto.ca.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nowicki</LastName>
                    <ForeName>Magda</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Muraleetharan</LastName>
                    <ForeName>Arrujyan</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Gerlai</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Psychopharmacology (Berl)</MedlineTA>
            <NlmUniqueID>7608025</NlmUniqueID>
            <ISSNLinking>0033-3158</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00213-014-3713-0</ArticleId>
            <ArticleId IdType="pubmed">25134500</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134489</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-0646</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Investigational new drugs</Title>
                <ISOAbbreviation>Invest New Drugs</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The anticancer activity of a novel pure 1,4-Diaryl-2-azetidinone (1), endowed with a higher solubility than the well known Combretastatin A4, is tested in mice. We previously reported that Compound (1) showed specific antiproliferative activity against duodenal and colon cancer cells, inducing activation of AMP-activated protein kinase and apoptosis. Here we estimate that the maximum tolerated dose in a mouse model is 40??mg/kg; the drug is well tolerated both in single dose and in repeated administration schedules. The drug displays a significant antitumor activity and a tumor growth delay when administered at the MTD both in single and fractionated i.v. administration in a mouse xenograft model of colorectal cancer. Arrest of tumor growth and relapse after drug suspension are parallel to modification in glucose demand as shown by PET studies with [(18)???F] FDG. These data strongly support Compound (1) as a promising molecule for in vivo treatment of colorectal cancer.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Valtorta</LastName>
                    <ForeName>Silvia</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>IBFM-CNR, Segrate, Milan, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nicolini</LastName>
                    <ForeName>Gabriella</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Tripodi</LastName>
                    <ForeName>Farida</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Meregalli</LastName>
                    <ForeName>Cristina</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Cavaletti</LastName>
                    <ForeName>Guido</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Avezza</LastName>
                    <ForeName>Federica</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Crippa</LastName>
                    <ForeName>Luca</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Bertoli</LastName>
                    <ForeName>Gloria</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Sanvito</LastName>
                    <ForeName>Francesca</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Fusi</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Pagliarin</LastName>
                    <ForeName>Roberto</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Orsini</LastName>
                    <ForeName>Fulvia</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Moresco</LastName>
                    <ForeName>Rosa Maria</ForeName>
                    <Initials>RM</Initials>
                </Author>
                <Author>
                    <LastName>Coccetti</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Invest New Drugs</MedlineTA>
            <NlmUniqueID>8309330</NlmUniqueID>
            <ISSNLinking>0167-6997</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10637-014-0148-8</ArticleId>
            <ArticleId IdType="pubmed">25134489</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134448</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1479-5876</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>12</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of translational medicine</Title>
                <ISOAbbreviation>J Transl Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Rapamycin protects kidney against ischemia reperfusion injury through recruitment of NKT cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>224</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">BackgroundNKT cells play a protective role in ischemia reperfusion (IR) injury, of which the trafficking in the body and recruitment in injured organs can be influenced by immunosuppressive therapy. Therefore, we investigated the effects of rapamycin on kidneys exposed to IR injury in early stage and on trafficking of NKT cells in a murine model.Material and methodsBalb/c mice were subjected to kidney 30??min ischemia followed by 24??h reperfusion. Rapamycin (2.5??ml/kg) was administered by gavage daily, starting 1??day before the operation. Renal function and histological changes were assessed. The proportion of NKT cells in peripheral blood, spleen and kidney was detected by flow cytometry. The chemokines and corresponding receptor involved in NKT cell trafficking were determined by RT-PCR and flow cytometry respectively.ResultsRapamycin significantly improved renal function and ameliorated histological injury. In rapamycin-treated group, the proportion of NKT cells in spleen was significantly decreased but increased in peripheral blood and kidney. In addition, the CXCR3+ NKT cell in the kidney increased remarkably in the rapamycin-treated group. The chemokines, CXCL9 and CXCL10, as the ligands of CXCR3, were also increased in the rapamycin-treated kidney.ConclusionsRapamycin may recruit NKT cells from spleen to the IR-induced kidney to ameliorate renal IR injury in the early stage.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Chao</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Zheng</LastName>
                    <ForeName>Long</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Long</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Lingyan</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Liping</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Shang</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Gu</LastName>
                    <ForeName>Chenli</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Lexi</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Cheng</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Zhu</LastName>
                    <ForeName>Tongyu</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Rong</LastName>
                    <ForeName>Ruiming</ForeName>
                    <Initials>R</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Transl Med</MedlineTA>
            <NlmUniqueID>101190741</NlmUniqueID>
            <ISSNLinking>1479-5876</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">s12967-014-0224-z</ArticleId>
            <ArticleId IdType="doi">10.1186/s12967-014-0224-z</ArticleId>
            <ArticleId IdType="pubmed">25134448</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134447</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1423-0127</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>21</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of biomedical science</Title>
                <ISOAbbreviation>J. Biomed. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The role of carbonic anhydrase VI in bitter taste perception: evidence from the.</ArticleTitle>
            <Pagination>
                <MedlinePgn>82</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">BackgroundCarbonic anhydrase VI (CA VI) is a secretory isozyme of the ??-CA gene family. It is highly expressed in the salivary and mammary glands and secreted into saliva and milk. Although CA VI was first described as a gustatory protein, its exact functional roles have remained enigmatic. Interestingly, polymorphism of the CA6 gene was recently linked to bitter taste perception in humans. In this study, we compared the preference of Car6 ??/?? and wild-type mice for different taste modalities in an IntelliCage monitoring environment. Morphologies of taste buds, tongue papillae, and von Ebner??s glands were evaluated by light microscopy. Cell proliferation and rate of apoptosis in tongue specimens were examined by Ki67 immunostaining and fluorescent DNA fragmentation staining, respectively.ResultsThe behavioral follow up of the mice in an IntelliCage system revealed that Car6 ??/?? mice preferred 3????M quinine (bitter) solution, whereas wild type mice preferred water. When the quinine concentration increased, both groups preferentially selected water. Histological analysis, Ki67 immunostaining and detection of apoptosis did not reveal any significant changes between tongue specimens of the knockout and wild type mice.ConclusionsOur knockout mouse model confirms that CA VI is involved in bitter taste perception. CA VI may be one of the factors which contribute to avoidance of bitter, potentially harmful, substances.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Patrikainen</LastName>
                    <ForeName>Maarit</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Pan</LastName>
                    <ForeName>Peiwen</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Kulesskaya</LastName>
                    <ForeName>Natalia</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Voikar</LastName>
                    <ForeName>Vootele</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author>
                    <LastName>Parkkila</LastName>
                    <ForeName>Seppo</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Biomed Sci</MedlineTA>
            <NlmUniqueID>9421567</NlmUniqueID>
            <ISSNLinking>1021-7770</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">s12929-014-0082-2</ArticleId>
            <ArticleId IdType="doi">10.1186/s12929-014-0082-2</ArticleId>
            <ArticleId IdType="pubmed">25134447</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25134439</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1537-2995</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Transfusion</Title>
                <ISOAbbreviation>Transfusion</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pathogen reduction by ultraviolet???C light effectively inactivates human white blood cells in platelet products.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/trf.12836</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Residual white blood cells (WBCs) in cellular blood components induce a variety of adverse immune events, including nonhemolytic febrile transfusion reactions, alloimmunization to HLA antigens, and transfusion-associated graft-versus-host disease (TA-GVHD). Pathogen reduction (PR) methods such as the ultraviolet C (UVC) light-based THERAFLEX UV-Platelets system were developed to reduce the risk of transfusion-transmitted infection. As UVC light targets nucleic acids, it interferes with the replication of both pathogens and WBCs. This preclinical study aimed to evaluate the ability of UVC light to inactivate contaminating WBCs in platelet concentrates (PCs).</AbstractText>
                <AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="METHODS">The in vitro and in vivo function of WBCs from UVC-treated PCs was compared to that of WBCs from gamma-irradiated and untreated PCs by measuring cell viability, proliferation, cytokine secretion, antigen presentation in vitro, and xenogeneic GVHD responses in a humanized mouse model.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">UVC light was at least as effective as gamma irradiation in preventing GVHD in the mouse model. It was more effective in suppressing T-cell proliferation (&gt;5-log reduction in the limiting dilution assay), cytokine secretion, and antigen presentation than gamma irradiation.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The THERAFLEX UV-Platelets (MacoPharma) PR system can substitute gamma irradiation for TA-GVHD prophylaxis in platelet (PLT) transfusion. Moreover, UVC treatment achieves suppression of antigen presentation and inhibition of cytokine accumulation during storage of PCs, which has potential benefits for transfusion recipients.</AbstractText>
                <CopyrightInformation>?? 2014 AABB.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Pohler</LastName>
                    <ForeName>Petra</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>German Red Cross Blood Service NSTOB, Institute Springe, Springe, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>M??ller</LastName>
                    <ForeName>Meike</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Winkler</LastName>
                    <ForeName>Carla</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Schaudien</LastName>
                    <ForeName>Dirk</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Sewald</LastName>
                    <ForeName>Katherina</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>M??ller</LastName>
                    <ForeName>Thomas H</ForeName>
                    <Initials>TH</Initials>
                </Author>
                <Author>
                    <LastName>Seltsam</LastName>
                    <ForeName>Axel</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Transfusion</MedlineTA>
            <NlmUniqueID>0417360</NlmUniqueID>
            <ISSNLinking>0041-1132</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/trf.12836</ArticleId>
            <ArticleId IdType="pubmed">25134439</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Process">
        <PMID Version="1">25134349</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0032-5422</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>60</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Postepy biochemii</Title>
                <ISOAbbreviation>Postepy Biochem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Aging and longevity].</ArticleTitle>
            <Pagination>
                <MedlinePgn>125-37</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>During the last three centuries the expected lifespan in civilized countries has increased several times. The fastest growing groups are seniors (65+) and centenarians. Increased lifespan results in postponing of aging and age-related diseases. On the other hand, an increase in the number of people suffering from age-related diseases can be observed. Studies concerning longevity and aging help to elucidate the mechanisms responsible for these processes and give hope for finding the recipe for a healthy and long lifespan. Aging and longevity are modulated by genetic, epigenetic and stochastic factors. Already some variants of genes which correlate with longevity are known. Products of these genes are involved in lipid metabolism and in nutrient sensing signaling pathways such as: insulin/IGF-1 and TOR. Good indicators for human polymorphism study are results obtained using model organisms such as S. cerevisiae, C. elegans, D. melanogaster and laboratory mice. Aging and longevity are evolutionary conserved. Evolutionary theories concerning aging can be divided into two general categories: programmed and non-programmed ones. According to programmed theories aging is adaptive and can lead to altruistic death of kins. Non-programmed theories predict that organisms only have a limited amount of energy that has to be divided between reproductive activities and the maintenance of the non-reproductive aspects of the organism. Aging is the effect of natural degrading processes that result in the accumulation of damage. Accumulation of damaged DNA and proteins can lead to cellular senescence, inflammaging and age-related diseases. Strategies for postponing aging mainly rely on protecting and/or eliminating these lesions.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sikora</LastName>
                    <ForeName>Ewa</ForeName>
                    <Initials>E</Initials>
                </Author>
            </AuthorList>
            <Language>pol</Language>
            <PublicationTypeList>
                <PublicationType>English Abstract</PublicationType>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <VernacularTitle>Starzenie i d??ugowieczno????.</VernacularTitle>
        </Article>
        <MedlineJournalInfo>
            <Country>Poland</Country>
            <MedlineTA>Postepy Biochem</MedlineTA>
            <NlmUniqueID>0023525</NlmUniqueID>
            <ISSNLinking>0032-5422</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25134349</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133938</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1742-2051</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular bioSystems</Title>
                <ISOAbbreviation>Mol Biosyst</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A bird's eye view of anisatin induced convulsive seizures in brain by a (1)H NMR based metabolic approach.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Anisatin is the main convulsant component in plants of the genus Illicium, many of which are important spices or folk medicines. The neurotoxicity of anisatin has been widely investigated, mainly focusing on its action on the ??-amino butyrate (GABA) system; however, little is known about the metabolic alterations that it causes. In this study, a NMR-based metabolomic approach was performed on the extracts of cortexes and cerebellums of mice administered with anisatin to explore the metabolic events associated with its intoxication. Orthogonal partial least squares-discriminant analysis (OPLS-DA) revealed many differential metabolites that indicated metabolic disturbance in neurotransmission and neuromodulation (GABA, glutamate, glutamine, and taurine), stress of reactive oxygen species (ROS) (ascorbate, phosphatidylcholine, choline, and ethanolamine), energy metabolism (NAD(+)i.e., nicotinamide-adenine dinucleotide, lactate, citrate, fumarate, creatine/phosphocreatine, and creatinine), amino acid metabolism (leucine, isoleucine, valine, phenylalanine, tyrosine, tryptophan, alanine, threonine, and glycine) and nucleic acid metabolism (NAD(+), nicotinamide/niacinamide, adenosine, and guanosine). This pilot metabolomic study on anisatin intoxication should help to develop a holistic view of convulsive seizures induced by anisatin, and provide a better understanding of the mechanisms.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wei</LastName>
                    <ForeName>Dan-Dan</ForeName>
                    <Initials>DD</Initials>
                    <Affiliation>State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, P. R. China. cpu_lykong@126.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ge-Dong</LastName>
                </Author>
                <Author>
                    <LastName>Guo</LastName>
                    <ForeName>Ping-Ping</ForeName>
                    <Initials>PP</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Jun-Song</ForeName>
                    <Initials>JS</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Ming-Hui</ForeName>
                    <Initials>MH</Initials>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Ming-Hua</ForeName>
                    <Initials>MH</Initials>
                </Author>
                <Author>
                    <LastName>Kong</LastName>
                    <ForeName>Ling-Yi</ForeName>
                    <Initials>LY</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Mol Biosyst</MedlineTA>
            <NlmUniqueID>101251620</NlmUniqueID>
            <ISSNLinking>1742-2051</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1039/c4mb00279b</ArticleId>
            <ArticleId IdType="pubmed">25133938</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133820</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Ca2+ Sensor Protein Swiprosin-1/EFhd2 Is Present in Neurites and Involved in Kinesin-Mediated Transport in Neurons.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e103976</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0103976</ELocationID>
            <Abstract>
                <AbstractText>Swiprosin-1/EFhd2 (EFhd2) is a cytoskeletal Ca2+ sensor protein strongly expressed in the brain. It has been shown to interact with mutant tau, which can promote neurodegeneration, but nothing is known about the physiological function of EFhd2 in the nervous system. To elucidate this question, we analyzed EFhd2-/-/lacZ reporter mice and showed that lacZ was strongly expressed in the cortex, the dentate gyrus, the CA1 and CA2 regions of the hippocampus, the thalamus, and the olfactory bulb. Immunohistochemistry and western blotting confirmed this pattern and revealed expression of EFhd2 during neuronal maturation. In cortical neurons, EFhd2 was detected in neurites marked by MAP2 and co-localized with pre- and post-synaptic markers. Approximately one third of EFhd2 associated with a biochemically isolated synaptosome preparation. There, EFhd2 was mostly confined to the cytosolic and plasma membrane fractions. Both synaptic endocytosis and exocytosis in primary hippocampal EFhd2-/- neurons were unaltered but transport of synaptophysin-GFP containing vesicles was enhanced in EFhd2-/- primary hippocampal neurons, and notably, EFhd2 inhibited kinesin mediated microtubule gliding. Therefore, we found that EFhd2 is a neuronal protein that interferes with kinesin-mediated transport.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Purohit</LastName>
                    <ForeName>Pavitra</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Division of Molecular Immunology, Dept. of Internal Medicine III, Universit??tsklinikum Erlangen, and Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perez-Branguli</LastName>
                    <ForeName>Francesc</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>IZKF Nachwuchsgruppe III, Universit??tsklinikum Erlangen, and Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prots</LastName>
                    <ForeName>Iryna</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>IZKF Nachwuchsgruppe III, Universit??tsklinikum Erlangen, and Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Borger</LastName>
                    <ForeName>Eva</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>School of Biology, Medical and Biological Sciences Building, University of St. Andrews, North Haugh, St Andrews, Fife, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gunn-Moore</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>School of Biology, Medical and Biological Sciences Building, University of St. Andrews, North Haugh, St Andrews, Fife, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Welzel</LastName>
                    <ForeName>Oliver</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Department of Psychiatry, Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Loy</LastName>
                    <ForeName>Kristina</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Psychiatry, Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wenzel</LastName>
                    <ForeName>Eva Maria</ForeName>
                    <Initials>EM</Initials>
                    <Affiliation>Department of Psychiatry, Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gr??mer</LastName>
                    <ForeName>Teja W</ForeName>
                    <Initials>TW</Initials>
                    <Affiliation>Department of Psychiatry, Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brachs</LastName>
                    <ForeName>Sebastian</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Division of Molecular Immunology, Dept. of Internal Medicine III, Universit??tsklinikum Erlangen, and Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Holzer</LastName>
                    <ForeName>Max</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Paul Flechsig Institute for Brain Research, University of Leipzig, Leipzig, Germany, and Leibniz Institute for Age Research, Jena, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Buslei</LastName>
                    <ForeName>Rolf</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Institute for Neuropathology, Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fritsch</LastName>
                    <ForeName>Kristin</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Division of Molecular Immunology, Dept. of Internal Medicine III, Universit??tsklinikum Erlangen, and Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Regensburger</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>IZKF Nachwuchsgruppe III, Universit??tsklinikum Erlangen, and Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany; Department of Neurology, Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>B??hm</LastName>
                    <ForeName>Konrad J</ForeName>
                    <Initials>KJ</Initials>
                    <Affiliation>Fritz Lipmann Institute, Molecular Motors Lab, Jena, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Winner</LastName>
                    <ForeName>Beate</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>IZKF Nachwuchsgruppe III, Universit??tsklinikum Erlangen, and Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mielenz</LastName>
                    <ForeName>Dirk</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Division of Molecular Immunology, Dept. of Internal Medicine III, Universit??tsklinikum Erlangen, and Friedrich-Alexander-Universit??t Erlangen-N??rnberg, Erlangen, Germany.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int Rev Cytol. 2002;214:103-59</RefSource>
                <PMID Version="1">11893164</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Mol Life Sci. 2013 Dec;70(24):4841-54</RefSource>
                <PMID Version="1">23959172</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1975 May;72(5):1858-62</RefSource>
                <PMID Version="1">1057175</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Biol. 1983 May;96(5):1374-88</RefSource>
                <PMID Version="1">6404912</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 1984 Jul 5-11;310(5972):56-8</RefSource>
                <PMID Version="1">6204208</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 1988 Apr;8(4):1454-68</RefSource>
                <PMID Version="1">3282038</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Tissue Res. 1995 Dec;282(3):423-33</RefSource>
                <PMID Version="1">8581936</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1996 May 14;93(10):4760-4</RefSource>
                <PMID Version="1">8643476</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Motil Cytoskeleton. 1997;37(3):226-31</RefSource>
                <PMID Version="1">9227852</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 1997 Sep;19(3):625-34</RefSource>
                <PMID Version="1">9331353</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Trends Neurosci. 1998 Aug;21(8):339-44</RefSource>
                <PMID Version="1">9720601</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2005 Mar 15;174(6):3508-17</RefSource>
                <PMID Version="1">15749887</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Neurosci. 2005 May;8(5):606-15</RefSource>
                <PMID Version="1">15834419</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Acta Neuropathol. 2007 May;113(5):585-90</RefSource>
                <PMID Version="1">17221204</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2007 May 4;316(5825):750-4</RefSource>
                <PMID Version="1">17478722</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Neurosci. 2007 Sep;8(9):663-72</RefSource>
                <PMID Version="1">17684513</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Death Differ. 2007 Nov;14(11):1936-47</RefSource>
                <PMID Version="1">17673920</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2008 Feb 13;28(7):1682-7</RefSource>
                <PMID Version="1">18272688</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2008 Feb 22;319(5866):1086-9</RefSource>
                <PMID Version="1">18202255</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Biol Int. 2008 May;32(5):588-90</RefSource>
                <PMID Version="1">18337130</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurochem. 2008 Jul;106(1):96-106</RefSource>
                <PMID Version="1">18346207</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Mol Biol. 2008 Sep 26;382(1):127-35</RefSource>
                <PMID Version="1">18640125</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Neurosci. 2009 May;10(5):319-32</RefSource>
                <PMID Version="1">19377501</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Pharmacol. 2009 Jun;9(3):297-305</RefSource>
                <PMID Version="1">19394273</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2010 Apr 1;184(7):3665-76</RefSource>
                <PMID Version="1">20194721</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Trends Neurosci. 2010 Jul;33(7):335-44</RefSource>
                <PMID Version="1">20434225</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cell Proteomics. 2011 Jan;10(1):M110.001172</RefSource>
                <PMID Version="1">20876399</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Trends Neurosci. 2011 Jun;34(6):326-37</RefSource>
                <PMID Version="1">21596448</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cytometry A. 2011 Jul;79(7):545-59</RefSource>
                <PMID Version="1">21674772</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur Biophys J. 2011 Sep;40(9):1061-9</RefSource>
                <PMID Version="1">21695534</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Sci. 2011 Oct 1;124(Pt 19):3266-78</RefSource>
                <PMID Version="1">21896648</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2011 Oct 28;147(3):690-703</RefSource>
                <PMID Version="1">22036573</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Signal. 2012 Feb;24(2):378-87</RefSource>
                <PMID Version="1">21982882</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Calcium. 2012 May;51(5):411-7</RefSource>
                <PMID Version="1">22317918</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2012 Jul 12;75(1):11-25</RefSource>
                <PMID Version="1">22794257</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Neurosci. 2013 Mar;14(3):161-76</RefSource>
                <PMID Version="1">23361386</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Protein Pept Lett. 2013 May;20(5):573-83</RefSource>
                <PMID Version="1">22973849</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurochem. 2013 Jun;125(6):921-31</RefSource>
                <PMID Version="1">23331044</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Monoclon Antib Immunodiagn Immunother. 2013 Aug;32(4):237-45</RefSource>
                <PMID Version="1">23909416</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(8):e71626</RefSource>
                <PMID Version="1">23977092</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Biol Int. 2003;27(3):251-3</RefSource>
                <PMID Version="1">12681326</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136728</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0103976</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-04678</ArticleId>
            <ArticleId IdType="pubmed">25133820</ArticleId>
            <ArticleId IdType="pmc">PMC4136728</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133801</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1557-7600</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medicinal food</Title>
                <ISOAbbreviation>J Med Food</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mechanisms of Analgesic and Anti-Inflammatory Properties of Annona muricata Linn. (Annonaceae) Fruit Extract in Rodents.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Abstract Unripe fruit of Annona muricata Linn. (Annonaceae) (soursop) is used in traditional African medicine for the treatment of neuralgia, rheumatism, and arthritic pain. This study sought to investigate the analgesic and anti-inflammatory effects of lyophilized fruit extract of Annona muricata (AM) in rodents. The analgesic activity was evaluated using the mouse writhing, formalin, and hot-plate tests while the anti-inflammatory action was investigated using the carrageenan-induced rat paw edema and xylene-induced ear edema tests. Pretreatment with AM (50, 100, and 200???mg/kg, p.o.) produced dose-dependent (P&lt;.001) inhibition of writhes and formalin-induced pain in the late phase. AM and morphine produced time-course increase in pain threshold in hot-plate test. However, the analgesic effect elicited by AM was reversed (P&lt;.05) by naloxone pretreatment. Similarly, the time-dependent increase in paw circumference induced by carrageenan was inhibited by AM treatment with peak effect (0.23??0.10???cm; P&lt;.001, 200???mg/kg; 6???h), which was comparatively similar to that of diclofenac treated. Further, the xylene-induced ear edema was significantly reduced by AM (50 or 100???mg/kg) pretreatment; however, the anti-inflammatory effect elicited by AM was prevented by pretreatment of mice with N(G)-nitro-l-arginine (20???mg/kg, i.p., nitric-oxide synthase inhibitor) 15???min before AM (200???mg/kg, p.o.). The in vitro cyclooxygenase assay also showed that AM produced concentration-dependent inhibition of both cyclooxygenase (COX)-1 and COX-2 activity by 39.44%??0.05% and 55.71%??0.12%, respectively, at 100 ??g/mL. In conclusion, A. muricata possesses analgesic effect through interaction with opioidergic pathway and anti-inflammatory property through inhibition of chemical mediators of inflammation.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ishola</LastName>
                    <ForeName>Ismail O</ForeName>
                    <Initials>IO</Initials>
                    <Affiliation>1 Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos , Idi-Araba Lagos, Nigeria .</Affiliation>
                </Author>
                <Author>
                    <LastName>Awodele</LastName>
                    <ForeName>Olufunsho</ForeName>
                    <Initials>O</Initials>
                </Author>
                <Author>
                    <LastName>Olusayero</LastName>
                    <ForeName>Abayomi Micheal</ForeName>
                    <Initials>AM</Initials>
                </Author>
                <Author>
                    <LastName>Ochieng</LastName>
                    <ForeName>Charles O</ForeName>
                    <Initials>CO</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Med Food</MedlineTA>
            <NlmUniqueID>9812512</NlmUniqueID>
            <ISSNLinking>1096-620X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">carrageenan</Keyword>
            <Keyword MajorTopicYN="N">cyclooxygenase</Keyword>
            <Keyword MajorTopicYN="N">formalin test</Keyword>
            <Keyword MajorTopicYN="N">inflammation</Keyword>
            <Keyword MajorTopicYN="N">naloxone</Keyword>
            <Keyword MajorTopicYN="N">nitric oxide</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1089/jmf.2013.0088</ArticleId>
            <ArticleId IdType="pubmed">25133801</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133741</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mice in bion-m 1 space mission: training and selection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e104830</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0104830</ELocationID>
            <Abstract>
                <AbstractText>After a 16-year hiatus, Russia has resumed its program of biomedical research in space, with the successful 30-day flight of the Bion-M 1 biosatellite (April 19-May 19, 2013). The principal species for biomedical research in this project was the mouse. This paper presents an overview of the scientific goals, the experimental design and the mouse training/selection program. The aim of mice experiments in the Bion-M 1 project was to elucidate cellular and molecular mechanisms, underlying the adaptation of key physiological systems to long-term exposure in microgravity. The studies with mice combined in vivo measurements, both in flight and post-flight (including continuous blood pressure measurement), with extensive in vitro studies carried out shortly after return of the mice and in the end of recovery study. Male C57/BL6 mice group housed in space habitats were flown aboard the Bion-M 1 biosatellite, or remained on ground in the control experiment that replicated environmental and housing conditions in the spacecraft. Vivarium control groups were used to account for housing effects and possible seasonal differences. Mice training included the co-adaptation in housing groups and mice adaptation to paste food diet. The measures taken to co-adapt aggressive male mice in housing groups and the peculiarities of &quot;space&quot; paste food are described. The training program for mice designated for in vivo studies was broader and included behavioral/functional test battery and continuous behavioral measurements in the home-cage. The results of the preliminary tests were used for the selection of homogenous groups. After the flight, mice were in good condition for biomedical studies and displayed signs of pronounced disadaptation to Earth's gravity. The outcomes of the training program for the mice welfare are discussed. We conclude that our training program was effective and that male mice can be successfully employed in space biomedical research.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Andreev-Andrievskiy</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Institute for Biomedical Problems, Russian Academy of Sciences, Moscow, Russia; Moscow State University, Biology Faculty, Moscow, Russia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Popova</LastName>
                    <ForeName>Anfisa</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Institute for Biomedical Problems, Russian Academy of Sciences, Moscow, Russia; Moscow State University, Biology Faculty, Moscow, Russia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boyle</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Bio-Visualization, Imaging and Simulation Technology Center (BioVIS), NASA Ames Research Center, Moffett Field, California, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alberts</LastName>
                    <ForeName>Jeffrey</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Indiana University, Department of Psychological and Brain Sciences, Bloomington, Indiana, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shenkman</LastName>
                    <ForeName>Boris</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Institute for Biomedical Problems, Russian Academy of Sciences, Moscow, Russia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vinogradova</LastName>
                    <ForeName>Olga</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Institute for Biomedical Problems, Russian Academy of Sciences, Moscow, Russia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dolgov</LastName>
                    <ForeName>Oleg</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Anokhin Institute of Normal Physiology, Russian Academy of Medical Sciences, Moscow, Russia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Anokhin</LastName>
                    <ForeName>Konstantin</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Anokhin Institute of Normal Physiology, Russian Academy of Medical Sciences, Moscow, Russia; Kurchatov NBIC-center, National Research Centre &quot;Kurchatov Institute&quot;, Moscow, Russia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsvirkun</LastName>
                    <ForeName>Darya</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Institute for Biomedical Problems, Russian Academy of Sciences, Moscow, Russia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soldatov</LastName>
                    <ForeName>Pavel</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Institute for Biomedical Problems, Russian Academy of Sciences, Moscow, Russia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nemirovskaya</LastName>
                    <ForeName>Tatyana</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Institute for Biomedical Problems, Russian Academy of Sciences, Moscow, Russia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ilyin</LastName>
                    <ForeName>Eugeniy</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Institute for Biomedical Problems, Russian Academy of Sciences, Moscow, Russia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sychev</LastName>
                    <ForeName>Vladimir</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Institute for Biomedical Problems, Russian Academy of Sciences, Moscow, Russia.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Pharmacol. 2000 Jul 14;400(1):59-66</RefSource>
                <PMID Version="1">10913585</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Physiol Behav. 2014 Jun 10;132:1-9</RefSource>
                <PMID Version="1">24802359</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurosci Lett. 2001 Jun 22;306(1-2):89-92</RefSource>
                <PMID Version="1">11403965</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pharmacol Biochem Behav. 2002 Aug;73(1):7-17</RefSource>
                <PMID Version="1">12076720</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>ILAR J. 2002;43(4):194-201</RefSource>
                <PMID Version="1">12391394</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Appl Physiol (1985). 2003 May;94(5):2085-94</RefSource>
                <PMID Version="1">12514166</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Appl Physiol (1985). 2003 Jul;95(1):73-80</RefSource>
                <PMID Version="1">12626488</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurotoxicol Teratol. 2003 Sep-Oct;25(5):543-53</RefSource>
                <PMID Version="1">12972067</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lab Anim. 2003 Oct;37(4):300-13</RefSource>
                <PMID Version="1">14599305</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Anat. 1990 Dec;173:87-95</RefSource>
                <PMID Version="1">2074233</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hypertension. 2005 Feb;45(2):299-310</RefSource>
                <PMID Version="1">15611363</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genes Brain Behav. 2006 Mar;5(2):139-49</RefSource>
                <PMID Version="1">16507005</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci Methods. 2006 Oct 15;157(1):82-90</RefSource>
                <PMID Version="1">16720049</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2933-41</RefSource>
                <PMID Version="1">16891405</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2008;3(12):e3923</RefSource>
                <PMID Version="1">19079590</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Appl Physiol (1985). 2009 Jun;106(6):1935-42</RefSource>
                <PMID Version="1">19342437</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Methods. 2010 Oct;7(10):825-6</RefSource>
                <PMID Version="1">20835246</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Brain Res. 2011 Jan 1;216(1):349-57</RefSource>
                <PMID Version="1">20732356</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lab Anim (NY). 2011 Apr;40(4):119-28</RefSource>
                <PMID Version="1">21427691</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(5):e32243</RefSource>
                <PMID Version="1">22666312</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FASEB J. 2013 Jan;27(1):399-409</RefSource>
                <PMID Version="1">23099650</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(9):e75097</RefSource>
                <PMID Version="1">24069384</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2014;9(3):e90012</RefSource>
                <PMID Version="1">24658028</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Gravit Physiol. 2000 Jan;7(1):S1-8</RefSource>
                <PMID Version="1">11543436</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136787</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0104830</ArticleId>
            <ArticleId IdType="pii">PONE-D-13-54586</ArticleId>
            <ArticleId IdType="pubmed">25133741</ArticleId>
            <ArticleId IdType="pmc">PMC4136787</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133713</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic Acid-induced animal model of autism.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e104927</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0104927</ELocationID>
            <Abstract>
                <AbstractText>Autism spectrum disorder (ASD) is a group of pervasive developmental disorders with core symptoms such as sociability deficit, language impairment, and repetitive/restricted behaviors. Although worldwide prevalence of ASD has been increased continuously, therapeutic agents to ameliorate the core symptoms especially social deficits, are very limited. In this study, we investigated therapeutic potential of donepezil for ASD using valproic acid-induced autistic animal model (VPA animal model). We found that prenatal exposure of valproic acid (VPA) induced dysregulation of cholinergic neuronal development, most notably the up-regulation of acetylcholinesterase (AChE) in the prefrontal cortex of affected rat and mouse offspring. Similarly, differentiating cortical neural progenitor cell in culture treated with VPA showed increased expression of AChE in vitro. Chromatin precipitation experiments revealed that acetylation of histone H3 bound to AChE promoter region was increased by VPA. In addition, other histone deacetyalse inhibitors (HDACIs) such as trichostatin A and sodium butyrate also increased the expression of AChE in differentiating neural progenitor cells suggesting the essential role of HDACIs in the regulation of AChE expression. For behavioral analysis, we injected PBS or donepezil (0.3 mg/kg) intraperitoneally to control and VPA mice once daily from postnatal day 14 all throughout the experiment. Subchronic treatment of donepezil improved sociability and prevented repetitive behavior and hyperactivity of VPA-treated mice offspring. Taken together, these results provide evidence that dysregulation of ACh system represented by the up-regulation of AChE may serve as an effective pharmacological therapeutic target against autistic behaviors in VPA animal model of ASD, which should be subjected for further investigation to verify the clinical relevance.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Ji-Woon</ForeName>
                    <Initials>JW</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Seung</LastName>
                    <ForeName>Hana</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kwon</LastName>
                    <ForeName>Kyung Ja</ForeName>
                    <Initials>KJ</Initials>
                    <Affiliation>Center for Neuroscience Research, Institute of Biomedical Science and Technology, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ko</LastName>
                    <ForeName>Mee Jung</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Eun Joo</ForeName>
                    <Initials>EJ</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oh</LastName>
                    <ForeName>Hyun Ah</ForeName>
                    <Initials>HA</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Choi</LastName>
                    <ForeName>Chang Soon</ForeName>
                    <Initials>CS</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Ki Chan</ForeName>
                    <Initials>KC</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gonzales</LastName>
                    <ForeName>Edson Luck</ForeName>
                    <Initials>EL</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>You</LastName>
                    <ForeName>Jueng Soo</ForeName>
                    <Initials>JS</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Choi</LastName>
                    <ForeName>Dong-Hee</ForeName>
                    <Initials>DH</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Jongmin</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Seol-Heui</ForeName>
                    <Initials>SH</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Sung Min</ForeName>
                    <Initials>SM</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cheong</LastName>
                    <ForeName>Jae Hoon</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Department of Pharmacology, College of Pharmacy, Sahmyook University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shin</LastName>
                    <ForeName>Chan Young</ForeName>
                    <Initials>CY</Initials>
                    <Affiliation>Department of Neuroscience, School of Medicine, Konkuk University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bahn</LastName>
                    <ForeName>Geon Ho</ForeName>
                    <Initials>GH</Initials>
                    <Affiliation>Department of Neuropsychiatry, School of Medicine, Kyung Hee University, Seoul, Korea.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuropsychopharmacology. 2014 Mar;39(4):831-40</RefSource>
                <PMID Version="1">24096295</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Child Adolesc Psychopharmacol. 2006 Oct;16(5):621-9</RefSource>
                <PMID Version="1">17069550</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Protoc. 2006;1(1):122-4</RefSource>
                <PMID Version="1">17406223</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Protoc. 2006;1(1):179-85</RefSource>
                <PMID Version="1">17406230</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Protoc. 2006;1(3):1306-11</RefSource>
                <PMID Version="1">17406415</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13501-6</RefSource>
                <PMID Version="1">17675408</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Dev Neurosci. 2007 Dec;25(8):515-21</RefSource>
                <PMID Version="1">17980995</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuropsychopharmacology. 2008 Mar;33(4):901-12</RefSource>
                <PMID Version="1">17507914</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genes Brain Behav. 2008 Mar;7(2):152-63</RefSource>
                <PMID Version="1">17559418</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2008;3(8):e3067</RefSource>
                <PMID Version="1">18728777</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychopharmacology (Berl). 2009 Jun;204(2):361-73</RefSource>
                <PMID Version="1">19189082</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Alzheimers Dis. 2009;17(1):161-76</RefSource>
                <PMID Version="1">19221411</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Brain Res. 2009 Dec 1;204(1):217-25</RefSource>
                <PMID Version="1">19527754</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2000 Jan 6;403(6765):41-5</RefSource>
                <PMID Version="1">10638745</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroscience. 2000;99(1):17-23</RefSource>
                <PMID Version="1">10924948</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dev Med Child Neurol. 2001 Mar;43(3):202-6</RefSource>
                <PMID Version="1">11263692</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurochem. 2001 Apr;77(2):638-46</RefSource>
                <PMID Version="1">11299326</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Psychiatry. 2001 Jul;158(7):1058-66</RefSource>
                <PMID Version="1">11431227</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2001 Sep 28;276(39):36734-41</RefSource>
                <PMID Version="1">11473107</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>EMBO J. 2001 Dec 17;20(24):6969-78</RefSource>
                <PMID Version="1">11742974</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Mol Neurosci. 2002 Feb-Apr;18(1-2):151-65</RefSource>
                <PMID Version="1">11931346</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Pharmacol. 2002 Feb;13(1):1-13</RefSource>
                <PMID Version="1">11990715</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain. 2002 Jul;125(Pt 7):1483-95</RefSource>
                <PMID Version="1">12076999</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Child Neurol. 2002 Apr;17(4):245-9</RefSource>
                <PMID Version="1">12088077</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Psychiatry. 2002;7(8):874-85</RefSource>
                <PMID Version="1">12232781</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Child Adolesc Psychopharmacol. 2002 Fall;12(3):237-41</RefSource>
                <PMID Version="1">12427297</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res Mol Brain Res. 2004 Apr 7;123(1-2):81-90</RefSource>
                <PMID Version="1">15046869</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychopharmacology (Berl). 2014 Mar;231(6):1023-36</RefSource>
                <PMID Version="1">23552907</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Psychiatry Med. 2003;33(4):395-8</RefSource>
                <PMID Version="1">15152789</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Drug Discov Today. 2014 Jul;19(7):838-44</RefSource>
                <PMID Version="1">24362109</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Genet. 2013 Dec;84(6):560-5</RefSource>
                <PMID Version="1">23350639</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurobiol Aging. 2004 Oct;25(9):1127-39</RefSource>
                <PMID Version="1">15312959</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lancet. 1986 Jun 14;1(8494):1392-3</RefSource>
                <PMID Version="1">2872511</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Epilepsia. 1992;33 Suppl 4:S41-8</RefSource>
                <PMID Version="1">1425493</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Med Genet. 1995 Sep;32(9):724-7</RefSource>
                <PMID Version="1">8544193</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 1997 Sep 25;389(6649):349-52</RefSource>
                <PMID Version="1">9311776</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):137-47</RefSource>
                <PMID Version="1">10071091</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuropsychopharmacology. 2005 Jan;30(1):80-9</RefSource>
                <PMID Version="1">15238991</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurobiol Dis. 2005 Aug;19(3):366-77</RefSource>
                <PMID Version="1">16023579</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Pharmacol Exp Ther. 2005 Oct;315(1):125-35</RefSource>
                <PMID Version="1">15951396</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 2006 Jul;63(7):786-94</RefSource>
                <PMID Version="1">16818868</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Alzheimers Dis. 2006 Sep;10(1):89-109</RefSource>
                <PMID Version="1">16988486</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Child Neurol. 2004 Mar;19(3):165-9</RefSource>
                <PMID Version="1">15119476</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychiatry Res. 2009 Nov 30;174(2):81-8</RefSource>
                <PMID Version="1">19833485</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuropsychopharmacology. 2010 Mar;35(4):976-89</RefSource>
                <PMID Version="1">20032969</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Neurosci. 2010 Jul;11(7):490-502</RefSource>
                <PMID Version="1">20559336</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Pharmacol. 2010 Sep;161(1):127-39</RefSource>
                <PMID Version="1">20718745</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicol Lett. 2011 Mar 5;201(2):137-42</RefSource>
                <PMID Version="1">21195144</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2011 Mar 2;31(9):3500-7</RefSource>
                <PMID Version="1">21368062</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Brain Res. 2011 Aug 10;221(2):564-73</RefSource>
                <PMID Version="1">20060022</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2011 Sep 30;147(1):235-46</RefSource>
                <PMID Version="1">21962519</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Med Genet A. 2011 Oct;155A(10):2386-96</RefSource>
                <PMID Version="1">22031302</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Neurosci. 2011 Dec;125(6):825-35</RefSource>
                <PMID Version="1">22122146</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Vis Exp. 2012;(59):e2607</RefSource>
                <PMID Version="1">22258546</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuropharmacology. 2012 Mar;62(3):1544-53</RefSource>
                <PMID Version="1">21156184</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dig Dis Sci. 2012 Apr;57(4):858-64</RefSource>
                <PMID Version="1">22052447</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Mol Genet. 2012 Oct 1;21(19):4286-300</RefSource>
                <PMID Version="1">22752306</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2012 Oct 4;76(1):116-29</RefSource>
                <PMID Version="1">23040810</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):E3687-95</RefSource>
                <PMID Version="1">23236169</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Med Genet. 2013 Feb;56(2):118-22</RefSource>
                <PMID Version="1">23253743</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(4):e62189</RefSource>
                <PMID Version="1">23638000</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Med. 2013 Jun;19(6):685-94</RefSource>
                <PMID Version="1">23744158</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Genomics Hum Genet. 2013;14:191-213</RefSource>
                <PMID Version="1">23875794</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Drug Discov. 2013 Oct;12(10):777-90</RefSource>
                <PMID Version="1">24080699</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Neurobiol. 2014 Feb;49(1):512-28</RefSource>
                <PMID Version="1">24030726</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136791</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0104927</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-07550</ArticleId>
            <ArticleId IdType="pubmed">25133713</ArticleId>
            <ArticleId IdType="pmc">PMC4136791</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133699</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A novel glycated hemoglobin a1c-lowering traditional chinese medicinal formula, identified by translational medicine study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e104650</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0104650</ELocationID>
            <Abstract>
                <AbstractText>Diabetes is a chronic metabolic disorder that has a significant impact on the health care system. The reduction of glycated hemoglobin A1c is highly associated with the improvements of glycemic control and diabetic complications. In this study, we identified a traditional Chinese medicinal formula with a HbA1c-lowering potential from clinical evidences. By surveying 9,973 diabetic patients enrolled in Taiwan Diabetic Care Management Program, we found that Chu-Yeh-Shih-Kao-Tang (CYSKT) significantly reduced HbA1c values in diabetic patients. CYSKT reduced the levels of HbA1c and fasting blood glucose, and stimulated the blood glucose clearance in type 2 diabetic mice. CYSKT affected the expressions of genes associated with insulin signaling pathway, increased the amount of phosphorylated insulin receptor in cells and tissues, and stimulated the translocation of glucose transporter 4. Moreover, CYSKT affected the expressions of genes related to diabetic complications, improved the levels of renal function indexes, and increased the survival rate of diabetic mice. In conclusion, this was a translational medicine study that applied a &quot;bedside-to-bench&quot; approach to identify a novel HbA1c-lowering formula. Our findings suggested that oral administration of CYSKT affected insulin signaling pathway, decreased HbA1c and blood glucose levels, and consequently reduced mortality rate in type 2 diabetic mice.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lo</LastName>
                    <ForeName>Hsin-Yi</ForeName>
                    <Initials>HY</Initials>
                    <Affiliation>Graduate Institute of Chinese Medicine, China Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hsiang</LastName>
                    <ForeName>Chien-Yun</ForeName>
                    <Initials>CY</Initials>
                    <Affiliation>Department of Microbiology, China Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Tsai-Chung</ForeName>
                    <Initials>TC</Initials>
                    <Affiliation>Graduate Institute of Biostatistics, China Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Chia-Cheng</ForeName>
                    <Initials>CC</Initials>
                    <Affiliation>Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Hui-Chi</ForeName>
                    <Initials>HC</Initials>
                    <Affiliation>Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Jaw-Chyun</ForeName>
                    <Initials>JC</Initials>
                    <Affiliation>Department of Medicinal Botany and Healthcare, Da-Yeh University, Changhua, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ho</LastName>
                    <ForeName>Tin-Yun</ForeName>
                    <Initials>TY</Initials>
                    <Affiliation>Graduate Institute of Chinese Medicine, China Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMJ. 2000 Aug 12;321(7258):405-12</RefSource>
                <PMID Version="1">10938048</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Agric Food Chem. 2013 Mar 13;61(10):2461-8</RefSource>
                <PMID Version="1">23414136</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Care. 2003 Apr;26(4):1277-94</RefSource>
                <PMID Version="1">12663610</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nutr. 2003 Nov;133(11):3369-77</RefSource>
                <PMID Version="1">14608046</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Genet. 2004 May;36(5):431-2</RefSource>
                <PMID Version="1">15118671</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 1976 Jun;57(6):1652-9</RefSource>
                <PMID Version="1">932199</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 1978 Apr 7;200(4337):21-7</RefSource>
                <PMID Version="1">635569</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br Med J (Clin Res Ed). 1981 Jun 6;282(6279):1823-4</RefSource>
                <PMID Version="1">6786635</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Horm Res. 1986;24(4):288-94</RefSource>
                <PMID Version="1">3096865</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 1990 Oct;30(3):281-94</RefSource>
                <PMID Version="1">2259216</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 1993 Sep 30;329(14):977-86</RefSource>
                <PMID Version="1">8366922</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Care. 1995 Oct;18(10):1373-5</RefSource>
                <PMID Version="1">8721940</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol. 1997 Jul;273(1 Pt 1):G217-26</RefSource>
                <PMID Version="1">9252529</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Metabolism. 1998 Jun;47(6):663-8</RefSource>
                <PMID Version="1">9627363</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lancet. 1998 Sep 12;352(9131):837-53</RefSource>
                <PMID Version="1">9742976</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 2005 Dec 22;353(25):2643-53</RefSource>
                <PMID Version="1">16371630</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes. 2006 Jun;55(6):1695-704</RefSource>
                <PMID Version="1">16731832</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):46-56</RefSource>
                <PMID Version="1">16860976</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Pathol. 2008 Sep;61(9):977-82</RefSource>
                <PMID Version="1">18755721</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Care. 2010 Jul;33(7):1665-73</RefSource>
                <PMID Version="1">20587727</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Care. 2011 Jun;34(6):1249-57</RefSource>
                <PMID Version="1">21617109</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lancet. 2011 Jul 2;378(9785):31-40</RefSource>
                <PMID Version="1">21705069</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(3):e31808</RefSource>
                <PMID Version="1">22412841</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes. 2012 Apr;61(4):933-43</RefSource>
                <PMID Version="1">22396199</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Expert Opin Pharmacother. 2012 Aug;13(12):1797-805</RefSource>
                <PMID Version="1">22775758</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lancet. 2012 Aug 4;380(9840):475-83</RefSource>
                <PMID Version="1">22748821</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2012 Aug 30;143(1):347-54</RefSource>
                <PMID Version="1">22776833</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Care. 2013 Jan;36 Suppl 1:S67-74</RefSource>
                <PMID Version="1">23264425</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2013 Jan 9;145(1):233-40</RefSource>
                <PMID Version="1">23147499</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Expert Opin Drug Saf. 2013 Mar;12(2):153-75</RefSource>
                <PMID Version="1">23241069</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Care. 2013 Apr;36(4):1033-46</RefSource>
                <PMID Version="1">23468086</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Carbohydr Polym. 2013 Apr 15;94(1):378-85</RefSource>
                <PMID Version="1">23544552</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2001 Dec 13;414(6865):799-806</RefSource>
                <PMID Version="1">11742412</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136774</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0104650</ArticleId>
            <ArticleId IdType="pii">PONE-D-13-55160</ArticleId>
            <ArticleId IdType="pubmed">25133699</ArticleId>
            <ArticleId IdType="pmc">PMC4136774</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133692</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Diabetes Mellitus Aggravates Hemorrhagic Transformation after Ischemic Stroke via Mitochondrial Defects Leading to Endothelial Apoptosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e103818</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0103818</ELocationID>
            <Abstract>
                <AbstractText>Diabetes is a crucial risk factor for stroke and is associated with increased frequency and poor prognosis. Although endothelial dysfunction is a known contributor of stroke, the underlying mechanisms have not been elucidated. The aim of this study was to elucidate the mechanism by which chronic hyperglycemia may contribute to the worsened prognosis following stroke, especially focusing on mitochondrial alterations. We examined the effect of hyperglycemia on hemorrhagic transformation at 24 hours after middle cerebral artery occlusion (MCAO) in streptozotocin (STZ) -induced diabetic mice. We also examined the effects of high-glucose exposure for 6 days on cell death, mitochondrial functions and morphology in human brain microvascular endothelial cells (HBMVECs) or human endothelial cells derived from induced pluripotent stem cells (iCell endothelial cells). Hyperglycemia aggravated hemorrhagic transformation, but not infarction following stroke. High-glucose exposure increased apoptosis, capase-3 activity, and release of apoptosis inducing factor (AIF) and cytochrome c in HBMVECs as well as affected mitochondrial functions (decreased cell proliferation, ATP contents, mitochondrial membrane potential, and increased matrix metalloproteinase (MMP)-9 activity, but not reactive oxygen species production). Furthermore, morphological aberration of mitochondria was observed in diabetic cells (a great deal of fragmentation, vacuolation, and cristae disruption). A similar phenomena were seen also in iCell endothelial cells. In conclusion, chronic hyperglycemia aggravated hemorrhagic transformation after stroke through mitochondrial dysfunction and morphological alteration, partially via MMP-9 activation, leading to caspase-dependent apoptosis of endothelial cells of diabetic mice. Mitochondria-targeting therapy may be a clinically innovative therapeutic strategy for diabetic complications in the future.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mishiro</LastName>
                    <ForeName>Keisuke</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Imai</LastName>
                    <ForeName>Takahiko</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sugitani</LastName>
                    <ForeName>Sou</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kitashoji</LastName>
                    <ForeName>Akira</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suzuki</LastName>
                    <ForeName>Yukiya</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Takagi</LastName>
                    <ForeName>Toshinori</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan; Departments of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Huayue</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Anatomy, Gifu University Graduate School of Medicine, Gifu, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oumi</LastName>
                    <ForeName>Yasunori</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Division of Instrument Analysis, Life Science Research Center, Gifu University, Gifu, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsuruma</LastName>
                    <ForeName>Kazuhiro</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shimazawa</LastName>
                    <ForeName>Masamitsu</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hara</LastName>
                    <ForeName>Hideaki</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stroke. 2001 Oct;32(10):2426-32</RefSource>
                <PMID Version="1">11588337</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neuroimmune Pharmacol. 2013 Sep;8(4):867-87</RefSource>
                <PMID Version="1">23673977</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2003 May 9;278(19):17190-7</RefSource>
                <PMID Version="1">12598526</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Circ Res. 2003 Sep 19;93(6):507-14</RefSource>
                <PMID Version="1">12933701</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Care. 2004 May;27(5):1047-53</RefSource>
                <PMID Version="1">15111519</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Med. 1983 Apr;74(4):540-4</RefSource>
                <PMID Version="1">6837584</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Care. 1993 Feb;16(2):434-44</RefSource>
                <PMID Version="1">8432214</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetologia. 1995 Sep;38(9):1061-8</RefSource>
                <PMID Version="1">8591820</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cereb Blood Flow Metab. 1996 Jul;16(4):605-11</RefSource>
                <PMID Version="1">8964799</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stroke. 1997 Jan;28(1):149-54</RefSource>
                <PMID Version="1">8996504</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):2007-12</RefSource>
                <PMID Version="1">9050895</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cereb Blood Flow Metab. 1997 May;17(5):553-9</RefSource>
                <PMID Version="1">9183293</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 1998 May 1;101(9):1905-15</RefSource>
                <PMID Version="1">9576755</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Care. 1999 Jul;22(7):1077-83</RefSource>
                <PMID Version="1">10388971</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2005 Jan 21;307(5708):384-7</RefSource>
                <PMID Version="1">15662004</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Care. 2005 Feb;28(2):355-9</RefSource>
                <PMID Version="1">15677792</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Neurosci. 2005 Oct;22(7):1597-608</RefSource>
                <PMID Version="1">16197500</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2653-8</RefSource>
                <PMID Version="1">16477035</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Metab Res Rev. 2006 May-Jun;22(3):198-203</RefSource>
                <PMID Version="1">16453381</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Biol. 2006 Jul 25;16(14):R551-60</RefSource>
                <PMID Version="1">16860735</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetologia. 2007 Jan;50(1):202-11</RefSource>
                <PMID Version="1">17143608</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cereb Blood Flow Metab. 2007 Mar;27(3):435-51</RefSource>
                <PMID Version="1">16804552</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem Biophys Res Commun. 2007 Jun 22;358(1):203-8</RefSource>
                <PMID Version="1">17475217</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Neurol. 2007;7:33</RefSource>
                <PMID Version="1">17937795</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochim Biophys Acta. 2008 Sep;1777(9):1092-7</RefSource>
                <PMID Version="1">18519024</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Biochem Cell Biol. 2009 Oct;41(10):1846-54</RefSource>
                <PMID Version="1">19703653</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes. 2009 Oct;58(10):2303-15</RefSource>
                <PMID Version="1">19581419</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes Res Clin Pract. 2010 Jan;87(1):4-14</RefSource>
                <PMID Version="1">19896746</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):607-18</RefSource>
                <PMID Version="1">20470749</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetologia. 2010 Aug;53(8):1783-94</RefSource>
                <PMID Version="1">20461356</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Pathol. 2010 Jul;177(1):447-55</RefSource>
                <PMID Version="1">20522647</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Transl Res. 2010 Jul;156(1):15-25</RefSource>
                <PMID Version="1">20621033</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stroke. 2010 Sep;41(9):2077-82</RefSource>
                <PMID Version="1">20671243</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurochem. 2011 Feb;116(4):499-507</RefSource>
                <PMID Version="1">21133923</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochim Biophys Acta. 2011 Jun;1813(6):1211-9</RefSource>
                <PMID Version="1">21435358</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurology. 2011 May 24;76(21):1831-7</RefSource>
                <PMID Version="1">21606455</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lancet. 2011 Jul 2;378(9785):31-40</RefSource>
                <PMID Version="1">21705069</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cardiovasc Diabetol. 2011;10:73</RefSource>
                <PMID Version="1">21816064</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann Neurol. 2011 Oct;70(4):583-90</RefSource>
                <PMID Version="1">22002675</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurochem. 2011 Dec;119(5):1029-40</RefSource>
                <PMID Version="1">21923664</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Mol Life Sci. 2012 Jan;69(1):115-28</RefSource>
                <PMID Version="1">21617913</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2012 Apr 6;287(15):12184-94</RefSource>
                <PMID Version="1">22351756</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes. 2012 Jun;61(6):1533-42</RefSource>
                <PMID Version="1">22403298</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroscience. 2012 Oct 11;222:326-32</RefSource>
                <PMID Version="1">22820263</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Urology. 2012 Nov;80(5):1162.e7-11</RefSource>
                <PMID Version="1">22951001</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Commun. 2013;4:1410</RefSource>
                <PMID Version="1">23361001</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2013 Mar 21;495(7441):389-93</RefSource>
                <PMID Version="1">23455425</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neuroinflammation. 2013;10:28</RefSource>
                <PMID Version="1">23414442</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stroke. 2013 Jun;44(6):1682-9</RefSource>
                <PMID Version="1">23592763</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes. 2002 Jan;51(1):198-203</RefSource>
                <PMID Version="1">11756341</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136737</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0103818</ArticleId>
            <ArticleId IdType="pii">PONE-D-13-53131</ArticleId>
            <ArticleId IdType="pubmed">25133692</ArticleId>
            <ArticleId IdType="pmc">PMC4136737</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133686</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Transferred BCR/ABL DNA from K562 Extracellular Vesicles Causes Chronic Myeloid Leukemia in Immunodeficient Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105200</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105200</ELocationID>
            <Abstract>
                <AbstractText>Our previous study showed that besides mRNAs and microRNAs, there are DNA fragments within extracellular vesicles (EVs). The BCR/ABL hybrid gene, involved in the pathogenesis of chronic myeloid leukemia (CML), could be transferred from K562 EVs to neutrophils and decrease their phagocytic activity in vitro. Our present study provides evidence that BCR/ABL DNAs transferred from EVs have pathophysiological significance in vivo. Two months after injection of K562 EVs into the tail vein of Sprague-Dawley (SD) rats, they showed some characteristics of CML, e.g., feeble, febrile, and thin, with splenomegaly and neutrophilia but with reduced neutrophil phagocytic activity. These findings were also observed in immunodeficient NOD/SCID mice treated with K562 EVs; BCR/ABL mRNA and protein were found in their neutrophils. The administration of actinomycin D, an inhibitor of de novo mRNA synthesis, prevented the abnormalities caused by K562 EVs in NOD/SCID mice related to CML, including neutrophilia and bone marrow hyperplasia. As a specific inhibitor of tyrosine kinases, imatinib blocked the activity of tyrosine kinases and the expression of phospho-Crkl, induced by the de novo BCR/ABL protein caused by K562 EVs bearing BCR/ABL DNA. Our current study shows the pathophysiological significance of transferred tumor gene from EVs in vivo, which may represent an important mechanism for tumorigenesis, tumor progression, and metastasis.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cai</LastName>
                    <ForeName>Jin</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China; Clinic of Health Service, Logistics Department, Air Force of Nanjing Area Command, Nanjing, Jiangsu, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Gengze</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>Xiaorong</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Caiyu</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Chuanwei</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Na</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zou</LastName>
                    <ForeName>Xue</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xinjian</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Faying</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>He</LastName>
                    <ForeName>Duofen</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Lin</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jose</LastName>
                    <ForeName>Pedro A</ForeName>
                    <Initials>PA</Initials>
                    <Affiliation>Division of Nephrology, Departments of Medicine and Physiology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zeng</LastName>
                    <ForeName>Chunyu</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2002 Jan 25;108(2):247-59</RefSource>
                <PMID Version="1">11832214</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Mol Cell Biol. 2013 Aug;5(4):227-38</RefSource>
                <PMID Version="1">23580760</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Leuk Res. 1998 Feb;22(2):115-7</RefSource>
                <PMID Version="1">9593467</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Cell Biol. 2008 Aug;20(4):470-5</RefSource>
                <PMID Version="1">18456488</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Biol. 2008 Dec 29;183(7):1187-91</RefSource>
                <PMID Version="1">19103810</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Inflamm Res. 2009 Jan;58(1):1-8</RefSource>
                <PMID Version="1">19132498</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Trends Cell Biol. 2009 Feb;19(2):43-51</RefSource>
                <PMID Version="1">19144520</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Kidney Int. 2010 Jul;78(2):191-9</RefSource>
                <PMID Version="1">20428099</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cell. 2010 Jul 9;39(1):133-44</RefSource>
                <PMID Version="1">20603081</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Res. 2011 Apr;49(1-3):227-34</RefSource>
                <PMID Version="1">21132466</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Biol. 2011 May 10;21(9):779-86</RefSource>
                <PMID Version="1">21514161</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Commun. 2011;2:180</RefSource>
                <PMID Version="1">21285958</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Angiogenesis. 2012 Mar;15(1):33-45</RefSource>
                <PMID Version="1">22203239</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Cell Biol. 2012 Mar;14(3):249-56</RefSource>
                <PMID Version="1">22327366</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Med Res Rev. 2012 Mar;32(2):326-48</RefSource>
                <PMID Version="1">22383180</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Med. 2012;18:159-66</RefSource>
                <PMID Version="1">22064971</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Mol Cell Biol. 2012 Aug;4(4):207-20</RefSource>
                <PMID Version="1">22467682</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Med. 2012 Jun;18(6):883-91</RefSource>
                <PMID Version="1">22635005</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Cell Biol. 2012 Oct;14(10):1036-45</RefSource>
                <PMID Version="1">22983114</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2013 May 23;153(5):1120-33</RefSource>
                <PMID Version="1">23683579</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosurg. 1993 Sep;79(3):400-7</RefSource>
                <PMID Version="1">8395592</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136837</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105200</ArticleId>
            <ArticleId IdType="pii">PONE-D-13-50220</ArticleId>
            <ArticleId IdType="pubmed">25133686</ArticleId>
            <ArticleId IdType="pmc">PMC4136837</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133679</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Activated CD8+ T Lymphocytes Inhibit Neural Stem/Progenitor Cell Proliferation: Role of Interferon-Gamma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105219</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105219</ELocationID>
            <Abstract>
                <AbstractText>The ability of neural stem/progenitor cells (NSCs) to self-renew, migrate to damaged sites, and differentiate into neurons has renewed interest in using them in therapies for neurodegenerative disorders. Neurological diseases, including viral infections of the brain, are often accompanied by chronic inflammation, whose impact on NSC function remains unexplored. We have previously shown that chronic neuroinflammation, a hallmark of experimental herpes simplex encephalitis (HSE) in mice, is dominated by brain-infiltrating activated CD8 T-cells. In the present study, activated CD8 lymphocytes were found to suppress NSC proliferation profoundly. Luciferase positive (luc+) NSCs co-cultured with activated, MHC-matched, CD8+ lymphocytes (luc-) showed two- to five-fold lower luminescence than co-cultures with un-stimulated lymphocytes. On the other hand, similarly activated CD4+ lymphocytes did not suppress NSC growth. This differential lymphocyte effect on proliferation was confirmed by decreased BrdU uptake by NSC cultured with activated CD8 T-cells. Interestingly, neutralizing antibodies to interferon-gamma (IFN-??) reversed the impact of CD8 lymphocytes on NSCs. Antibodies specific to the IFN-?? receptor-1 subunit complex abrogated the inhibitory effects of both CD8 lymphocytes and IFN-??, indicating that the inhibitory effect of these cells was mediated by IFN-?? in a receptor-specific manner. In addition, activated CD8 lymphocytes decreased levels of nestin and Sox2 expression in NSCs while increasing GFAP expression, suggesting possible induction of an altered differentiation state. Furthermore, NSCs obtained from IFN-?? receptor-1 knock-out embryos were refractory to the inhibitory effects of activated CD8+ T lymphocytes on cell proliferation and Sox2 expression. Taken together, the studies presented here demonstrate a role for activated CD8 T-cells in regulating NSC function mediated through the production of IFN-??. This cytokine may influence neuro-restorative processes and ultimately contribute to the long-term sequelae commonly seen following herpes encephalitis.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Shuxian</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Center for Infectious Diseases and Microbiology Translational Research, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rotschafer</LastName>
                    <ForeName>Jessica H</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Department of Veterinary Population Medicine, College of Veterinary Medicine, St. Paul, Minnesota, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lokensgard</LastName>
                    <ForeName>James R</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>Center for Infectious Diseases and Microbiology Translational Research, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cheeran</LastName>
                    <ForeName>Maxim C-J</ForeName>
                    <Initials>MC</Initials>
                    <Affiliation>Center for Infectious Diseases and Microbiology Translational Research, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America; Department of Veterinary Population Medicine, College of Veterinary Medicine, St. Paul, Minnesota, United States of America.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurovirol. 2008 Oct;14(5):437-47</RefSource>
                <PMID Version="1">18937121</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Behav Immun. 2008 Aug;22(6):861-9</RefSource>
                <PMID Version="1">18249087</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurosci Res. 2009 Mar;63(3):155-64</RefSource>
                <PMID Version="1">19118585</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurochem. 2009 Mar;108(6):1343-59</RefSource>
                <PMID Version="1">19154336</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Med. 2009 Aug;15(8):946-50</RefSource>
                <PMID Version="1">19648929</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroscience. 2010 Feb 17;165(4):1203-16</RefSource>
                <PMID Version="1">19895873</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurobiol Dis. 2010 Feb;37(2):267-74</RefSource>
                <PMID Version="1">19909815</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2010 Apr 7;30(14):5020-7</RefSource>
                <PMID Version="1">20371822</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2010 May 6;115(18):3835-42</RefSource>
                <PMID Version="1">20215643</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2010 Jul 7;30(27):9038-50</RefSource>
                <PMID Version="1">20610738</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci Res. 2010 Aug 15;88(11):2385-97</RefSource>
                <PMID Version="1">20623538</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Pathol. 2010 Jul;20(4):738-50</RefSource>
                <PMID Version="1">20002440</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Stem Cells. 2010;5(1):23-31</RefSource>
                <PMID Version="1">20861925</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Behav Immun. 2011 Feb;25(2):181-213</RefSource>
                <PMID Version="1">20970492</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann Neurol. 2011 Jan;69(1):119-29</RefSource>
                <PMID Version="1">21280082</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurochem. 2008 Aug;106(4):1624-36</RefSource>
                <PMID Version="1">18540995</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells. 2008 Sep;26(9):2444-54</RefSource>
                <PMID Version="1">18635871</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain. 2008 Oct;131(Pt 10):2564-78</RefSource>
                <PMID Version="1">18757884</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2008 Nov 1;181(9):6417-26</RefSource>
                <PMID Version="1">18941232</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurochem. 2011 Mar;116(6):947-56</RefSource>
                <PMID Version="1">21198642</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4194-9</RefSource>
                <PMID Version="1">21325059</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res. 2011 Apr 6;1383:187-95</RefSource>
                <PMID Version="1">21354115</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2011 May 26;70(4):687-702</RefSource>
                <PMID Version="1">21609825</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Respir Cell Mol Biol. 2011 Jul;45(1):101-10</RefSource>
                <PMID Version="1">20855650</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurovirol. 2011 Oct;17(5):424-37</RefSource>
                <PMID Version="1">21800103</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Behav Immun. 2012 Jan;26(1):1-10</RefSource>
                <PMID Version="1">21664452</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(3):e33143</RefSource>
                <PMID Version="1">22412996</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Struct Funct. 2012 Apr;217(2):411-20</RefSource>
                <PMID Version="1">21706330</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stroke. 2012 Jul;43(7):1941-6</RefSource>
                <PMID Version="1">22678086</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Neurosci. 2012 Aug;15(8):1078-87</RefSource>
                <PMID Version="1">22837038</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem J. 2013 Mar 15;450(3):e1-2</RefSource>
                <PMID Version="1">23445224</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Stem Cell. 2013 Apr 4;12(4):440-52</RefSource>
                <PMID Version="1">23499385</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E3017-26</RefSource>
                <PMID Version="1">23884650</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurobiol Dis. 2013 Oct;58:144-55</RefSource>
                <PMID Version="1">23748078</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann Neurol. 2008 Oct;64(4):417-27</RefSource>
                <PMID Version="1">18991353</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2000 Feb 25;287(5457):1433-8</RefSource>
                <PMID Version="1">10688783</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2001 Mar 1;410(6824):101-5</RefSource>
                <PMID Version="1">11242050</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2001 Oct 15;194(8):1069-80</RefSource>
                <PMID Version="1">11602637</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Med. 2002 Sep;8(9):963-70</RefSource>
                <PMID Version="1">12161747</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neuroimmunol. 2003 Aug;141(1-2):90-8</RefSource>
                <PMID Version="1">12965258</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2004 Mar 4;41(5):683-6</RefSource>
                <PMID Version="1">15003168</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Neurol. 2004 May;187(1):171-7</RefSource>
                <PMID Version="1">15081598</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 2004 Jun;34(6):1617-26</RefSource>
                <PMID Version="1">15162431</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2004 May 25;101(21):8180-5</RefSource>
                <PMID Version="1">15141078</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Trends Neurosci. 2004 Aug;27(8):447-52</RefSource>
                <PMID Version="1">15271491</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res Dev Brain Res. 2004 Sep 17;152(2):159-69</RefSource>
                <PMID Version="1">15351504</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Immunol. 1997;15:563-91</RefSource>
                <PMID Version="1">9143700</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci Res. 2005 Dec 15;82(6):839-50</RefSource>
                <PMID Version="1">16273540</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2006 Jan 18;26(3):731-41</RefSource>
                <PMID Version="1">16421293</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Neurosci. 2006 Feb;9(2):268-75</RefSource>
                <PMID Version="1">16415867</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurol Res. 2006 Jul;28(5):488-92</RefSource>
                <PMID Version="1">16808877</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurochem Res. 2007 Aug;32(8):1399-406</RefSource>
                <PMID Version="1">17415631</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2007 Jul 20;317(5836):381-4</RefSource>
                <PMID Version="1">17615304</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cereb Blood Flow Metab. 2007 Nov;27(11):1798-805</RefSource>
                <PMID Version="1">17392692</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neuroimmunol. 2009 Jan 3;206(1-2):32-8</RefSource>
                <PMID Version="1">19027965</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136865</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>8</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105219</ArticleId>
            <ArticleId IdType="pii">PONE-D-13-34922</ArticleId>
            <ArticleId IdType="pubmed">25133679</ArticleId>
            <ArticleId IdType="pmc">PMC4136865</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133649</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-1705</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International immunopharmacology</Title>
                <ISOAbbreviation>Int. Immunopharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Potential therapeutic utility of mesenchymal stem cells in inflammatory bowel disease in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1567-5769(14)00307-5</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.intimp.2014.07.030</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Mesenchymal stem cells (MSCs) were found to provide an effective therapeutic role in inflammatory diseases by modulating inflammatory responses and tissue regeneration by their differentiation ability. The present work sought to demonstrate the potential therapeutic use of MSCs in treating chronic inflammatory bowel disease (IBD) in mice. A new model to induce chronic IBD based on alternative administration periods of Dextran Sodium Sulfate (DSS). Mice were divided into 2 groups; one was treated with MSCs and the other was treated with phosphate-buffered saline (PBS). Assessment of therapeutic efficacy of MSCs was by measuring weight, stool scoring, histopathologic examination, and measuring the gene expression of inflammatory markers: Interleukin-23 (IL-23), Tumor necrosis factor-?? (TNF-??), Interferon-?? (IFN-??), and Intercellular adhesion molecule-1 (ICAM-1). The results showed that DSS administration causes bloody and watery stool, weight loss, and altered histopathologic picture. MSC treated mice showed a significant improvement in stool condition, weight gain, and normal histopathologic picture compared to the PBS treated mice. Moreover, gene expressions of inflammatory markers in the intestines of the MSC treated mice were also significantly lower than those of the PBS treated mice. In conclusion, the data here showed that MSCs have a clear potential efficacy in the treatment for IBD, as their immune modulation effects include inhibition in the expression of key inflammatory markers that each plays an important role in the pathogenesis of IBD.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Salam</LastName>
                    <ForeName>Ahmed Gouda Abdel Rahman Abdel</ForeName>
                    <Initials>AG</Initials>
                    <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Misr International University, Cairo, Egypt. Electronic address: ahmed.gouda@miuegypt.edu.eg.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ata</LastName>
                    <ForeName>Hazem M</ForeName>
                    <Initials>HM</Initials>
                    <Affiliation>Department of Biochemistry, Faculty of Medicine, Cairo University, Egypt.</Affiliation>
                </Author>
                <Author>
                    <LastName>Salman</LastName>
                    <ForeName>Tarek M</ForeName>
                    <Initials>TM</Initials>
                    <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Al Azhar University, Cairo, Egypt.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rashed</LastName>
                    <ForeName>Laila A</ForeName>
                    <Initials>LA</Initials>
                    <Affiliation>Department of Biochemistry, Faculty of Medicine, Cairo University, Egypt.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sabry</LastName>
                    <ForeName>Dina</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Biochemistry, Faculty of Medicine, Cairo University, Egypt.</Affiliation>
                </Author>
                <Author>
                    <LastName>Schaalan</LastName>
                    <ForeName>Mona F</ForeName>
                    <Initials>MF</Initials>
                    <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Misr International University, Cairo, Egypt.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Int Immunopharmacol</MedlineTA>
            <NlmUniqueID>100965259</NlmUniqueID>
            <ISSNLinking>1567-5769</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adhesion molecules</Keyword>
            <Keyword MajorTopicYN="N">Bone marrow derived mesenchymal stem cell transplantation</Keyword>
            <Keyword MajorTopicYN="N">DSS induced colitis</Keyword>
            <Keyword MajorTopicYN="N">Immunomodulation</Keyword>
            <Keyword MajorTopicYN="N">Interferon</Keyword>
            <Keyword MajorTopicYN="N">Interleukin</Keyword>
            <Keyword MajorTopicYN="N">Tumor necrosis factors</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1567-5769(14)00307-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.intimp.2014.07.030</ArticleId>
            <ArticleId IdType="pubmed">25133649</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133611</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mst1 Directs Myosin IIa Partitioning of Low and Higher Affinity Integrins during T Cell Migration.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105561</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105561</ELocationID>
            <Abstract>
                <AbstractText>Chemokines promote T cell migration by transmitting signals that induce T cell polarization and integrin activation and adhesion. Mst1 kinase is a key signal mediator required for both of these processes; however, its molecular mechanism remains unclear. Here, we present a mouse model in which Mst1 function is disrupted by a hypomorphic mutation. Microscopic analysis of Mst1-deficient CD4 T cells revealed a necessary role for Mst1 in controlling the localization and activity of Myosin IIa, a molecular motor that moves along actin filaments. Using affinity specific LFA-1 antibodies, we identified a requirement for Myosin IIa-dependent contraction in the precise spatial distribution of low and higher affinity LFA-1 on the membrane of migrating T cells. Mst1 deficiency or Myosin inhibition resulted in multipolar cells, difficulties in uropod detachment and mis-localization of low affinity LFA-1. Thus, Mst1 regulates Myosin IIa dynamics to organize high and low affinity LFA-1 to the anterior and posterior membrane during T cell migration.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Xiaolu</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Pathology and Immunology, Washington University, St. Louis, Missouri, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jaeger</LastName>
                    <ForeName>Emily R</ForeName>
                    <Initials>ER</Initials>
                    <Affiliation>Department of Pathology and Immunology, Washington University, St. Louis, Missouri, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Xinxin</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Pathology and Immunology, Washington University, St. Louis, Missouri, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lagler-Ferrez</LastName>
                    <ForeName>Erica</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Batalov</LastName>
                    <ForeName>Serge</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mathis</LastName>
                    <ForeName>Nancy L</ForeName>
                    <Initials>NL</Initials>
                    <Affiliation>Department of Pathology and Immunology, Washington University, St. Louis, Missouri, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wiltshire</LastName>
                    <ForeName>Tim</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Walker</LastName>
                    <ForeName>John R</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cooke</LastName>
                    <ForeName>Michael P</ForeName>
                    <Initials>MP</Initials>
                    <Affiliation>Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sauer</LastName>
                    <ForeName>Karsten</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Yina H</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Department of Pathology and Immunology, Washington University, St. Louis, Missouri, United States of America; Departments of Pathology and Microbiology &amp; Immunology, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, United States of America.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 2000 Oct 5;343(14):1020-34</RefSource>
                <PMID Version="1">11018170</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Rev. 2013 Nov;256(1):95-106</RefSource>
                <PMID Version="1">24117815</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2002 Sep 6;110(5):599-11</RefSource>
                <PMID Version="1">12230977</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2003 Mar 14;299(5613):1743-7</RefSource>
                <PMID Version="1">12637748</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3380-5</RefSource>
                <PMID Version="1">12612341</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Sci. 2003 Aug 1;116(Pt 15):3123-33</RefSource>
                <PMID Version="1">12799414</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>EMBO J. 1999 Feb 1;18(3):501-11</RefSource>
                <PMID Version="1">9927410</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Biol. 2004 Dec;2(12):e393</RefSource>
                <PMID Version="1">15534693</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Biol. 2005 Jul 4;170(1):141-51</RefSource>
                <PMID Version="1">15983060</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Immunol. 2005 Jul;5(7):546-59</RefSource>
                <PMID Version="1">15965491</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Rev. 2006 Apr;210:27-39</RefSource>
                <PMID Version="1">16623762</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Adv Exp Med Biol. 2006;584:245-76</RefSource>
                <PMID Version="1">16802612</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2006 Sep;7(9):919-28</RefSource>
                <PMID Version="1">16892067</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2007 Feb 9;128(3):561-75</RefSource>
                <PMID Version="1">17289574</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Cell Biol. 2007 Mar;9(3):299-309</RefSource>
                <PMID Version="1">17310241</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Rev. 2007 Aug;218:135-46</RefSource>
                <PMID Version="1">17624950</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2007 Oct;8(10):1076-85</RefSource>
                <PMID Version="1">17721537</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>EMBO J. 2008 Jan 9;27(1):62-75</RefSource>
                <PMID Version="1">18079697</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2008 Jan 21;205(1):195-205</RefSource>
                <PMID Version="1">18195072</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Rev. 2008 Feb;221:77-89</RefSource>
                <PMID Version="1">18275476</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2008 May 1;453(7191):51-5</RefSource>
                <PMID Version="1">18451854</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20321-6</RefSource>
                <PMID Version="1">19073936</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2009 Feb 15;182(4):2041-50</RefSource>
                <PMID Version="1">19201857</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Res. 2009 Apr 15;69(8):3713-20</RefSource>
                <PMID Version="1">19351860</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2009 May 8;284(19):12645-53</RefSource>
                <PMID Version="1">19297325</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>EMBO J. 2009 May 6;28(9):1319-31</RefSource>
                <PMID Version="1">19339990</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2009 Sep 15;183(6):3865-72</RefSource>
                <PMID Version="1">19692642</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Cell Biol. 2009 Oct;21(5):636-44</RefSource>
                <PMID Version="1">19523798</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Mol Cell Biol. 2009 Nov;10(11):778-90</RefSource>
                <PMID Version="1">19851336</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2010 Oct;11(10):953-61</RefSource>
                <PMID Version="1">20835229</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Biol. 2011 Apr 18;193(2):381-96</RefSource>
                <PMID Version="1">21482721</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Immunol. 2011 Jun;11(6):416-26</RefSource>
                <PMID Version="1">21597477</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2011 Jun 9;474(7350):179-83</RefSource>
                <PMID Version="1">21654799</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2011 Sep 1;187(5):2356-64</RefSource>
                <PMID Version="1">21795598</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2012 Jan 19;119(3):777-85</RefSource>
                <PMID Version="1">22117043</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Biol Cell. 2012 Mar;23(5):834-52</RefSource>
                <PMID Version="1">22219382</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2012 Apr 9;209(4):741-59</RefSource>
                <PMID Version="1">22412158</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2012 Apr 12;119(15):3458-68</RefSource>
                <PMID Version="1">22174160</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2012 Apr 12;119(15):3450-7</RefSource>
                <PMID Version="1">22294732</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2012 May 25;149(5):1073-83</RefSource>
                <PMID Version="1">22632971</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(8):e44010</RefSource>
                <PMID Version="1">22952854</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Commun. 2012;3:1098</RefSource>
                <PMID Version="1">23033074</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Immunol. 2013 May;13(5):309-20</RefSource>
                <PMID Version="1">23598650</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11976-81</RefSource>
                <PMID Version="1">23818610</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Mol Cell Biol. 2013 Aug;14(8):503-17</RefSource>
                <PMID Version="1">23860236</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2013 Sep;14(9):949-58</RefSource>
                <PMID Version="1">23933892</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(9):e75151</RefSource>
                <PMID Version="1">24069389</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mamm Genome. 2001 Dec;12(12):930-2</RefSource>
                <PMID Version="1">11707780</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136924</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105561</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-10884</ArticleId>
            <ArticleId IdType="pubmed">25133611</ArticleId>
            <ArticleId IdType="pmc">PMC4136924</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133606</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-9867</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pharmaceutical development and technology</Title>
                <ISOAbbreviation>Pharm Dev Technol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Formulation, in vitro and in vivo evaluation of halofantrine-loaded solid lipid microparticles.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-8</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Abstract Context: Formulation, characterization, in vitro and in vivo evaluation of halofantrine-loaded solid lipid microparticles (SLMs). Objective: The objective of the study was to formulate and evaluate halofantrine-loaded SLMs. Materials and methods: Formulations of halofantrine-loaded SLMs were prepared by hot homogenization and thereafter lyophilized and characterized using particle size, pH stability, loading capacity (LC) and encapsulation efficiency (EE). In vitro release of halofantrine (Hf) from the optimized SLMs was performed in SIF and SGF. In vivo study using Peter's Four day suppressive protocol in mice and the mice thereafter subjected to histological studies in kidney and liver. Results: Results obtained indicated that EE of 76.32% and 61.43% were obtained for the SLMs containing 7% and 3% of Hf respectively. The SLMs loaded with 3% of Hf had the highest yield of 73.33%. Time-dependent pH stability analysis showed little variations in pH ranging from 3.49????????0.04 to 4.03????????0.05. Discussion: The SLMs showed pH-dependent release profile; in SIF (43.5% of the drug for each of H2 and H3) compared with SGF (13 and 18% for H2 and H3 respectively) after 8???h. The optimized SLMs formulation and Halfan?? produced a percentage reduction in parasitemia of 72.96% and 85.71% respectively. The histological studies revealed that the SLMs formulations have no harmful effects on the kidney and liver. Conclusion: SLMs formulations might be an alternative for patients with parasitemia as there were no harmful effects on vital organs of the mice.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ogbonna</LastName>
                    <ForeName>John D N</ForeName>
                    <Initials>JD</Initials>
                    <Affiliation>Drug Delivery Research Unit, Department of Pharmaceutics, University of Nigeria , Nsukka , Nigeria.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kenechukwu</LastName>
                    <ForeName>Franklin C</ForeName>
                    <Initials>FC</Initials>
                </Author>
                <Author>
                    <LastName>Nwobi</LastName>
                    <ForeName>Chinekwu S</ForeName>
                    <Initials>CS</Initials>
                </Author>
                <Author>
                    <LastName>Chibueze</LastName>
                    <ForeName>Onochie S</ForeName>
                    <Initials>OS</Initials>
                </Author>
                <Author>
                    <LastName>Attama</LastName>
                    <ForeName>Anthony A</ForeName>
                    <Initials>AA</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Pharm Dev Technol</MedlineTA>
            <NlmUniqueID>9610932</NlmUniqueID>
            <ISSNLinking>1083-7450</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Hematological parameters</Keyword>
            <Keyword MajorTopicYN="N">halofantrine</Keyword>
            <Keyword MajorTopicYN="N">histological studies</Keyword>
            <Keyword MajorTopicYN="N">parasitemia</Keyword>
            <Keyword MajorTopicYN="N">solid???lipid microparticles</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3109/10837450.2014.949270</ArticleId>
            <ArticleId IdType="pubmed">25133606</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133605</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Increased sensitivity to inflammatory pain induced by subcutaneous formalin injection in serine racemase knock-out mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105282</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105282</ELocationID>
            <Abstract>
                <AbstractText>D-Serine, an endogenous coagonist of the N-methyl-D-aspartate receptor (NMDAR), is widely distributed in the central nervous system and is synthesized from L-serine by serine racemase (SR). NMDAR plays an important role in pain processing including central sensitization that eventually causes hyperalgesia. To elucidate the roles of D-serine and SR in pain transmission, we evaluated the behavioral changes and spinal nociceptive processing induced by formalin using SR knock-out (KO) mice. We found that SR is mainly distributed in lamina II of the dorsal horn of the spinal cord in wild-type (WT) mice. Although the formalin injected subcutaneously induced the biphasic pain response of licking in SR-KO and WT mice, the time spent on licking was significantly longer in the SR-KO mice during the second phase of the formalin test. The number of neurons immunopositive for c-Fos and phosphorylated extracellular signal-regulated kinase (p-ERK), which are molecular pain markers, in laminae I-II of the ipsilateral dorsal horn was significantly larger in the SR-KO mice. Immunohistochemical staining revealed that the distribution of SR changed from being broad to being concentrated in cell bodies after the formalin injection. On the other hand, the expression level of the cytosolic SR in the ipsilateral dorsal horn significantly decreased. Oral administration of 10 mM D-serine in drinking water for one week cancelled the difference in pain behaviors between WT and SR-KO mice in phase 2 of the formalin test. These findings demonstrate that the SR-KO mice showed increased sensitivity to inflammatory pain and the WT mice showed translocation of SR and decreased SR expression levels after the formalin injection, which suggest a novel antinociceptive mechanism via SR indicating an important role of D-serine in pain transmission.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tabata-Imai</LastName>
                    <ForeName>Ayako</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Molecular Neuroscience, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Inoue</LastName>
                    <ForeName>Ran</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Molecular Neuroscience, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mori</LastName>
                    <ForeName>Hisashi</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Molecular Neuroscience, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurobiol Aging. 2011 Aug;32(8):1495-504</RefSource>
                <PMID Version="1">19800712</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Can J Anaesth. 2011 Oct;58(10):911-23</RefSource>
                <PMID Version="1">21773855</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Pharmacol. 2012 Mar;165(6):1941-55</RefSource>
                <PMID Version="1">21950354</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pain. 2012 May;153(5):1022-9</RefSource>
                <PMID Version="1">22424878</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13409-14</RefSource>
                <PMID Version="1">10557334</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Neurosci. 1999 Dec;2(12):1114-9</RefSource>
                <PMID Version="1">10570489</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4926-31</RefSource>
                <PMID Version="1">10781100</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurochem Res. 2000 May;25(5):553-60</RefSource>
                <PMID Version="1">10905615</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurosci Lett. 2001 Jan 5;297(1):25-8</RefSource>
                <PMID Version="1">11114476</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pain. 2003 Jan;101(1-2):109-16</RefSource>
                <PMID Version="1">12507705</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2003 Jun 27;300(5628):2094-7</RefSource>
                <PMID Version="1">12829784</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuropharmacology. 2004 Jan;46(1):23-30</RefSource>
                <PMID Version="1">14654094</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15194-9</RefSource>
                <PMID Version="1">14638938</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2004 Mar 17;24(11):2727-32</RefSource>
                <PMID Version="1">15028765</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pain. 2004 Jul;110(1-2):250-8</RefSource>
                <PMID Version="1">15275775</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pain. 1977 Dec;4(2):161-74</RefSource>
                <PMID Version="1">564014</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Biol. 1983 May;96(5):1374-88</RefSource>
                <PMID Version="1">6404912</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 1983 Dec 15-21;306(5944):686-8</RefSource>
                <PMID Version="1">6656869</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci Methods. 1985 Jun;14(1):69-76</RefSource>
                <PMID Version="1">4033190</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pain. 1987 Jul;30(1):103-14</RefSource>
                <PMID Version="1">3614974</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 1988 Aug 12;241(4867):835-7</RefSource>
                <PMID Version="1">2841759</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pain. 1990 Feb;40(2):229-38</RefSource>
                <PMID Version="1">2308768</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pain. 1991 Mar;44(3):293-9</RefSource>
                <PMID Version="1">1828878</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pain. 1991 May;45(2):211-6</RefSource>
                <PMID Version="1">1876429</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Pharmacol Exp Ther. 1992 Oct;263(1):136-46</RefSource>
                <PMID Version="1">1403779</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurochem. 1993 Feb;60(2):783-6</RefSource>
                <PMID Version="1">8419554</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Comp Neurol. 1994 Jul 8;345(2):314-9</RefSource>
                <PMID Version="1">7929904</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroscience. 1994 Dec;63(4):925-36</RefSource>
                <PMID Version="1">7535397</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res. 2011 Sep 30;1415:56-62</RefSource>
                <PMID Version="1">21880302</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Nov 1;879(29):3184-9</RefSource>
                <PMID Version="1">20851062</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3948-52</RefSource>
                <PMID Version="1">7732010</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurochem. 1995 Jul;65(1):454-8</RefSource>
                <PMID Version="1">7790891</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Invest Dermatol. 2014 Jun;134(6):1618-26</RefSource>
                <PMID Version="1">24441099</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2002 Jan 15;22(2):478-85</RefSource>
                <PMID Version="1">11784793</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuropharmacology. 1995 Oct;34(10):1219-37</RefSource>
                <PMID Version="1">8570021</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res Bull. 1998;45(1):1-8</RefSource>
                <PMID Version="1">9434195</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):721-5</RefSource>
                <PMID Version="1">9892700</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuropharmacology. 1999 May;38(5):611-23</RefSource>
                <PMID Version="1">10340299</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Anesth Analg. 1999 Aug;89(2):434-9</RefSource>
                <PMID Version="1">10439761</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Neurosci. 2004 Dec;20(12):3301-12</RefSource>
                <PMID Version="1">15610162</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2005 Jan 6;45(1):17-25</RefSource>
                <PMID Version="1">15629699</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Anesth Analg. 2006 Mar;102(3):811-4</RefSource>
                <PMID Version="1">16492833</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2006 May 19;125(4):775-84</RefSource>
                <PMID Version="1">16713567</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Aging Cell. 2006 Jun;5(3):267-74</RefSource>
                <PMID Version="1">16842499</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2006 Jul 21;281(29):20291-302</RefSource>
                <PMID Version="1">16714286</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Anesth Analg. 2006 Aug;103(2):478-83, table of contents</RefSource>
                <PMID Version="1">16861438</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Res Bull. 2006 Dec 11;71(1-3):279-86</RefSource>
                <PMID Version="1">17113957</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FEBS Lett. 2006 Dec 11;580(28-29):6629-34</RefSource>
                <PMID Version="1">17113581</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Pain. 2007;3:4</RefSource>
                <PMID Version="1">17309799</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2950-5</RefSource>
                <PMID Version="1">17293453</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Pain. 2007;3:9</RefSource>
                <PMID Version="1">17407590</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>EMBO J. 2007 Sep 19;26(18):4149-59</RefSource>
                <PMID Version="1">17762863</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Acta Physiol (Oxf). 2008 Mar;192(3):421-7</RefSource>
                <PMID Version="1">17970830</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Comp Neurol. 2008 Jun 1;508(4):592-604</RefSource>
                <PMID Version="1">18383051</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Mol Neurobiol. 2008 Jun;28(4):581-91</RefSource>
                <PMID Version="1">17874293</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Comp Neurol. 2008 Oct 20;510(6):641-54</RefSource>
                <PMID Version="1">18698599</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2008 Dec 31;28(53):14486-91</RefSource>
                <PMID Version="1">19118183</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2009 May 5;106(18):7589-94</RefSource>
                <PMID Version="1">19380732</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Pharmacol. 2009 Jun 24;613(1-3):68-73</RefSource>
                <PMID Version="1">19394327</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Psychiatry. 2009 Jul;14(7):719-27</RefSource>
                <PMID Version="1">19065142</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Mol Genet. 2009 Sep 1;18(17):3227-43</RefSource>
                <PMID Version="1">19483194</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Pain. 2009 Sep;10(9):895-926</RefSource>
                <PMID Version="1">19712899</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Anesth Analg. 2009 Oct;109(4):1318-22</RefSource>
                <PMID Version="1">19762763</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2009 Oct 16;139(2):267-84</RefSource>
                <PMID Version="1">19837031</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Chem Biodivers. 2010 Jun;7(6):1573-8</RefSource>
                <PMID Version="1">20564570</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Pharmacol Exp Ther. 2011 Jan;336(1):282-93</RefSource>
                <PMID Version="1">20952482</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136830</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105282</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-07916</ArticleId>
            <ArticleId IdType="pubmed">25133605</ArticleId>
            <ArticleId IdType="pmc">PMC4136830</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133579</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Visualization of Mouse Neuronal Ganglia Infected by Herpes Simplex Virus 1 (HSV-1) Using Multimodal Non-Linear Optical Microscopy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105103</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105103</ELocationID>
            <Abstract>
                <AbstractText>Herpes simplex virus 1 (HSV-1) is a neurotropic virus that causes skin lesions and goes on to enter a latent state in neurons of the trigeminal ganglia. Following stress, the virus may reactivate from latency leading to recurrent lesions. The in situ study of neuronal infections by HSV-1 is critical to understanding the mechanisms involved in the biology of this virus and how it causes disease; however, this normally requires fixation and sectioning of the target tissues followed by treatment with contrast agents to visualize key structures, which can lead to artifacts. To further our ability to study HSV-1 neuropathogenesis, we have generated a recombinant virus expressing a second generation red fluorescent protein (mCherry), which behaves like the parental virus in vivo. By optimizing the application of a multimodal non-linear optical microscopy platform, we have successfully visualized in unsectioned trigeminal ganglia of mice both infected cells by two-photon fluorescence microscopy, and myelinated axons of uninfected surrounding cells by coherent anti-Stokes Raman scattering (CARS) microscopy. These results represent the first report of CARS microscopy being combined with 2-photon fluorescence microscopy to visualize virus-infected cells deep within unsectioned explanted tissue, and demonstrate the application of multimodal non-linear optical microscopy for high spatial resolution biological imaging of tissues without the use of stains or fixatives.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rochette</LastName>
                    <ForeName>Pierre-Alexandre</ForeName>
                    <Initials>PA</Initials>
                    <Affiliation>INRS - Institut Armand-Frappier, Laval, Qu??bec, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lalibert??</LastName>
                    <ForeName>Mathieu</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>INRS - Centre ??nergie Mat??riaux T??l??communications, Varennes, Qu??bec, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bertrand-Grenier</LastName>
                    <ForeName>Antony</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>INRS - Centre ??nergie Mat??riaux T??l??communications, Varennes, Qu??bec, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Houle</LastName>
                    <ForeName>Marie-Andr??e</ForeName>
                    <Initials>MA</Initials>
                    <Affiliation>INRS - Centre ??nergie Mat??riaux T??l??communications, Varennes, Qu??bec, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Blache</LastName>
                    <ForeName>Marie-Claire</ForeName>
                    <Initials>MC</Initials>
                    <Affiliation>INRS - Centre ??nergie Mat??riaux T??l??communications, Varennes, Qu??bec, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>L??gar??</LastName>
                    <ForeName>Fran??ois</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>INRS - Centre ??nergie Mat??riaux T??l??communications, Varennes, Qu??bec, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pearson</LastName>
                    <ForeName>Angela</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>INRS - Institut Armand-Frappier, Laval, Qu??bec, Canada.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2003 Dec;77(23):12579-91</RefSource>
                <PMID Version="1">14610181</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2003 Oct;77(20):11082-93</RefSource>
                <PMID Version="1">14512556</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Herpes. 2004 Jun;11 Suppl 2:65A-76A</RefSource>
                <PMID Version="1">15319092</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 1973 Mar 29;288(13):648-50</RefSource>
                <PMID Version="1">4347057</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 1973 Feb;7(2):272-88</RefSource>
                <PMID Version="1">4348966</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 1980 Sep;29(3):902-7</RefSource>
                <PMID Version="1">6253401</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Prog Brain Res. 1983;59:173-84</RefSource>
                <PMID Version="1">6320263</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Gen Virol. 1984 Sep;65 ( Pt 9):1477-86</RefSource>
                <PMID Version="1">6088680</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 1985 Feb;53(2):477-88</RefSource>
                <PMID Version="1">2982032</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Gen Virol. 1987 Dec;68 ( Pt 12):2989-95</RefSource>
                <PMID Version="1">2826644</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 1989 Feb;63(2):759-68</RefSource>
                <PMID Version="1">2536101</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1989 Jun;86(12):4736-40</RefSource>
                <PMID Version="1">2543985</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 1990 Apr 6;248(4951):73-6</RefSource>
                <PMID Version="1">2321027</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 1992 Apr;66(4):2150-6</RefSource>
                <PMID Version="1">1312625</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Acta Histochem. 1993 Sep;95(1):13-21</RefSource>
                <PMID Version="1">7506474</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Zoolog Sci. 1995 Jun;12(3):283-8</RefSource>
                <PMID Version="1">7580812</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Agents Dis. 1995 Sep;4(3):115-24</RefSource>
                <PMID Version="1">8548189</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 1999 Oct;73(10):8457-68</RefSource>
                <PMID Version="1">10482598</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Biotechnol. 2004 Dec;22(12):1567-72</RefSource>
                <PMID Version="1">15558047</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biophys J. 2005 Jul;89(1):581-91</RefSource>
                <PMID Version="1">15834003</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biotechnol Annu Rev. 2005;11:227-56</RefSource>
                <PMID Version="1">16216779</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16807-12</RefSource>
                <PMID Version="1">16263923</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Methods. 2005 Dec;2(12):932-40</RefSource>
                <PMID Version="1">16299478</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1216-24</RefSource>
                <PMID Version="1">16505061</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neoplasia. 2006 Oct;8(10):796-806</RefSource>
                <PMID Version="1">17032496</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Virology. 2007 May 10;361(2):372-83</RefSource>
                <PMID Version="1">17207829</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2007 Jun;81(11):6106-10</RefSource>
                <PMID Version="1">17360760</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2007 Aug;81(15):8337-40</RefSource>
                <PMID Version="1">17522199</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14658-63</RefSource>
                <PMID Version="1">17804796</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci Res. 2007 Oct;85(13):2870-81</RefSource>
                <PMID Version="1">17551984</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2008 Mar;82(6):3109-24</RefSource>
                <PMID Version="1">18160444</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2008 Apr;82(8):3971-83</RefSource>
                <PMID Version="1">18256143</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2008 May;82(10):4974-90</RefSource>
                <PMID Version="1">18337577</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Virology. 2008 Sep 1;378(2):254-64</RefSource>
                <PMID Version="1">18619637</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biomed Opt. 2008 Sep-Oct;13(5):050502</RefSource>
                <PMID Version="1">19021374</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biomed Opt. 2008 Nov-Dec;13(6):064039</RefSource>
                <PMID Version="1">19123685</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Virology. 2009 Nov 10;394(1):130-42</RefSource>
                <PMID Version="1">19747705</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biophotonics. 2010 Mar;3(3):138-46</RefSource>
                <PMID Version="1">19670191</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurotrauma. 2010 Jun;27(6):1109-20</RefSource>
                <PMID Version="1">20373847</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biophys J. 2010 Sep 22;99(6):1842-51</RefSource>
                <PMID Version="1">20858429</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2010 Dec;84(24):13019-30</RefSource>
                <PMID Version="1">20810730</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Genet Dev. 2011 Oct;21(5):585-90</RefSource>
                <PMID Version="1">21945002</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Lipid Res. 2011 Dec;52(12):2177-86</RefSource>
                <PMID Version="1">21949051</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Mech Behav Biomed Mater. 2012 Jan;5(1):62-70</RefSource>
                <PMID Version="1">22100080</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biophys J. 2012 May 2;102(9):2220-9</RefSource>
                <PMID Version="1">22824287</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(8):e44177</RefSource>
                <PMID Version="1">22952920</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2001 Jun;75(11):5069-75</RefSource>
                <PMID Version="1">11333887</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol Methods. 2002 Aug;105(1):13-23</RefSource>
                <PMID Version="1">12176138</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2002 Dec;76(23):12149-61</RefSource>
                <PMID Version="1">12414955</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2003 Feb;77(3):2282-6</RefSource>
                <PMID Version="1">12525666</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2003 Apr;77(7):4127-38</RefSource>
                <PMID Version="1">12634371</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microbes Infect. 2004 Apr;6(5):485-93</RefSource>
                <PMID Version="1">15109964</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136817</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105103</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-02238</ArticleId>
            <ArticleId IdType="pubmed">25133579</ArticleId>
            <ArticleId IdType="pmc">PMC4136817</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133578</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1944-8252</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>ACS applied materials &amp; interfaces</Title>
                <ISOAbbreviation>ACS Appl Mater Interfaces</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Stable, covalent attachment of laminin to microposts improves the contractility of mouse neonatal cardiomyocytes.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The mechanical output of contracting cardiomyocytes, the muscle cells of the heart, relates to healthy and disease states of the heart. Culturing cardiomyocytes on arrays of elastomeric microposts can enable inexpensive and high-throughput studies of heart disease at the single-cell level. However, cardiomyocytes weakly adhere to these microposts, which limits the possibility of using biomechanical assays of single cardiomyocytes to study heart disease. We hypothesized that a stable covalent attachment of laminin to the surface of microposts improves cardiomyocyte contractility. We cultured cells on polydimethylsiloxane microposts with laminin covalently bonded with the organosilanes 3-glycidoxypropyltrimethoxysilane and 3-aminopropyltriethoxysilane with glutaraldehyde. We measured displacement of microposts induced by the contractility of mouse neonatal cardiomyocytes, which attach better to substrates than mature cardiomyocytes. We observed time-dependent changes in contractile parameters such as micropost deformation, contractility rates, contraction and relaxation speeds, and the times of contractions. These parameters were affected by the density of laminin on microposts and by the stability of laminin binding to micropost surfaces. Organosilane-mediated binding resulted in higher laminin surface density and laminin binding stability. 3-glycidoxypropyltrimethoxysilane provided the highest laminin density, but did not provide stable protein binding with time. Higher surface protein binding stability and strength were observed with 3-aminopropyltriethoxysilane with glutaraldehyde. In cultured cardiomyocytes, contractility rate, contraction speeds, and contraction time increased with higher laminin stability. Given these variations in contractile function, we conclude that binding of laminin to microposts via 3-aminopropyltriethoxysilane with glutaraldehyde improves contractility observed by an increase in beating rate and contraction speed as it occurs during the postnatal maturation of cardiomyocytes. This approach is promising for future studies to mimic in vivo tissue environments.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ribeiro</LastName>
                    <ForeName>Alexandre J S</ForeName>
                    <Initials>AJ</Initials>
                </Author>
                <Author>
                    <LastName>Zaleta-Rivera</LastName>
                    <ForeName>Kathia</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Ashley</LastName>
                    <ForeName>Euan A</ForeName>
                    <Initials>EA</Initials>
                </Author>
                <Author>
                    <LastName>Pruitt</LastName>
                    <ForeName>Beth L</ForeName>
                    <Initials>BL</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>ACS Appl Mater Interfaces</MedlineTA>
            <NlmUniqueID>101504991</NlmUniqueID>
            <ISSNLinking>1944-8244</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1021/am5042324</ArticleId>
            <ArticleId IdType="pubmed">25133578</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133574</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Possible Link between Food and Mood: Dietary Impact on Gut Microbiota and Behavior in BALB/c Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e103398</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0103398</ELocationID>
            <Abstract>
                <AbstractText>Major depressive disorder is a debilitating disease in the Western World. A western diet high in saturated fat and refined sugar seems to play an important part in disease development. Therefore, this study is aimed at investigating whether saturated fat or sucrose predisposes mice to develop behavioral symptoms which can be interpreted as depression-like, and the possible influence of the gut microbiota (GM) in this. Fourty-two mice were randomly assigned to one of three experimental diets, a high-fat, a high-sucrose or a control diet for thirteen weeks. Mice on high-fat diet gained more weight (p???=???0.00009), displayed significantly less burrowing behavior than the control mice (p???=???0.034), and showed decreased memory in the Morris water maze test compared to mice on high-sucrose diet (p???=???0.031). Mice on high-sucrose diet burrowed less goal-oriented, showed greater latency to first bout of immobility in the forced swim test when compared to control mice (p???=???0.039) and high-fat fed mice (p???=???0.013), and displayed less anxiety than mice on high-fat diet in the triple test (p???=???0.009). Behavioral changes were accompanied by a significant change in GM composition of mice fed a high-fat diet, while no difference between diet groups was observed for sucrose preferences, LPS, cholesterol, HbA1c, BDNF and the cytokines IL-1??, IL-1??, IL-6, IL-10, IL-12(p70), IL-17 and TNF-??. A series of correlations was found between GM, behavior, BDNF and inflammatory mediators. In conclusion, the study shows that dietary fat and sucrose affect behavior, sometimes in opposite directions, and suggests a possible association between GM and behavior.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pyndt J??rgensen</LastName>
                    <ForeName>Bettina</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Section of Experimental Animal Models, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hansen</LastName>
                    <ForeName>Julie Torpe</ForeName>
                    <Initials>JT</Initials>
                    <Affiliation>Section of Experimental Animal Models, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krych</LastName>
                    <ForeName>Lukasz</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Food Science, Faculty of Science, University of Copenhagen, Frederiksberg C, Denmark.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Larsen</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Section of Experimental Animal Models, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Klein</LastName>
                    <ForeName>Anders Bue</ForeName>
                    <Initials>AB</Initials>
                    <Affiliation>Neurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nielsen</LastName>
                    <ForeName>Dennis Sandris</ForeName>
                    <Initials>DS</Initials>
                    <Affiliation>Department of Food Science, Faculty of Science, University of Copenhagen, Frederiksberg C, Denmark.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Josefsen</LastName>
                    <ForeName>Knud</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Bartholin Institute, Rigshospitalet, Copenhagen, Denmark.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hansen</LastName>
                    <ForeName>Axel Kornerup</ForeName>
                    <Initials>AK</Initials>
                    <Affiliation>Section of Experimental Animal Models, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>S??rensen</LastName>
                    <ForeName>Dorte Bratbo</ForeName>
                    <Initials>DB</Initials>
                    <Affiliation>Section of Experimental Animal Models, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Neurosci. 2001 May;2(5):343-51</RefSource>
                <PMID Version="1">11331918</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychiatry Res. 2002 Mar 15;109(2):143-8</RefSource>
                <PMID Version="1">11927139</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroscience. 2002;112(4):803-14</RefSource>
                <PMID Version="1">12088740</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain Behav Immun. 2004 May;18(3):238-45</RefSource>
                <PMID Version="1">15050651</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Physiol. 2004 Jul 1;558(Pt 1):263-75</RefSource>
                <PMID Version="1">15133062</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Prog Neuropsychopharmacol Biol Psychiatry. 1990;14(6):863-77</RefSource>
                <PMID Version="1">2277851</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Neurosci. 1998 Aug;112(4):1012-9</RefSource>
                <PMID Version="1">9733207</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Pharm Des. 2005;11(8):963-72</RefSource>
                <PMID Version="1">15777247</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Endocrinol Metab. 2005 May;90(5):2522-30</RefSource>
                <PMID Version="1">15705924</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurosci Biobehav Rev. 2005;29(4-5):515-23</RefSource>
                <PMID Version="1">15893377</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Clin Nutr. 2008 May;87(5):1219-23</RefSource>
                <PMID Version="1">18469242</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Alzheimers Dis. 2008 Jun;14(2):133-45</RefSource>
                <PMID Version="1">18560126</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Immunol. 2008;9:65</RefSource>
                <PMID Version="1">18990206</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Physiol Behav. 2009 Mar 23;96(4-5):557-67</RefSource>
                <PMID Version="1">19135464</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Pharmacol. 2009 Dec;9(6):737-43</RefSource>
                <PMID Version="1">19628432</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Behav Brain Res. 2010 Mar 17;208(1):72-9</RefSource>
                <PMID Version="1">19896506</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neuroimmunol. 2010 Feb 26;219(1-2):25-32</RefSource>
                <PMID Version="1">20004026</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Sci Transl Med. 2009 Nov 11;1(6):6ra14</RefSource>
                <PMID Version="1">20368178</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Methods. 2010 May;7(5):335-6</RefSource>
                <PMID Version="1">20383131</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2010;5(4):e10404</RefSource>
                <PMID Version="1">20436931</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychopharmacology (Berl). 2010 Jul;211(1):99-112</RefSource>
                <PMID Version="1">20454890</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurosci Biobehav Rev. 2010 Jul;34(8):1366-79</RefSource>
                <PMID Version="1">20470821</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Comp Med. 2010 Oct;60(5):336-47</RefSource>
                <PMID Version="1">21262117</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3047-52</RefSource>
                <PMID Version="1">21282636</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Bioinformatics. 2011 Aug 15;27(16):2194-200</RefSource>
                <PMID Version="1">21700674</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterology. 2011 Aug;141(2):599-609, 609.e1-3</RefSource>
                <PMID Version="1">21683077</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16050-5</RefSource>
                <PMID Version="1">21876150</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>ISME J. 2012 Mar;6(3):610-8</RefSource>
                <PMID Version="1">22134646</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>ISME J. 2012 Jul;6(7):1415-26</RefSource>
                <PMID Version="1">22258098</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(10):e46231</RefSource>
                <PMID Version="1">23056268</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Affect Disord. 2013 May 15;148(1):12-27</RefSource>
                <PMID Version="1">23415826</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FEMS Microbiol Ecol. 2013 Aug;85(2):376-88</RefSource>
                <PMID Version="1">23614882</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Microbiol. 2013 Jun;16(3):240-5</RefSource>
                <PMID Version="1">23845749</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychoneuroendocrinology. 2013 Sep;38(9):1738-47</RefSource>
                <PMID Version="1">23566632</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2013 Dec 19;155(7):1451-63</RefSource>
                <PMID Version="1">24315484</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Diabetes Res. 2013;2013:319321</RefSource>
                <PMID Version="1">24369539</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>ScientificWorldJournal. 2013;2013:135142</RefSource>
                <PMID Version="1">24470789</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychosom Med. 2001 Jul-Aug;63(4):619-30</RefSource>
                <PMID Version="1">11485116</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136797</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0103398</ArticleId>
            <ArticleId IdType="pii">PONE-D-13-49086</ArticleId>
            <ArticleId IdType="pubmed">25133574</ArticleId>
            <ArticleId IdType="pmc">PMC4136797</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133542</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Coptidis rhizome and Si Jun Zi Tang Can Prevent Salmonella enterica Serovar Typhimurium Infection in Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105362</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105362</ELocationID>
            <Abstract>
                <AbstractText>Salmonella, a common zoonotic pathogen, causes gastroenteritis in both humans and animals. Traditional Chinese Medicine (TCM) has been used to improve gastrointestinal dysfunction and to modify the immune response to inflammation for centuries. This study used six herbal plants and four TCM formulae to rate their efficacy in preventing S. Typhimurium infection via mouse model. Minimum bactericidal concentration (MBC) of Coptidis rhizome (CR) against the reference strain tallied 12.5 mg/ml and against clinical isolate ST21 was 25 mg/ml. MBCs of other herbal extracts and formulae on Salmonella Typhimurium strains were above 50 mg/ml. In the mice model, CR and Si Jun Zi Tang (SJZT) could significantly decrease the bacterial load in organs and blood after being challenged, along with body weight loss due to the infection. CR and SJZT alleviated infection-induced interferon-gamma levels in the serum and tissues, and tumor necrosis factor-alpha (TNF-??) levels in intestinal tissues. CR and SJZT serum metabolites could suppress S. Typhimurium invasion and TNF-?? expression in RAW264.7 cells. The therapeutic activity of CR and SJZT may involve berberine, ginsenoside Rb1, and glycyrrhizin, interfering with Salmonella when invading macrophages. CR and SJZT has shown potential in preventing S. Typhimurium infection through the regulation of the immune response.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chang</LastName>
                    <ForeName>Chiung-Hung</ForeName>
                    <Initials>CH</Initials>
                    <Affiliation>Graduate Institute of Chinese Medicine, School of Chinese Medicine, China Medical University, Taichung, Taiwan; Department of Traditional Chinese Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Department of Traditional Chinese Medicine, Tainan Municipal Hospital, Tainan City, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Bi</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Department of Animal Science, College of Agriculture and Natural Resources, National Chung Hsing University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Su</LastName>
                    <ForeName>Chiu-Hsian</ForeName>
                    <Initials>CH</Initials>
                    <Affiliation>Department of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Daniel S</ForeName>
                    <Initials>DS</Initials>
                    <Affiliation>Department of Biochemistry, College of Agriculture and Life Sciences, University of Wisconsin at Madison, Madison, Wisconsin, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hou</LastName>
                    <ForeName>Yu-Chi</ForeName>
                    <Initials>YC</Initials>
                    <Affiliation>Department of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Yueh-Sheng</ForeName>
                    <Initials>YS</Initials>
                    <Affiliation>Graduate Institute of Chinese Medicine, School of Chinese Medicine, China Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hsu</LastName>
                    <ForeName>Yuan-Man</ForeName>
                    <Initials>YM</Initials>
                    <Affiliation>Department of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Zhong Yao Cai. 2000 Sep;23(9):563-5</RefSource>
                <PMID Version="1">12575285</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Infect Dis. 2002 Jun 1;34 Suppl 3:S78-84</RefSource>
                <PMID Version="1">11988877</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Res Microbiol. 2004 Sep;155(7):568-70</RefSource>
                <PMID Version="1">15313257</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Zhong Yao Tong Bao. 1987 Jun;12(6):49-50</RefSource>
                <PMID Version="1">3328655</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Indian J Med Sci. 1989 Jun;43(6):145-50</RefSource>
                <PMID Version="1">2687164</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Chin Med. 1996;24(1):45-52</RefSource>
                <PMID Version="1">8739181</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Clin Microbiol Infect Dis. 1998 Jun;17(6):385-7</RefSource>
                <PMID Version="1">9758275</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Paediatr Child Health. 1999 Aug;35(4):372-4</RefSource>
                <PMID Version="1">10457295</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Emerg Infect Dis. 1999 Sep-Oct;5(5):607-25</RefSource>
                <PMID Version="1">10511517</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Nutr. 2005 Jan;93(1):21-9</RefSource>
                <PMID Version="1">15705221</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Food Microbiol. 2006 Oct 1;111(3):270-5</RefSource>
                <PMID Version="1">16876280</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>World J Gastroenterol. 2006 Dec 7;12(45):7346-9</RefSource>
                <PMID Version="1">17143954</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Zhong Xi Yi Jie He Xue Bao. 2008 Jan;6(1):37-40</RefSource>
                <PMID Version="1">18184544</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Food Microbiol. 2008 Sep 30;127(1-2):180-3</RefSource>
                <PMID Version="1">18675484</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Pharm Bull. 2008 Nov;31(11):2012-7</RefSource>
                <PMID Version="1">18981565</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microbes Infect. 2010 Oct;12(11):809-18</RefSource>
                <PMID Version="1">20538070</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Rev. 2011 Mar;240(1):185-95</RefSource>
                <PMID Version="1">21349094</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Immunol. 2011 Aug;23(4):456-63</RefSource>
                <PMID Version="1">21726991</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2011 Oct 11;137(3):1542-6</RefSource>
                <PMID Version="1">21872652</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Gastrointest Liver Physiol. 2012 Mar 1;302(5):G504-14</RefSource>
                <PMID Version="1">22173918</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Leukoc Biol. 2012 Jun;91(6):967-76</RefSource>
                <PMID Version="1">22422925</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Emerg Infect Dis. 1999 Nov-Dec;5(6):802-6</RefSource>
                <PMID Version="1">10603215</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microb Drug Resist. 2000 Spring;6(1):77-83</RefSource>
                <PMID Version="1">10868811</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Epidemiol Infect. 2001 Oct;127(2):207-13</RefSource>
                <PMID Version="1">11693497</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 2002 Feb 7;346(6):413-9</RefSource>
                <PMID Version="1">11832529</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Microbiol. 2004 Apr;42(4):1734-8</RefSource>
                <PMID Version="1">15071035</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136861</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105362</ArticleId>
            <ArticleId IdType="pii">PONE-D-13-54923</ArticleId>
            <ArticleId IdType="pubmed">25133542</ArticleId>
            <ArticleId IdType="pmc">PMC4136861</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133541</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Osteopontin Is Expressed in the Mouse Uterus during Early Pregnancy and Promotes Mouse Blastocyst Attachment and Invasion In Vitro.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e104955</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0104955</ELocationID>
            <Abstract>
                <AbstractText>Embryo implantation into the maternal uterus is a decisive step for successful mammalian pregnancy. Osteopontin (OPN) is a member of the small integrin-binding ligand N-linked glycoprotein family and participates in cell adhesion and invasion. In this study, we showed that Opn mRNA levels are up-regulated in the mouse uterus on day 4 and at the implantation sites on days 5 and 8 of pregnancy. Immunohistochemistry localized the OPN protein to the glandular epithelium on day 4 and to the decidual zone on day 8 of pregnancy. OPN mRNA and proteins are induced by in vivo and in vitro decidualization. OPN expression in the endometrial stromal cells is regulated by progesterone, a key regulator during decidualization. As a secreted protein, the protein level of OPN in the uterine cavity is enriched on day 4, and in vitro embryo culturing has indicated that OPN can facilitate blastocyst hatching and adhesion. Knockdown of OPN attenuates the adhesion and invasion of blastocysts in mouse endometrial stromal cells by suppressing the expression and enzymatic activity of matrix metalloproteinase-9 in the trophoblast. Our data indicated that OPN expression in the mouse uterus during early pregnancy is essential for blastocyst hatching and adhesion and that the knockdown of OPN in mouse endometrial stroma cells could lead to a restrained in vitro trophoblast invasion.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Qi</LastName>
                    <ForeName>Qian-Rong</ForeName>
                    <Initials>QR</Initials>
                    <Affiliation>Center for Reproductive Medicine, Renmin Hospital of Wuhan University, Wuhan, P. R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xie</LastName>
                    <ForeName>Qing-Zhen</ForeName>
                    <Initials>QZ</Initials>
                    <Affiliation>Center for Reproductive Medicine, Renmin Hospital of Wuhan University, Wuhan, P. R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Xue-Li</ForeName>
                    <Initials>XL</Initials>
                    <Affiliation>Medical College of Wuhan University, Wuhan, P. R. China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Yun</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Center for Reproductive Medicine, Renmin Hospital of Wuhan University, Wuhan, P. R. China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Reprod. 2001 Sep;65(3):820-8</RefSource>
                <PMID Version="1">11514347</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann N Y Acad Sci. 2002 Mar;955:48-59; discussion 86-8, 396-406</RefSource>
                <PMID Version="1">11949965</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Reprod. 2003 Jul;69(1):92-8</RefSource>
                <PMID Version="1">12606367</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Development. 2003 Sep;130(18):4439-50</RefSource>
                <PMID Version="1">12900459</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Fertil Steril. 2003 Sep;80 Suppl 2:736-42</RefSource>
                <PMID Version="1">14505747</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Reprod. 2003 Nov;69(5):1458-71</RefSource>
                <PMID Version="1">12890718</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pediatr Res. 2004 Mar;55(3):419-24</RefSource>
                <PMID Version="1">14711899</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Development. 1999 May;126(9):1997-2005</RefSource>
                <PMID Version="1">10101133</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Reproduction. 2005 Jan;129(1):103-13</RefSource>
                <PMID Version="1">15615902</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Reprod. 2005 Oct;73(4):672-80</RefSource>
                <PMID Version="1">15944241</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Genet. 2006 Mar;7(3):185-99</RefSource>
                <PMID Version="1">16485018</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Reproduction. 2006 Dec;132(6):919-29</RefSource>
                <PMID Version="1">17127752</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Reproduction. 2007 Feb;133(2):405-14</RefSource>
                <PMID Version="1">17307908</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cancer. 2007;6:18</RefSource>
                <PMID Version="1">17343740</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Reproduction. 2007 May;133(5):909-17</RefSource>
                <PMID Version="1">17616721</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Reproduction. 2007 Jun;133(6):1213-21</RefSource>
                <PMID Version="1">17636175</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19357-62</RefSource>
                <PMID Version="1">18042698</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Hum Reprod. 2008 Jul;14(7):413-21</RefSource>
                <PMID Version="1">18524812</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Fertil Steril. 2008 Oct;90(4 Suppl):1390-5</RefSource>
                <PMID Version="1">18291374</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Reprod. 2009 May;80(5):920-7</RefSource>
                <PMID Version="1">19144959</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Physiol. 2009 Oct;221(1):98-108</RefSource>
                <PMID Version="1">19475568</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Reprod. 2010 Jan;25(1):192-7</RefSource>
                <PMID Version="1">19897854</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2010 Mar;120(3):803-15</RefSource>
                <PMID Version="1">20124728</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Tissue Cell. 2010 Oct;42(5):301-6</RefSource>
                <PMID Version="1">20810141</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Fertil Steril. 2010 Nov;94(6):2264-71</RefSource>
                <PMID Version="1">20226447</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Reprod. 2001 May;64(5):1331-7</RefSource>
                <PMID Version="1">11319136</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2001 Jul 27;276(30):28261-7</RefSource>
                <PMID Version="1">11375993</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Res. 2010 Dec 15;70(24):10381-91</RefSource>
                <PMID Version="1">20980434</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Apr;33(2):210-3</RefSource>
                <PMID Version="1">21529453</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FASEB J. 2011 Jul;25(7):2245-55</RefSource>
                <PMID Version="1">21402718</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2011 Sep 1;187(5):2723-31</RefSource>
                <PMID Version="1">21810612</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Reprod Domest Anim. 2011 Oct;46(5):840-7</RefSource>
                <PMID Version="1">21605197</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Hum Reprod. 2011 Oct;17(10):637-52</RefSource>
                <PMID Version="1">21565864</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Fertil Steril. 2011 Oct;96(4):943-50</RefSource>
                <PMID Version="1">21821247</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Lab. 2011;57(11-12):953-7</RefSource>
                <PMID Version="1">22239027</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(1):e30508</RefSource>
                <PMID Version="1">22291969</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Reprod. 2012 Mar;27(3):805-13</RefSource>
                <PMID Version="1">22215628</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Fertil Steril. 2012 Apr;97(4):974-8</RefSource>
                <PMID Version="1">22341638</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2012 May 4;287(19):15174-92</RefSource>
                <PMID Version="1">22403396</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Zhonghua Nan Ke Xue. 2012 May;18(5):446-9</RefSource>
                <PMID Version="1">22741446</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Reprod Biol. 2012 Jul;12(2):97-118</RefSource>
                <PMID Version="1">22850465</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Glycoconj J. 2012 Aug;29(5-6):347-56</RefSource>
                <PMID Version="1">22847114</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Womens Health. 2012;12:10</RefSource>
                <PMID Version="1">22520363</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(11):e48933</RefSource>
                <PMID Version="1">23152823</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Acta Biomater. 2013 Mar;9(3):5600-8</RefSource>
                <PMID Version="1">23142478</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(2):e55714</RefSource>
                <PMID Version="1">23441154</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Reprod. 2013 Apr;88(4):93</RefSource>
                <PMID Version="1">23407384</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2013 May 28;110(22):9042-7</RefSource>
                <PMID Version="1">23671068</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Mol Sci. 2013;14(7):14504-17</RefSource>
                <PMID Version="1">23852023</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Aspects Med. 2013 Oct;34(5):939-80</RefSource>
                <PMID Version="1">23290997</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Endocrinol. 2013 Sep;27(9):1492-501</RefSource>
                <PMID Version="1">23885093</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Biol Med (Maywood). 2013 Nov 1;238(11):1297-304</RefSource>
                <PMID Version="1">24006305</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Reprod. 2002 Mar;66(3):718-25</RefSource>
                <PMID Version="1">11870079</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136843</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0104955</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-21119</ArticleId>
            <ArticleId IdType="pubmed">25133541</ArticleId>
            <ArticleId IdType="pmc">PMC4136843</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133509</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>MCP/CCR2 Signaling Is Essential for Recruitment of Mesenchymal Progenitor Cells during the Early Phase of Fracture Healing.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e104954</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0104954</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this study was to investigate chemokine profiles and their functional roles in the early phase of fracture healing in mouse models.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">The expression profiles of chemokines were examined during fracture healing in wild-type (WT) mice using a polymerase chain reaction array and histological staining. The functional effect of monocyte chemotactic protein-1 (MCP-1) on primary mouse bone marrow stromal cells (mBMSCs) was evaluated using an in vitro migration assay. MCP-1-/- and C-C chemokine receptor 2 (CCR2)-/- mice were fractured and evaluated by histological staining and micro-computed tomography (micro-CT). RS102895, an antagonist of CCR2, was continuously administered in WT mice before or after rib fracture and evaluated by histological staining and micro-CT. Bone graft exchange models were created in WT and MCP-1-/- mice and were evaluated by histological staining and micro-CT.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">MCP-1 and MCP-3 expression in the early phase of fracture healing were up-regulated, and high levels of MCP-1 and MCP-3 protein expression observed in the periosteum and endosteum in the same period. MCP-1, but not MCP-3, increased migration of mBMSCs in a dose-dependent manner. Fracture healing in MCP-1-/- and CCR2-/- mice was delayed compared with WT mice on day 21. Administration of RS102895 in the early, but not in the late phase, caused delayed fracture healing. Transplantation of WT-derived graft into host MCP-1-/- mice significantly increased new bone formation in the bone graft exchange models. Furthermore, marked induction of MCP-1 expression in the periosteum and endosteum was observed around the WT-derived graft in the host MCP-1-/- mouse. Conversely, transplantation of MCP-1-/- mouse-derived grafts into host WT mice markedly decreased new bone formation.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MCP-1/CCR2 signaling in the periosteum and endosteum is essential for the recruitment of mesenchymal progenitor cells in the early phase of fracture healing.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ishikawa</LastName>
                    <ForeName>Masahiro</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of the Control for Rheumatic Disease, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ito</LastName>
                    <ForeName>Hiromu</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kitaori</LastName>
                    <ForeName>Toshiyuki</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murata</LastName>
                    <ForeName>Koichi</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shibuya</LastName>
                    <ForeName>Hideyuki</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Furu</LastName>
                    <ForeName>Moritoshi</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of the Control for Rheumatic Disease, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoshitomi</LastName>
                    <ForeName>Hiroyuki</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>The Center for Innovation in Immunoregulative Technology and Therapeutics, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fujii</LastName>
                    <ForeName>Takayuki</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yamamoto</LastName>
                    <ForeName>Koji</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matsuda</LastName>
                    <ForeName>Shuichi</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Orthop Trauma. 1996;10(4):279-84</RefSource>
                <PMID Version="1">8723407</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bone Miner Res. 2014 Feb;29(2):316-26</RefSource>
                <PMID Version="1">23857760</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem Biophys Res Commun. 1999 Aug 27;262(2):443-51</RefSource>
                <PMID Version="1">10462495</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Med. 2005 Mar;11(3):291-7</RefSource>
                <PMID Version="1">15711561</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bone Joint Surg Br. 2005 Jul;87(7):896-902</RefSource>
                <PMID Version="1">15972899</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Injury. 2005 Dec;36(12):1392-404</RefSource>
                <PMID Version="1">16102764</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2006 Mar;7(3):311-7</RefSource>
                <PMID Version="1">16462739</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Surg Res. 2006 Jul;134(1):145-57</RefSource>
                <PMID Version="1">16488443</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells. 2007 Jan;25(1):245-51</RefSource>
                <PMID Version="1">17053210</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Leukoc Biol. 2007 Mar;81(3):775-85</RefSource>
                <PMID Version="1">17135576</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Injury. 2007 Mar;38 Suppl 1:S26-32</RefSource>
                <PMID Version="1">17383482</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2007 Apr;117(4):902-9</RefSource>
                <PMID Version="1">17364026</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bone Joint Surg Br. 2007 Apr;89(4):461-6</RefSource>
                <PMID Version="1">17463112</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2008 Feb 15;180(4):2581-7</RefSource>
                <PMID Version="1">18250469</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Stem Cell. 2008 Jun 5;2(6):566-75</RefSource>
                <PMID Version="1">18522849</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Tissue Eng Part B Rev. 2008 Jun;14(2):179-86</RefSource>
                <PMID Version="1">18544015</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Pathol. 2009 Jan;217(2):318-24</RefSource>
                <PMID Version="1">19023885</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>JAMA. 2009 Feb 4;301(5):513-21</RefSource>
                <PMID Version="1">19190316</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arthritis Rheum. 2009 Mar;60(3):813-23</RefSource>
                <PMID Version="1">19248097</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bone Miner Res. 2009 Feb;24(2):274-82</RefSource>
                <PMID Version="1">18847330</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2009 Jun 26;284(26):17564-74</RefSource>
                <PMID Version="1">19406748</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells. 2009 Aug;27(8):1887-98</RefSource>
                <PMID Version="1">19544445</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2010 Apr;120(4):1192-203</RefSource>
                <PMID Version="1">20234092</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Orthop Res. 2010 Jun;28(6):778-84</RefSource>
                <PMID Version="1">20041490</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Ther. 2010 May;18(5):1026-34</RefSource>
                <PMID Version="1">20068549</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dis Model Mech. 2010 Jul-Aug;3(7-8):451-8</RefSource>
                <PMID Version="1">20354109</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stem Cells. 2010 Dec;28(12):2124-8</RefSource>
                <PMID Version="1">20960512</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FASEB J. 2011 Jan;25(1):358-69</RefSource>
                <PMID Version="1">20889618</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur Cell Mater. 2010;20:121-33</RefSource>
                <PMID Version="1">21249629</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1585-90</RefSource>
                <PMID Version="1">21209334</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bone Joint Surg Br. 2011 Apr;93(4):427-34</RefSource>
                <PMID Version="1">21464477</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mod Rheumatol. 2011 Apr;21(2):113-21</RefSource>
                <PMID Version="1">20830500</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Injury. 2011 Jun;42(6):562-8</RefSource>
                <PMID Version="1">21489533</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2011 Jul 14;475(7355):222-5</RefSource>
                <PMID Version="1">21654748</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Rheumatol. 2012 Mar;8(3):133-43</RefSource>
                <PMID Version="1">22293759</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(5):e37163</RefSource>
                <PMID Version="1">22623989</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bone Miner Metab. 2013 Jul;31(4):390-8</RefSource>
                <PMID Version="1">23475152</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mech Dev. 1998 Feb;71(1-2):65-76</RefSource>
                <PMID Version="1">9507067</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136826</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0104954</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-20995</ArticleId>
            <ArticleId IdType="pubmed">25133509</ArticleId>
            <ArticleId IdType="pmc">PMC4136826</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133429</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1558-8238</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of clinical investigation</Title>
                <ISOAbbreviation>J. Clin. Invest.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>PAX7 expression defines germline stem cells in the adult testis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">75943</ELocationID>
            <ELocationID EIdType="doi">10.1172/JCI75943</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Spermatogenesis is a complex, multistep process that maintains male fertility and is sustained by rare germline stem cells. Spermatogenic progression begins with spermatogonia, populations of which express distinct markers. The identity of the spermatogonial stem cell population in the undisturbed testis is controversial due to a lack of reliable and specific markers. Here we identified the transcription factor PAX7 as a specific marker of a rare subpopulation of Asingle spermatogonia in mice. PAX7+ cells were present in the testis at birth. Compared with the adult testis, PAX7+ cells constituted a much higher percentage of neonatal germ cells. Lineage tracing in healthy adult mice revealed that PAX7+ spermatogonia self-maintained and produced expanding clones that gave rise to mature spermatozoa. Interestingly, in mice subjected to chemotherapy and radiotherapy, both of which damage the vast majority of germ cells and can result in sterility, PAX7+ spermatogonia selectively survived, and their subsequent expansion contributed to the recovery of spermatogenesis. Finally, PAX7+ spermatogonia were present in the testes of a diverse set of mammals. Our data indicate that the PAX7+ subset of Asingle spermatogonia functions as robust testis stem cells that maintain fertility in normal spermatogenesis in healthy mice and mediate recovery after severe germline injury, such as occurs after cancer therapy.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Aloisio</LastName>
                    <ForeName>Gina M</ForeName>
                    <Initials>GM</Initials>
                </Author>
                <Author>
                    <LastName>Nakada</LastName>
                    <ForeName>Yuji</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Saatcioglu</LastName>
                    <ForeName>Hatice D</ForeName>
                    <Initials>HD</Initials>
                </Author>
                <Author>
                    <LastName>Pe??a</LastName>
                    <ForeName>Christopher G</ForeName>
                    <Initials>CG</Initials>
                </Author>
                <Author>
                    <LastName>Baker</LastName>
                    <ForeName>Michael D</ForeName>
                    <Initials>MD</Initials>
                </Author>
                <Author>
                    <LastName>Tarnawa</LastName>
                    <ForeName>Edward D</ForeName>
                    <Initials>ED</Initials>
                </Author>
                <Author>
                    <LastName>Mukherjee</LastName>
                    <ForeName>Jishnu</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Manjunath</LastName>
                    <ForeName>Hema</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Bugde</LastName>
                    <ForeName>Abhijit</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Sengupta</LastName>
                    <ForeName>Anita L</ForeName>
                    <Initials>AL</Initials>
                </Author>
                <Author>
                    <LastName>Amatruda</LastName>
                    <ForeName>James F</ForeName>
                    <Initials>JF</Initials>
                </Author>
                <Author>
                    <LastName>Cuevas</LastName>
                    <ForeName>Ileana</ForeName>
                    <Initials>I</Initials>
                </Author>
                <Author>
                    <LastName>Hamra</LastName>
                    <ForeName>F Kent</ForeName>
                    <Initials>FK</Initials>
                </Author>
                <Author>
                    <LastName>Castrillon</LastName>
                    <ForeName>Diego H</ForeName>
                    <Initials>DH</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Clin Invest</MedlineTA>
            <NlmUniqueID>7802877</NlmUniqueID>
            <ISSNLinking>0021-9738</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">75943</ArticleId>
            <ArticleId IdType="doi">10.1172/JCI75943</ArticleId>
            <ArticleId IdType="pubmed">25133429</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133427</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1558-8238</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of clinical investigation</Title>
                <ISOAbbreviation>J. Clin. Invest.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>FGF21 is an endocrine signal of protein restriction.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">74915</ELocationID>
            <ELocationID EIdType="doi">10.1172/JCI74915</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Enhanced fibroblast growth factor 21 (FGF21) production and circulation has been linked to the metabolic adaptation to starvation. Here, we demonstrated that hepatic FGF21 expression is induced by dietary protein restriction, but not energy restriction. Circulating FGF21 was increased 10-fold in mice and rats fed a low-protein (LP) diet. In these animals, liver Fgf21 expression was increased within 24 hours of reduced protein intake. In humans, circulating FGF21 levels increased dramatically following 28 days on a LP diet. LP-induced increases in FGF21 were associated with increased phosphorylation of eukaryotic initiation factor 2?? (eIF2??) in the liver, and both baseline and LP-induced serum FGF21 levels were reduced in mice lacking the eIF2?? kinase general control nonderepressible 2 (GCN2). Finally, while protein restriction altered food intake, energy expenditure, and body weight gain in WT mice, FGF21-deficient animals did not exhibit these changes in response to a LP diet. These and other data demonstrate that reduced protein intake underlies the increase in circulating FGF21 in response to starvation and a ketogenic diet and that FGF21 is required for behavioral and metabolic responses to protein restriction. FGF21 therefore represents an endocrine signal of protein restriction, which acts to coordinate metabolism and growth during periods of reduced protein intake.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Laeger</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Henagan</LastName>
                    <ForeName>Tara M</ForeName>
                    <Initials>TM</Initials>
                </Author>
                <Author>
                    <LastName>Albarado</LastName>
                    <ForeName>Diana C</ForeName>
                    <Initials>DC</Initials>
                </Author>
                <Author>
                    <LastName>Redman</LastName>
                    <ForeName>Leanne M</ForeName>
                    <Initials>LM</Initials>
                </Author>
                <Author>
                    <LastName>Bray</LastName>
                    <ForeName>George A</ForeName>
                    <Initials>GA</Initials>
                </Author>
                <Author>
                    <LastName>Noland</LastName>
                    <ForeName>Robert C</ForeName>
                    <Initials>RC</Initials>
                </Author>
                <Author>
                    <LastName>M??nzberg</LastName>
                    <ForeName>Heike</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Hutson</LastName>
                    <ForeName>Susan M</ForeName>
                    <Initials>SM</Initials>
                </Author>
                <Author>
                    <LastName>Gettys</LastName>
                    <ForeName>Thomas W</ForeName>
                    <Initials>TW</Initials>
                </Author>
                <Author>
                    <LastName>Schwartz</LastName>
                    <ForeName>Michael W</ForeName>
                    <Initials>MW</Initials>
                </Author>
                <Author>
                    <LastName>Morrison</LastName>
                    <ForeName>Christopher D</ForeName>
                    <Initials>CD</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Clin Invest</MedlineTA>
            <NlmUniqueID>7802877</NlmUniqueID>
            <ISSNLinking>0021-9738</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">74915</ArticleId>
            <ArticleId IdType="doi">10.1172/JCI74915</ArticleId>
            <ArticleId IdType="pubmed">25133427</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133425</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1558-8238</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of clinical investigation</Title>
                <ISOAbbreviation>J. Clin. Invest.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Periderm prevents pathological epithelial adhesions during embryogenesis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">71946</ELocationID>
            <ELocationID EIdType="doi">10.1172/JCI71946</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Appropriate development of stratified, squamous, keratinizing epithelia, such as the epidermis and oral epithelia, generates an outer protective permeability barrier that prevents water loss, entry of toxins, and microbial invasion. During embryogenesis, the immature ectoderm initially consists of a single layer of undifferentiated, cuboidal epithelial cells that stratifies to produce an outer layer of flattened periderm cells of unknown function. Here, we determined that periderm cells form in a distinct pattern early in embryogenesis, exhibit highly polarized expression of adhesion complexes, and are shed from the outer surface of the embryo late in development. Mice carrying loss-of-function mutations in the genes encoding IFN regulatory factor 6 (IRF6), I??B kinase-?? (IKK??), and stratifin (SFN) exhibit abnormal epidermal development, and we determined that mutant animals exhibit dysfunctional periderm formation, resulting in abnormal intracellular adhesions. Furthermore, tissue from a fetus with cocoon syndrome, a lethal disorder that results from a nonsense mutation in IKKA, revealed an absence of periderm. Together, these data indicate that periderm plays a transient but fundamental role during embryogenesis by acting as a protective barrier that prevents pathological adhesion between immature, adhesion-competent epithelia. Furthermore, this study suggests that failure of periderm formation underlies a series of devastating birth defects, including popliteal pterygium syndrome, cocoon syndrome, and Bartsocas-Papas syndrome.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Richardson</LastName>
                    <ForeName>Rebecca J</ForeName>
                    <Initials>RJ</Initials>
                </Author>
                <Author>
                    <LastName>Hammond</LastName>
                    <ForeName>Nigel L</ForeName>
                    <Initials>NL</Initials>
                </Author>
                <Author>
                    <LastName>Coulombe</LastName>
                    <ForeName>Pierre A</ForeName>
                    <Initials>PA</Initials>
                </Author>
                <Author>
                    <LastName>Saloranta</LastName>
                    <ForeName>Carola</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Nousiainen</LastName>
                    <ForeName>Heidi O</ForeName>
                    <Initials>HO</Initials>
                </Author>
                <Author>
                    <LastName>Salonen</LastName>
                    <ForeName>Riitta</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Berry</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Hanley</LastName>
                    <ForeName>Neil</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Headon</LastName>
                    <ForeName>Denis</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Karikoski</LastName>
                    <ForeName>Riitta</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Dixon</LastName>
                    <ForeName>Michael J</ForeName>
                    <Initials>MJ</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Clin Invest</MedlineTA>
            <NlmUniqueID>7802877</NlmUniqueID>
            <ISSNLinking>0021-9738</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">71946</ArticleId>
            <ArticleId IdType="doi">10.1172/JCI71946</ArticleId>
            <ArticleId IdType="pubmed">25133425</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133423</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1558-8238</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of clinical investigation</Title>
                <ISOAbbreviation>J. Clin. Invest.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Inflammatory lymphangiogenesis in postpartum breast tissue remodeling.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-4</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii">77765</ELocationID>
            <ELocationID EIdType="doi">10.1172/JCI77765</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Like many cancers, mammary carcinomas use lymphatic vessels to disseminate, and numerous clinical and experimental studies have documented a strong correlation between peritumoral lymphangiogenesis and tumor dissemination. At the same time, many other factors can affect the incidence, invasiveness, and mortality of breast cancer, including lactation history. Although lactation reduces overall cancer risk, patients diagnosed within 5 years of pregnancy have an increased incidence of metastatic disease. In this issue of the JCI, Lyons and colleagues demonstrate that postpartum breast tissue remodeling during involution coincides with inflammatory lymphangiogenesis. In mouse models, cyclooxygenase-2 (COX-2) inhibition during involution reduced the risk of cancer metastasis and correlated with decreased lymphangiogenesis. In addition to lymphangiogenesis, COX-2 inhibition reduces many of the immune-suppressive features of the tumor microenvironment, including development of myeloid-derived suppressor cells and regulatory T cells; therefore, these results support the notion that inhibiting COX-2 during lactation weaning may lessen the incidence of breast cancer metastasis.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Swartz</LastName>
                    <ForeName>Melody A</ForeName>
                    <Initials>MA</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Clin Invest</MedlineTA>
            <NlmUniqueID>7802877</NlmUniqueID>
            <ISSNLinking>0021-9738</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">77765</ArticleId>
            <ArticleId IdType="doi">10.1172/JCI77765</ArticleId>
            <ArticleId IdType="pubmed">25133423</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133400</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Proteomics-Identified Bvg-Activated Autotransporters Protect against Bordetella pertussis in a Mouse Model.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105011</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105011</ELocationID>
            <Abstract>
                <AbstractText>Pertussis is a highly infectious respiratory disease of humans caused by the bacterium Bordetella pertussis. Despite high vaccination coverage, pertussis has re-emerged globally. Causes for the re-emergence of pertussis include limited duration of protection conferred by acellular pertussis vaccines (aP) and pathogen adaptation. Pathogen adaptations involve antigenic divergence with vaccine strains, the emergence of strains which show enhanced in vitro expression of a number of virulence-associated genes and of strains that do not express pertactin, an important aP component. Clearly, the identification of more effective B. pertussis vaccine antigens is of utmost importance. To identify novel antigens, we used proteomics to identify B. pertussis proteins regulated by the master virulence regulatory system BvgAS in vitro. Five candidates proteins were selected and it was confirmed that they were also expressed in the lungs of na??ve mice seven days after infection. The five proteins were expressed in recombinant form, adjuvanted with alum and used to immunize mice as stand-alone antigens. Subsequent respiratory challenge showed that immunization with the autotransporters Vag8 and SphB1 significantly reduced bacterial load in the lungs. Whilst these antigens induced strong opsonizing antibody responses, we found that none of the tested alum-adjuvanted vaccines - including a three-component aP - reduced bacterial load in the nasopharynx, suggesting that alternative immunological responses may be required for efficient bacterial clearance from the nasopharynx.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gouw</LastName>
                    <ForeName>Daan de</ForeName>
                    <Initials>Dd</Initials>
                    <Affiliation>Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Centre, Nijmegen, The Netherlands; Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jonge</LastName>
                    <ForeName>Marien I de</ForeName>
                    <Initials>MI</Initials>
                    <Affiliation>Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Centre, Nijmegen, The Netherlands; Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hermans</LastName>
                    <ForeName>Peter W M</ForeName>
                    <Initials>PW</Initials>
                    <Affiliation>Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Centre, Nijmegen, The Netherlands; Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wessels</LastName>
                    <ForeName>Hans J C T</ForeName>
                    <Initials>HJ</Initials>
                    <Affiliation>Nijmegen Centre for Mitochondrial Disorders, Department of Laboratory Medicine, Radboud Proteomics Centre, Radboud University Medical Centre, Nijmegen, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zomer</LastName>
                    <ForeName>Aldert</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Centre, Nijmegen, The Netherlands; Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berends</LastName>
                    <ForeName>Alinda</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Centre, Nijmegen, The Netherlands; Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pratt</LastName>
                    <ForeName>Catherine</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Public Health England, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berbers</LastName>
                    <ForeName>Guy A</ForeName>
                    <Initials>GA</Initials>
                    <Affiliation>Netherlands Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mooi</LastName>
                    <ForeName>Frits R</ForeName>
                    <Initials>FR</Initials>
                    <Affiliation>Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Centre, Nijmegen, The Netherlands; Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands; Netherlands Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Diavatopoulos</LastName>
                    <ForeName>Dimitri A</ForeName>
                    <Initials>DA</Initials>
                    <Affiliation>Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Medical Centre, Nijmegen, The Netherlands; Laboratory of Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Epidemiol Infect. 2014 Apr;142(4):685-94</RefSource>
                <PMID Version="1">23406868</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Vaccine Immunol. 2014 Feb;21(2):119-25</RefSource>
                <PMID Version="1">24256623</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>MBio. 2014;5(2):e01074</RefSource>
                <PMID Version="1">24757216</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biotechnol. 1999 Oct 8;75(2-3):147-59</RefSource>
                <PMID Version="1">10553654</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Methods. 2001 Dec;25(4):402-8</RefSource>
                <PMID Version="1">11846609</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2003 Apr;71(4):1719-24</RefSource>
                <PMID Version="1">12654784</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Microbiol. 2003 Jul;49(2):529-39</RefSource>
                <PMID Version="1">12828647</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Genet. 2003 Sep;35(1):32-40</RefSource>
                <PMID Version="1">12910271</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Med Microbiol. 1988 Jul;26(3):177-80</RefSource>
                <PMID Version="1">3134550</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 1988 Jul 21;334(6179):255-8</RefSource>
                <PMID Version="1">2456466</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Vaccine. 1992;10(1):43-8</RefSource>
                <PMID Version="1">1539459</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Microbiol. 1992 Sep;6(17):2499-506</RefSource>
                <PMID Version="1">1406285</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 1993 Mar;61(3):807-15</RefSource>
                <PMID Version="1">8432601</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pediatr Infect Dis J. 2004 Nov;23(11):985-9</RefSource>
                <PMID Version="1">15545851</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4848-53</RefSource>
                <PMID Version="1">15781870</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Protein Expr Purif. 2005 May;41(1):106-12</RefSource>
                <PMID Version="1">15802227</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cell Proteomics. 2005 Sep;4(9):1265-72</RefSource>
                <PMID Version="1">15958392</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2005 Nov;73(11):7317-23</RefSource>
                <PMID Version="1">16239529</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Microbiol. 2006 Nov;62(3):641-54</RefSource>
                <PMID Version="1">16999837</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2006 Dec 1;177(11):7980-9</RefSource>
                <PMID Version="1">17114471</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pediatr Infect Dis J. 2007 Mar;26(3):238-42</RefSource>
                <PMID Version="1">17484221</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2008 Jun;76(6):2678-84</RefSource>
                <PMID Version="1">18391006</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Genomics. 2008;9:311</RefSource>
                <PMID Version="1">18590534</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Pathog. 2008;4(9):e1000159</RefSource>
                <PMID Version="1">18802458</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2009 Feb;77(2):885-95</RefSource>
                <PMID Version="1">19064638</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2009 Jul;119(7):1899-909</RefSource>
                <PMID Version="1">19509469</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2009 Sep 1;183(5):3294-301</RefSource>
                <PMID Version="1">19648276</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Emerg Infect Dis. 2009 Aug;15(8):1206-13</RefSource>
                <PMID Version="1">19751581</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cell Proteomics. 2010 Jan;9(1):131-44</RefSource>
                <PMID Version="1">19752006</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2010;5(1):e8734</RefSource>
                <PMID Version="1">20090944</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2010 Feb;78(2):704-15</RefSource>
                <PMID Version="1">19948837</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microbes Infect. 2010 Mar;12(3):238-45</RefSource>
                <PMID Version="1">20005302</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Infect Dis. 2010 May 15;50(10):1339-45</RefSource>
                <PMID Version="1">20370464</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Bioinformatics. 2010 Jul 1;26(13):1608-15</RefSource>
                <PMID Version="1">20472543</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2010 Aug 1;185(3):1711-9</RefSource>
                <PMID Version="1">20610650</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Genomics. 2010;11:627</RefSource>
                <PMID Version="1">21070624</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2010;5(12):e14183</RefSource>
                <PMID Version="1">21152071</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Protein Expr Purif. 2011 May;77(1):98-103</RefSource>
                <PMID Version="1">21130880</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FEMS Microbiol Rev. 2011 May;35(3):441-74</RefSource>
                <PMID Version="1">21204863</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2011;6(6):e20585</RefSource>
                <PMID Version="1">21695123</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Infect Immun. 2011 Sep;79(9):3697-710</RefSource>
                <PMID Version="1">21768284</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(2):e31985</RefSource>
                <PMID Version="1">22348138</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(4):e35874</RefSource>
                <PMID Version="1">22558249</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Infect Dis. 2012 Jun;54(12):1730-5</RefSource>
                <PMID Version="1">22423127</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Microbiology. 2012 Jul;158(Pt 7):1665-76</RefSource>
                <PMID Version="1">22628479</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Vaccine Immunol. 2012 Oct;19(10):1703-4</RefSource>
                <PMID Version="1">22914363</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(9):e46407</RefSource>
                <PMID Version="1">23029513</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS Pathog. 2013;9(4):e1003264</RefSource>
                <PMID Version="1">23592988</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mucosal Immunol. 2013 Jul;6(4):787-96</RefSource>
                <PMID Version="1">23187316</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Vaccine. 2013 Jun 28;31(31):3148-55</RefSource>
                <PMID Version="1">23684829</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Vaccine. 2013 Sep 23;31(41):4541-7</RefSource>
                <PMID Version="1">23933365</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Nurs. 2013 Oct 10-23;22(18):1046-50</RefSource>
                <PMID Version="1">24121847</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2014;9(1):e84523</RefSource>
                <PMID Version="1">24416242</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):787-92</RefSource>
                <PMID Version="1">24277828</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Emerg Infect Dis. 2014 Apr;20(4):626-33</RefSource>
                <PMID Version="1">24655754</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136822</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105011</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-23742</ArticleId>
            <ArticleId IdType="pubmed">25133400</ArticleId>
            <ArticleId IdType="pmc">PMC4136822</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133396</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Differential Modulation by IL-17A of Cholangitis versus Colitis in IL-2R?? Deleted Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105351</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105351</ELocationID>
            <Abstract>
                <AbstractText>IFN-?? is a signature Th1 cell associated cytokine critical for the inflammatory response in autoimmunity with both pro-inflammatory and potentially protective functions. IL-17A is the hallmark of T helper 17 (Th17) cell subsets, produced by ????T, CD8+ T, NK and NKT cells. We have taken advantage of our colony of IL-2R??-/- mice that spontaneously develop both autoimmune cholangitis and inflammatory bowel disease. In this model CD8+ T cells mediate biliary ductular damage, whereas CD4+ T cells mediate induction of colon-specific autoimmunity. Importantly, IL-2R??-/- mice have high levels of interferon ?? (IFN-??), and interleukin-17A (IL-17A). We produced unique double deletions of mice that were either IL-17A-/-IL-2R??-/- or IFN-??-/-IL-2R??-/- to specifically address the precise role of these two cytokines in the natural history of autoimmune cholangitis and colitis. Of note, deletion of IL-17A in IL-2R??-/- mice led to more severe liver inflammation, but ameliorated colitis. In contrast, there were no significant changes in the immunopathology of double knock-out IFN-??-/- IL-2R??-/- mice, compared to single knock-out IL-2R??-/- mice with respect to cholangitis or colitis. Furthermore, there was a significant increase in pathogenetic CD8+ T cells in the liver of IL-17A-/-IL-2R??-/- mice. Our data suggest that while IL-17A plays a protective role in autoimmune cholangitis, it has a pro-inflammatory role in inflammatory bowel disease. These data take on particular significance in the potential use of anti-IL-17A therapy in humans with primary biliary cirrhosis.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Liver Immunology Laboratory, Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yao</LastName>
                    <ForeName>Yuan</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Liver Immunology Laboratory, Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Yan-Qing</ForeName>
                    <Initials>YQ</Initials>
                    <Affiliation>Liver Immunology Laboratory, Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lu</LastName>
                    <ForeName>Fang-Ting</ForeName>
                    <Initials>FT</Initials>
                    <Affiliation>Liver Immunology Laboratory, Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Liang</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Liver Immunology Laboratory, Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yin-Hu</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Liver Immunology Laboratory, Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakajima</LastName>
                    <ForeName>Takahiko</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Diagnostic Pathology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsuneyama</LastName>
                    <ForeName>Koichi</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Diagnostic Pathology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ridgway</LastName>
                    <ForeName>William M</ForeName>
                    <Initials>WM</Initials>
                    <Affiliation>Division of Immunology, Allergy and Rheumatology, University of Cincinnati, Cincinnati, OH, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gershwin</LastName>
                    <ForeName>M Eric</ForeName>
                    <Initials>ME</Initials>
                    <Affiliation>Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lian</LastName>
                    <ForeName>Zhe-Xiong</ForeName>
                    <Initials>ZX</Initials>
                    <Affiliation>Liver Immunology Laboratory, Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, China; Innovation Center for Cell Biology, Hefei National Laboratory for Physical Sciences at Microscale, Hefei, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2003 Mar 1;170(5):2323-30</RefSource>
                <PMID Version="1">12594254</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2009 Jan;10(1):66-74</RefSource>
                <PMID Version="1">19029905</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 1995 Oct;3(4):521-30</RefSource>
                <PMID Version="1">7584142</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cytokine. 1998 Nov;10(11):841-50</RefSource>
                <PMID Version="1">9878122</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Rev. 2004 Dec;202:96-105</RefSource>
                <PMID Version="1">15546388</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2005 Jan 17;201(2):233-40</RefSource>
                <PMID Version="1">15657292</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2005 Mar;22(3):285-94</RefSource>
                <PMID Version="1">15780986</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Inflamm Bowel Dis. 2006 May;12(5):382-8</RefSource>
                <PMID Version="1">16670527</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hepatology. 2006 Nov;44(5):1240-9</RefSource>
                <PMID Version="1">17058261</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2006 Nov 15;177(10):6852-8</RefSource>
                <PMID Version="1">17082599</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2007 Apr 1;178(7):4548-56</RefSource>
                <PMID Version="1">17372013</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2007 Apr;117(4):871-3</RefSource>
                <PMID Version="1">17404615</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterology. 2007 Jun;132(7):2359-70</RefSource>
                <PMID Version="1">17570211</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Immunol. 2008 Jan;251(1):50-5</RefSource>
                <PMID Version="1">18423430</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2008 Sep 1;112(5):2101-10</RefSource>
                <PMID Version="1">18596226</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hepatology. 2009 Jan;49(1):133-40</RefSource>
                <PMID Version="1">19065673</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hepatology. 2009 Feb;49(2):646-57</RefSource>
                <PMID Version="1">19177575</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Autoimmun. 2009 Feb;32(1):43-51</RefSource>
                <PMID Version="1">19101114</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2009 Jun;10(6):603-9</RefSource>
                <PMID Version="1">19448631</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Exp Immunol. 2009 Aug;157(2):261-70</RefSource>
                <PMID Version="1">19604266</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Immunol. 2009 Aug;9(8):556-67</RefSource>
                <PMID Version="1">19575028</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Rheumatol Rep. 2009 Oct;11(5):365-70</RefSource>
                <PMID Version="1">19772832</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Rheumatol. 2009 Oct;5(10):549-53</RefSource>
                <PMID Version="1">19798029</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterology. 2009 Dec;137(6):2125-35.e1-2</RefSource>
                <PMID Version="1">19686746</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hepatology. 2010 Jan;51(1):81-91</RefSource>
                <PMID Version="1">19842207</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Immunol. 2010 Jan;30(1):60-7</RefSource>
                <PMID Version="1">19756987</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Immunol. 2010 Jun;11(6):471-6</RefSource>
                <PMID Version="1">20485275</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Mol Immunol. 2010 Jul;7(4):250-4</RefSource>
                <PMID Version="1">20305686</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2011 May 9;208(5):1027-40</RefSource>
                <PMID Version="1">21518800</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hepatology. 2012 Oct;56(4):1418-26</RefSource>
                <PMID Version="1">22532156</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Pathol. 2013 Jan 24;8:303-30</RefSource>
                <PMID Version="1">23347352</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Immunol. 2004 Jan;110(1):55-62</RefSource>
                <PMID Version="1">14962796</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136813</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105351</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-03973</ArticleId>
            <ArticleId IdType="pubmed">25133396</ArticleId>
            <ArticleId IdType="pmc">PMC4136813</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133393</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>MiR-152 May Silence Translation of CaMK II and Induce Spontaneous Immune Tolerance in Mouse Liver Transplantation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105096</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105096</ELocationID>
            <Abstract>
                <AbstractText>Spontaneous immune tolerance in mouse liver transplantation has always been a hotspot in transplantation-immune research. Recent studies revealed that regulatory T cells (Tregs), hepatic satellite cells and Kupffer cells play a potential role in spontaneous immune tolerance, however the precise mechanism of spontaneous immune tolerance is still undefined. By using Microarray Chips, we investigated different immune regulatory factors to decipher critical mechanisms of spontaneous tolerance after mouse liver transplantation. Allogeneic (C57BL/6-C3H) and syngeneic (C3H-C3H) liver transplantation were performed by 6-8 weeks old male C57BL/6 and C3H mice. Graft samples (N???=???4 each group) were collected from 8 weeks post-operation mice. 11 differentially expressed miRNAs in allogeneic grafts (Allografts) vs. syngeneic grafts (Syngrafts) were identified using Agilent Mouse miRNA Chips. It was revealed that 185 genes were modified by the 11 miRNAs, furthermore, within the 185 target genes, 11 of them were tightly correlated with immune regulation after Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and Genbank data cross-comparison. Verified by real-time PCR and western blot, our results indicated that mRNA expression levels of IL-6 and TAB2 were respectively down regulated following miR-142-3p and miR-155 augment. In addition, increased miR-152 just silenced mRNA of CaMK II and down-regulated translation of CaMK II in tolerated liver grafts, which may play a critical role in immune regulation and spontaneous tolerance induction of mouse liver transplantation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tian</LastName>
                    <ForeName>Yang</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ding</LastName>
                    <ForeName>Yuan</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jingcheng</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yan</LastName>
                    <ForeName>Sheng</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Lin</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xie</LastName>
                    <ForeName>Haiyang</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Jinhua</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Jiacong</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>Shusen</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Transplantation. 2001 Mar 27;71(6):711-3</RefSource>
                <PMID Version="1">11330529</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Transplant Proc. 1991 Feb;23(1 Pt 1):705-6</RefSource>
                <PMID Version="1">1990658</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Transplant Proc. 1995 Feb;27(1):509-10</RefSource>
                <PMID Version="1">7879081</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Transplant. 2005 May;5(5):978-86</RefSource>
                <PMID Version="1">15816877</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2005 Jul 1;175(1):139-46</RefSource>
                <PMID Version="1">15972640</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Transplantation. 2006 Nov 15;82(9):1202-9</RefSource>
                <PMID Version="1">17102772</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hepatology. 2008 Jan;47(1):296-305</RefSource>
                <PMID Version="1">17975811</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Mol Cell Biol. 2008 Mar;9(3):219-30</RefSource>
                <PMID Version="1">18270516</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Transplant. 2008 Aug;8(8):1639-51</RefSource>
                <PMID Version="1">18557727</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Transplant. 2008 Nov;8(11):2297-306</RefSource>
                <PMID Version="1">18925901</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Transplantation. 2008 Nov 27;86(10):1370-8</RefSource>
                <PMID Version="1">19034005</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Transpl Immunol. 2009 Mar;20(4):229-31</RefSource>
                <PMID Version="1">19038339</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Presse Med. 2009 Sep;38(9):1307-13</RefSource>
                <PMID Version="1">19651486</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Transplant. 2010 Jan;10(1):40-6</RefSource>
                <PMID Version="1">19889124</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Transplant. 2010 Apr;10(4):713-9</RefSource>
                <PMID Version="1">20199506</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hepatology. 2010 May;51(5):1735-43</RefSource>
                <PMID Version="1">20432256</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2010 Dec 15;185(12):7244-51</RefSource>
                <PMID Version="1">21068402</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gastroenterol Hepatol. 2011 Mar;34(3):155-69</RefSource>
                <PMID Version="1">21376423</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FASEB J. 2011 May;25(5):1758-66</RefSource>
                <PMID Version="1">21285396</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 2011 Jun 9;117(23):6172-83</RefSource>
                <PMID Version="1">21474672</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11193-8</RefSource>
                <PMID Version="1">21690378</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Genet. 2011 Dec;12(12):861-74</RefSource>
                <PMID Version="1">22094949</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Invest Dermatol. 2012 Mar;132(3 Pt 1):658-66</RefSource>
                <PMID Version="1">22113482</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Sheng Li Xue Bao. 2012 Feb 25;64(1):101-6</RefSource>
                <PMID Version="1">22348968</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Am Soc Nephrol. 2012 Apr;23(4):597-606</RefSource>
                <PMID Version="1">22282590</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2012 Jul 1;189(1):211-21</RefSource>
                <PMID Version="1">22649192</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Liver Transpl. 2012 Jul;18(7):761-70</RefSource>
                <PMID Version="1">22523007</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Transplantation. 2012 Jul 27;94(2):123-31</RefSource>
                <PMID Version="1">22743548</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Transplantation. 2012 Jul 27;94(2):132-8</RefSource>
                <PMID Version="1">22766769</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Inflamm Allergy Drug Targets. 2012 Aug 1;11(4):262-5</RefSource>
                <PMID Version="1">22452603</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nucleic Acids Res. 2012 Sep 1;40(17):e135</RefSource>
                <PMID Version="1">22645320</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Transplant. 2012 Dec;12(12):3449-61</RefSource>
                <PMID Version="1">22994804</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Transplant. 2013 Jan;13(1):11-9</RefSource>
                <PMID Version="1">23136949</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Lett. 2013 Feb 28;329(2):146-54</RefSource>
                <PMID Version="1">23142217</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Transplant. 2013 Mar;13(3):569-79</RefSource>
                <PMID Version="1">23356407</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2013 Apr 15;190(8):4037-45</RefSource>
                <PMID Version="1">23509369</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2013 Apr 19;288(16):11074-9</RefSource>
                <PMID Version="1">23449975</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Anaesthesiol. 2013 Jun;26(3):382-90</RefSource>
                <PMID Version="1">23632566</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Organ Transplant. 2013 Jun;18(3):345-53</RefSource>
                <PMID Version="1">23619515</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Prostate. 2013 Jul;73(10):1082-9</RefSource>
                <PMID Version="1">23460133</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dig Dis. 2013;31(1):164-9</RefSource>
                <PMID Version="1">23797139</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Transplantation. 2013 Jul 15;96(1):17-24</RefSource>
                <PMID Version="1">23756770</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):122-34</RefSource>
                <PMID Version="1">23910616</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(9):e74782</RefSource>
                <PMID Version="1">24086374</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Oncol Res. 2012;20(12):557-64</RefSource>
                <PMID Version="1">24139413</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Allergy Clin Immunol. 2014 May;133(5):1429-38, 1438.e1-7</RefSource>
                <PMID Version="1">24373357</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136864</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105096</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-11703</ArticleId>
            <ArticleId IdType="pubmed">25133393</ArticleId>
            <ArticleId IdType="pmc">PMC4136864</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133392</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pyridostigmine restores cardiac autonomic balance after small myocardial infarction in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e104476</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0104476</ELocationID>
            <Abstract>
                <AbstractText>The effect of pyridostigmine (PYR) - an acetylcholinesterase inhibitor - on hemodynamics and cardiac autonomic control, was never studied in conscious myocardial infarcted mice. Telemetry transmitters were implanted into the carotid artery under isoflurane anesthesia. Seven to ten days after recovery from the surgery, basal arterial pressure and heart rate were recorded, while parasympathetic and sympathetic tone (??HR) was evaluated by means of methyl atropine and propranolol. After the basal hemodynamic recording the mice were subjected to left coronary artery ligation for producing myocardial infarction (MI), or sham operation, and implantation of minipumps filled with PYR or saline. Separate groups of anesthetized (isoflurane) mice previously (4 weeks) subjected to MI, or sham coronary artery ligation, were submitted to cardiac function examination. The mice exhibited an infarct length of approximately 12%, no change in arterial pressure and increased heart rate only in the 1st week after MI. Vagal tone decreased in the 1st week, while the sympathetic tone was increased in the 1st and 4th week after MI. PYR prevented the increase in heart rate but did not affect the arterial pressure. Moreover, PYR prevented the increase in sympathetic tone throughout the 4 weeks. Concerning the parasympathetic tone, PYR not only impaired its attenuation in the 1st week, but enhanced it in the 4th week. MI decreased ejection fraction and increased diastolic and systolic volume. Therefore, the pharmacological increase of peripheral acetylcholine availability by means of PYR prevented tachycardia, increased parasympathetic and decreased sympathetic tone after MI in mice.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Durand</LastName>
                    <ForeName>Marina T</ForeName>
                    <Initials>MT</Initials>
                    <Affiliation>Department of Physiology, School of Medicine of Ribeir??o Preto, University of S??o Paulo, Ribeir??o Preto, S??o Paulo, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Becari</LastName>
                    <ForeName>Christiane</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Physiology, School of Medicine of Ribeir??o Preto, University of S??o Paulo, Ribeir??o Preto, S??o Paulo, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oliveira</LastName>
                    <ForeName>Mauro de</ForeName>
                    <Initials>Md</Initials>
                    <Affiliation>Department of Physiology, School of Medicine of Ribeir??o Preto, University of S??o Paulo, Ribeir??o Preto, S??o Paulo, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>do Carmo</LastName>
                    <ForeName>Jussara M</ForeName>
                    <Initials>JM</Initials>
                    <Affiliation>Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aguiar Silva</LastName>
                    <ForeName>Carlos Alberto</ForeName>
                    <Initials>CA</Initials>
                    <Affiliation>Department of Physiology, School of Medicine of Ribeir??o Preto, University of S??o Paulo, Ribeir??o Preto, S??o Paulo, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prado</LastName>
                    <ForeName>Cibele M</ForeName>
                    <Initials>CM</Initials>
                    <Affiliation>Department of Pathology, School of Medicine of Ribeir??o Preto, University of S??o Paulo, Ribeir??o Preto, S??o Paulo, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fazan</LastName>
                    <ForeName>Rubens</ForeName>
                    <Initials>R</Initials>
                    <Suffix>Jr</Suffix>
                    <Affiliation>Department of Physiology, School of Medicine of Ribeir??o Preto, University of S??o Paulo, Ribeir??o Preto, S??o Paulo, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Salgado</LastName>
                    <ForeName>Helio C</ForeName>
                    <Initials>HC</Initials>
                    <Affiliation>Department of Physiology, School of Medicine of Ribeir??o Preto, University of S??o Paulo, Ribeir??o Preto, S??o Paulo, Brazil.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hypertension. 2000 Feb;35(2):E1-5</RefSource>
                <PMID Version="1">10679520</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Heart Fail Rev. 2011 Mar;16(2):179-93</RefSource>
                <PMID Version="1">20924667</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Card Surg. 1999 Nov-Dec;14(6):401-7</RefSource>
                <PMID Version="1">11021364</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Physiol Genomics. 2001 Mar 8;5(2):89-97</RefSource>
                <PMID Version="1">11242593</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Auton Res. 2001 Feb;11(1):11-7</RefSource>
                <PMID Version="1">11503945</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pharmacol Biochem Behav. 2003 Mar;74(4):901-7</RefSource>
                <PMID Version="1">12667905</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Heart. 2003 Aug;89(8):854-8</RefSource>
                <PMID Version="1">12860856</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am Heart J. 2003 Sep;146(3):494-500</RefSource>
                <PMID Version="1">12947369</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Heart Circ Physiol. 2003 Oct;285(4):H1632-40</RefSource>
                <PMID Version="1">12829433</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Circulation. 2004 Jan 6;109(1):120-4</RefSource>
                <PMID Version="1">14662714</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H1201-7</RefSource>
                <PMID Version="1">14766681</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cardiovasc Pathol. 2004 Mar-Apr;13(2):91-7</RefSource>
                <PMID Version="1">15033158</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Auton Neurosci. 2004 Jun 30;113(1-2):24-31</RefSource>
                <PMID Version="1">15296792</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Heart. 2004 Oct;90(10):1119-23</RefSource>
                <PMID Version="1">15367503</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Appl Physiol. 1969 Oct;27(4):465-70</RefSource>
                <PMID Version="1">5822553</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 1971 Oct 14;285(16):877-83</RefSource>
                <PMID Version="1">4398792</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Circ Res. 1971 Nov;29(5):437-45</RefSource>
                <PMID Version="1">4330524</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol. 1980 Mar;238(3):H275-81</RefSource>
                <PMID Version="1">6245589</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol. 1980 Dec;239(6):H713-20</RefSource>
                <PMID Version="1">7192494</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Fed Proc. 1984 Aug;43(11):2618-23</RefSource>
                <PMID Version="1">6086411</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 1990 May;85(5):1362-71</RefSource>
                <PMID Version="1">2332495</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Auton Nerv Syst. 1991 Mar;32(3):233-42</RefSource>
                <PMID Version="1">1645381</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Am Coll Cardiol. 1991 Aug;18(2):464-72</RefSource>
                <PMID Version="1">1856414</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Appl Physiol (1985). 1998 Apr;84(4):1234-41</RefSource>
                <PMID Version="1">9516189</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol. 1998 May;274(5 Pt 2):H1812-20</RefSource>
                <PMID Version="1">9612394</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Basic Res Cardiol. 1999 Apr;94(2):78-84</RefSource>
                <PMID Version="1">10326655</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Circulation. 1999 Jul 20;100(3):274-9</RefSource>
                <PMID Version="1">10411852</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H586-92</RefSource>
                <PMID Version="1">15764682</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Cardiol. 2006 Feb 8;107(1):138-9</RefSource>
                <PMID Version="1">16337518</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Circulation. 2007 Feb 13;115(6):792-9</RefSource>
                <PMID Version="1">17296868</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Appl Physiol (1985). 2007 Jun;102(6):2104-11</RefSource>
                <PMID Version="1">17347379</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H86-92</RefSource>
                <PMID Version="1">17322413</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H810-20</RefSource>
                <PMID Version="1">18055517</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Cardiol. 2008 Apr 25;125(3):418-21</RefSource>
                <PMID Version="1">17397949</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Circulation. 2008 Aug 19;118(8):863-71</RefSource>
                <PMID Version="1">18711023</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Protoc. 2008;3(9):1422-34</RefSource>
                <PMID Version="1">18772869</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Card Fail. 2009 Mar;15(2):124-9</RefSource>
                <PMID Version="1">19254671</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Card Fail. 2009 Nov;15(9):805-11</RefSource>
                <PMID Version="1">19879468</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Circ Heart Fail. 2009 Nov;2(6):692-9</RefSource>
                <PMID Version="1">19919995</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Physiol Sci. 2010 Jan;60(1):67-74</RefSource>
                <PMID Version="1">19949913</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Braz J Med Biol Res. 2010 Feb;43(2):211-6</RefSource>
                <PMID Version="1">20084332</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Heart Fail Rev. 2011 Mar;16(2):195-203</RefSource>
                <PMID Version="1">21165697</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am Heart J. 2012 Jun;163(6):954-962.e1</RefSource>
                <PMID Version="1">22709747</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Auton Neurosci. 2013 Jan;173(1-2):58-64</RefSource>
                <PMID Version="1">23218833</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Med. 2013 Jun;126(6):515-22</RefSource>
                <PMID Version="1">23597799</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Exp Pharmacol Physiol. 2013 Sep;40(9):610-6</RefSource>
                <PMID Version="1">23701019</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Regul Integr Comp Physiol. 2013 Oct 15;305(8):R908-16</RefSource>
                <PMID Version="1">23948774</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Cell Biol. 2010 Apr;30(7):1746-56</RefSource>
                <PMID Version="1">20123977</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Circ Res. 2010 Jun 11;106(11):1763-74</RefSource>
                <PMID Version="1">20413786</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Mol Cell Cardiol. 2010 Aug;49(2):234-44</RefSource>
                <PMID Version="1">20302876</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Heart Fail Rev. 2011 Mar;16(2):101-7</RefSource>
                <PMID Version="1">20577900</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Heart Fail Rev. 2011 Mar;16(2):129-35</RefSource>
                <PMID Version="1">20820912</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Heart Circ Physiol. 2000 Jul;279(1):H422-8</RefSource>
                <PMID Version="1">10899082</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4136726</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0104476</ArticleId>
            <ArticleId IdType="pii">PONE-D-13-53945</ArticleId>
            <ArticleId IdType="pubmed">25133392</ArticleId>
            <ArticleId IdType="pmc">PMC4136726</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133350</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-1484</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>236</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>5</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Atherosclerosis</Title>
                <ISOAbbreviation>Atherosclerosis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cartilage oligomeric matrix protein (COMP) in murine brachiocephalic and carotid atherosclerotic lesions.</ArticleTitle>
            <Pagination>
                <MedlinePgn>366-372</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii">S0021-9150(14)01305-7</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.atherosclerosis.2014.07.029</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the hypothesis that COMP can influence the morphology, stability and size of murine atherosclerotic lesions.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">ApoE- and ApoE/COMP-knockout mice were fed a high-fat diet to develop atherosclerotic plaques at lesion sites of three different types; inflammatory and fibrous plaques induced in the carotid artery by low or oscillatory shear stress, respectively, and spontaneously developing plaques in the brachiocephalic artery. The localization of COMP in the plaques and the effect of COMP deficiency on plaque development were evaluated.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">COMP immunoreactivity was observed in about half of the investigated plaques from the ApoE null mice, mainly located along the intima-medial border. There were no significant differences in the size of inflammatory and fibrous carotid plaques between the genotypes. Plaques in the brachiocephalic artery from ApoE mice lacking COMP were increased in size with 54%. In these plaques the collagen content was also increased by 48%. There were no differences in relative collagen content in inflammatory and fibrous carotid plaques between genotypes. Polarized light microscopy showed that the increase in total collagen in brachiocephalic plaques was more than proportionally accounted for by an increase in thicker collagen fibrils.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We have shown that COMP deficiency has a significant impact on atherosclerotic plaque morphology and size. Our data also suggest that an altered collagen metabolism may be an important mechanism in this finding.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Ireland Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Bond</LastName>
                    <ForeName>Andrew R</ForeName>
                    <Initials>AR</Initials>
                    <Affiliation>Bristol Heart Institute, University of Bristol, Level 7, Bristol Royal Infirmary, Marlborough St, Bristol BS2 8HW, UK. Electronic address: andrew.bond@bristol.ac.uk.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hultg??rdh-Nilsson</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>University of Lund, Institute for Experimental Medical Science, Vascular Wall Biology, BMC B12, 22184 Lund, Sweden. Electronic address: anna.hultgardh@med.lu.se.</Affiliation>
                </Author>
                <Author>
                    <LastName>Knutsson</LastName>
                    <ForeName>Anki</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>University of Lund, Institute for Experimental Medical Science, Vascular Wall Biology, BMC B12, 22184 Lund, Sweden. Electronic address: anki.knutsson@med.lu.se.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jackson</LastName>
                    <ForeName>Christopher L</ForeName>
                    <Initials>CL</Initials>
                    <Affiliation>Bristol Heart Institute, University of Bristol, Level 7, Bristol Royal Infirmary, Marlborough St, Bristol BS2 8HW, UK. Electronic address: chris.jackson@bristol.ac.uk.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rauch</LastName>
                    <ForeName>Uwe</ForeName>
                    <Initials>U</Initials>
                    <Affiliation>University of Lund, Institute for Experimental Medical Science, Vascular Wall Biology, BMC B12, 22184 Lund, Sweden. Electronic address: uwe.rauch@med.lu.se.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Atherosclerosis</MedlineTA>
            <NlmUniqueID>0242543</NlmUniqueID>
            <ISSNLinking>0021-9150</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ApoE-KO mouse</Keyword>
            <Keyword MajorTopicYN="N">Atherosclerosis</Keyword>
            <Keyword MajorTopicYN="N">COMP</Keyword>
            <Keyword MajorTopicYN="N">Collagen fibre</Keyword>
            <Keyword MajorTopicYN="N">Plaque morphology</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0021-9150(14)01305-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.atherosclerosis.2014.07.029</ArticleId>
            <ArticleId IdType="pubmed">25133350</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133313</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1557-7600</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medicinal food</Title>
                <ISOAbbreviation>J Med Food</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Ligularia fischeri Extract Protects Against Oxidative-Stress-Induced Neurotoxicity in Mice and PC12 Cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Abstract Alzheimer's disease (AD) is pathologically characterized by the presence of amyloid plaques in brain and the overproduction of amyloid beta (A??), leading to learning and memory impairment and intense oxidative stress. In this study, the protective effect of Ligularia fischeri extract was investigated using PC12 cells. L. fischeri extract attenuated hydrogen-peroxide-induced DNA fragmentation in cells. In vivo behavioral tests were performed to examine the effects of the extract on amyloid-?? peptide1-42-induced impairment of learning and memory in mice. A diet containing the extract increased alternation behaviors in the Y-maze test and step-through latency of passive avoidance task. Moreover, we found that consumption of the extract decreased lipid peroxidation in a biochemical study of brain tissue in mice. High-performance liquid chromatography was used to identify the active compounds in the extract. These results suggest that L. fischeri extract could be protective against A??-induced neurotoxicity, possibly due to the antioxidative capacity of its constituent, 3-O-caffeoylquinic acid.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Choi</LastName>
                    <ForeName>Soo Jung</ForeName>
                    <Initials>SJ</Initials>
                    <Affiliation>1 Functional Food Research Center, Korea University , Seoul, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Jae Kyeom</ForeName>
                    <Initials>JK</Initials>
                </Author>
                <Author>
                    <LastName>Suh</LastName>
                    <ForeName>Soo Hwan</ForeName>
                    <Initials>SH</Initials>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Cho Rong</ForeName>
                    <Initials>CR</Initials>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Hye Kyung</ForeName>
                    <Initials>HK</Initials>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Chang-Ju</ForeName>
                    <Initials>CJ</Initials>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Gwi Gun</ForeName>
                    <Initials>GG</Initials>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Cheung-Seog</ForeName>
                    <Initials>CS</Initials>
                </Author>
                <Author>
                    <LastName>Shin</LastName>
                    <ForeName>Dong-Hoon</ForeName>
                    <Initials>DH</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Med Food</MedlineTA>
            <NlmUniqueID>9812512</NlmUniqueID>
            <ISSNLinking>1096-620X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">3-O-caffeoylquinic acid</Keyword>
            <Keyword MajorTopicYN="N">Ligularia fischeri</Keyword>
            <Keyword MajorTopicYN="N">amyloid beta peptide</Keyword>
            <Keyword MajorTopicYN="N">oxidative stress</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1089/jmf.2013.3014</ArticleId>
            <ArticleId IdType="pubmed">25133313</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133292</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1523-7052</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Organic letters</Title>
                <ISOAbbreviation>Org. Lett.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Development of Bifunctional Chelates Bearing Hydroxamate Arms for Highly Efficient (64)Cu Radiolabeling.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Convenient approaches for the synthesis of DOTHA2 and NOTHA2, two cyclic bifunctional chelates (BFCs) bearing hydroxamate arms, have been developed. These novel BFCs coordinate (64)Cu with fast kinetics at room temperature in a wide range of concentrations and pH. The corresponding radiochemical complexes showed high stability, low residual activity in various tissues, and fast clearance in normal mice. The ability to conjugate DOTHA2 to both a small peptide and a large protein is also reported.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ait-Mohand</LastName>
                    <ForeName>Samia</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Nuclear Medicine and Radiobiology, Universit?? de Sherbrooke , 3001 12th North Avenue Sherbrooke, Quebec J1H 5N4, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Denis</LastName>
                    <ForeName>C??line</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Tremblay</LastName>
                    <ForeName>Genevi??ve</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Paquette</LastName>
                    <ForeName>Michel</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Gu??rin</LastName>
                    <ForeName>Brigitte</ForeName>
                    <Initials>B</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Org Lett</MedlineTA>
            <NlmUniqueID>100890393</NlmUniqueID>
            <ISSNLinking>1523-7052</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ol5020575</ArticleId>
            <ArticleId IdType="pubmed">25133292</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133276</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>15</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1520-6017</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>103</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of pharmaceutical sciences</Title>
                <ISOAbbreviation>J Pharm Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Recombinant murine growth hormone particles are more immunogenic with intravenous than subcutaneous administration.</ArticleTitle>
            <Pagination>
                <MedlinePgn>128-39</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Evaluation and mitigation of the risk of immunogenicity to protein aggregates and particles in therapeutic protein products remains a primary concern for drug developers and regulatory agencies. To investigate how the presence of protein particles and the route of administration influence the immunogenicity of a model therapeutic protein, we measured the immune response in mice to injections of formulations of recombinant murine growth hormone (rmGH) that contained controlled levels of protein particles. Mice were injected twice over 6 weeks with rmGH formulations via the subcutaneous, intraperitoneal, or intravenous (i.v.) routes. In addition to soluble, monomeric rmGH, the samples prepared contained either nanoparticles of rmGH or both nano- and microparticles of rmGH.The appearance of anti-rmGH IgG1, IgG2a, IgG2b, IgG2c, and IgG3 titers following the second injection of both preparations implies that multiple mechanisms contributed to the immune response. No dependence of the immune response on particle size and distribution was observed. The immune response measured after the second injection was most pronounced when i.v. administration was used. Despite producing high anti-rmGH titers mice appeared to retain the ability to properly regulate and use endogenous growth hormone.</AbstractText>
                <CopyrightInformation>2013 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Christie</LastName>
                    <ForeName>Merry</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Dever, Anschutz Medical Campus, Aurora, Colorado 80045. merry.christie@ucdenver.edu</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Torres</LastName>
                    <ForeName>Raul M</ForeName>
                    <Initials>RM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kedl</LastName>
                    <ForeName>Ross M</ForeName>
                    <Initials>RM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Randolph</LastName>
                    <ForeName>Theodore W</ForeName>
                    <Initials>TW</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carpenter</LastName>
                    <ForeName>John F</ForeName>
                    <Initials>JF</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 EB006006</GrantID>
                    <Acronym>EB</Acronym>
                    <Agency>NIBIB NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 EB006006-01</GrantID>
                    <Acronym>EB</Acronym>
                    <Agency>NIBIB NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>T32 GM008732</GrantID>
                    <Acronym>GM</Acronym>
                    <Agency>NIGMS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
                <PublicationType>Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Pharm Sci</MedlineTA>
            <NlmUniqueID>2985195R</NlmUniqueID>
            <ISSNLinking>0022-3549</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <OtherID Source="NLM">NIHMS540702 [Available on 01/01/15]</OtherID>
        <OtherID Source="NLM">PMC4137484 [Available on 01/01/15]</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2015</Year>
                <Month>1</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25133276</ArticleId>
            <ArticleId IdType="pmc">PMC4137484</ArticleId>
            <ArticleId IdType="mid">NIHMS540702</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133251</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1537-744X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>TheScientificWorldJournal</Title>
                <ISOAbbreviation>ScientificWorldJournal</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Highly effective ex vivo gene manipulation to study kidney development using self-complementary adenoassociated viruses.</ArticleTitle>
            <Pagination>
                <MedlinePgn>682189</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/682189</ELocationID>
            <Abstract>
                <AbstractText>Background. Ex vivo culture of intact embryonic kidney has become a powerful system for studying renal development. However, few methods have been available for gene manipulation and have impeded the identification and investigation of genes in this developmental process. Results. Here we systemically compared eight different serotypes of pseudotyped self-complementary adenoassociated viruses (scAAVs) transduction in cultured embryonic kidney with a modified culture procedure. We demonstrated that scAAV was highly effective in delivering genes into and expressing in compacted tissues. scAAV serotypes 2 and 8 exhibited higher efficiency of transduction compared to others. Expression kinetics assay revealed that scAAV can be used for gene manipulation at the study of UB branching and nephrogenesis. Repressing WT1 in cultured kidney using shRNA impairs tubule formation. We for the first time employed and validated scAAV as a gene delivery tool in cultured kidney. Conclusions. These findings are expected to expedite the use of the ex vivo embryonic kidney cultures for kidney development research. For other ex vivo cultured organ models, scAAV could also be a promising tool for organogenesis study.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Tie-Lin</ForeName>
                    <Initials>TL</Initials>
                    <Affiliation>Core Facility of Genetically Engineered Mice, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Hong-Lian</ForeName>
                    <Initials>HL</Initials>
                    <Affiliation>Core Facility of Genetically Engineered Mice, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Yun-Hong</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Core Facility of Genetically Engineered Mice, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fang</LastName>
                    <ForeName>Yin</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Core Facility of Genetically Engineered Mice, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>Rui-Zhi</ForeName>
                    <Initials>RZ</Initials>
                    <Affiliation>Core Facility of Genetically Engineered Mice, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Pu-Hui</ForeName>
                    <Initials>PH</Initials>
                    <Affiliation>College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Qin</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Core Facility of Genetically Engineered Mice, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lv</LastName>
                    <ForeName>Xiao-Yan</ForeName>
                    <Initials>XY</Initials>
                    <Affiliation>Departments of Dermatology, West China Hospital, Sichuan University, Sichuan 610041, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>ScientificWorldJournal</MedlineTA>
            <NlmUniqueID>101131163</NlmUniqueID>
            <ISSNLinking>1537-744X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3428-32</RefSource>
                <PMID Version="1">10688913</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Development. 2011 Oct;138(19):4245-54</RefSource>
                <PMID Version="1">21852398</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Am Soc Nephrol. 2003 Apr;14(4):947-58</RefSource>
                <PMID Version="1">12660329</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gene Ther. 2003 Dec;10(26):2105-11</RefSource>
                <PMID Version="1">14625564</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gene Ther. 2003 Dec;10(26):2112-8</RefSource>
                <PMID Version="1">14625565</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Mol Genet. 2004 Jan 15;13(2):235-46</RefSource>
                <PMID Version="1">14645201</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nephron Exp Nephrol. 2004;96(4):e119-26</RefSource>
                <PMID Version="1">15122061</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2004 Jun;78(12):6381-8</RefSource>
                <PMID Version="1">15163731</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Development. 1991 Sep;113(1):193-8</RefSource>
                <PMID Version="1">1764994</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Mol Neurobiol. 1994 Oct;14(5):439-57</RefSource>
                <PMID Version="1">7621506</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Top Dev Biol. 1998;39:245-301</RefSource>
                <PMID Version="1">9476003</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Natl Cancer Inst. 1962 Sep;29:597-631</RefSource>
                <PMID Version="1">14497698</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dev Biol. 1963 Mar;6:432-44</RefSource>
                <PMID Version="1">13948549</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Genet. 2004;38:819-45</RefSource>
                <PMID Version="1">15568995</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Gene Ther. 2005 Jul;16(7):781-91</RefSource>
                <PMID Version="1">16000060</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Development. 2005 Dec;132(24):5437-49</RefSource>
                <PMID Version="1">16291795</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Cell Dev Biol. 2006;22:509-29</RefSource>
                <PMID Version="1">16822174</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Kidney Int. 2006 Dec;70(11):2031-4</RefSource>
                <PMID Version="1">17051144</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Urol. 2008 Jan;179(1):365-70</RefSource>
                <PMID Version="1">18006007</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Ther. 2008 Jun;16(6):1073-80</RefSource>
                <PMID Version="1">18414476</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Ther. 2008 Oct;16(10):1648-56</RefSource>
                <PMID Version="1">18682697</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Mol Ther. 2009 Aug;11(4):442-7</RefSource>
                <PMID Version="1">19649989</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Res Vet Sci. 2009 Dec;87(3):408-12</RefSource>
                <PMID Version="1">19386337</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2010;5(5):e10550</RefSource>
                <PMID Version="1">20479933</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Top Dev Biol. 2010;90:193-229</RefSource>
                <PMID Version="1">20691850</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Ther. 2011 Aug;19(8):1440-8</RefSource>
                <PMID Version="1">21610699</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Methods. 2001 Jul;24(3):247-56</RefSource>
                <PMID Version="1">11403574</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4123690</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/682189</ArticleId>
            <ArticleId IdType="pubmed">25133251</ArticleId>
            <ArticleId IdType="pmc">PMC4123690</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133246</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1537-744X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>TheScientificWorldJournal</Title>
                <ISOAbbreviation>ScientificWorldJournal</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genome Wide Analysis of Sex Difference in Gene Expression Profiles of Bone Formations Using sfx Mice and BXD RI Strains.</ArticleTitle>
            <Pagination>
                <MedlinePgn>584910</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/584910</ELocationID>
            <Abstract>
                <AbstractText>The objective of this study is to identify sex differentially expressed genes in bone using a mouse model of spontaneous fracture, sfx, which lacks the gene for L-gulonolactone oxidase (Gulo), a key enzyme in the ascorbic acid (AA) synthesis pathway. We first identified the genes that are differentially expressed in the femur between female and male in sfx mice. We then analyzed the potential gene network among those differentially expressed genes with whole genome expression profiles generated using spleens of female and male mice of a total of 67 BXD (C57BL/6J X DBA/2J) recombinant inbred (RI) and other strains. Our result indicated that there was a sex difference in the whole genome profiles in sfx mice as measured by the proportion of up- and downregulated genes. Several genes in the pathway of bone development are differentially expressed between the male and female of sfx mice. Comparison of gene network of up- and downregulated bone relevant genes also suggests a sex difference.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Yue</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Orthopedic Surgery and BME, University of Tennessee Health Science Center, 956 Court Avenue, Memphis, TN 38163, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Xiaodong</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Mudanjiang Medical College, Tongxiang Road, Aimin District, Mudanjiang City, Heilongjiang 157001, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Lishi</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Orthopedic Surgery and BME, University of Tennessee Health Science Center, 956 Court Avenue, Memphis, TN 38163, USA ; Department of Basic Research, Inner Mongolia Medical College, Inner Mongolia 010110, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Xiaoyun</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Orthopedic Surgery and BME, University of Tennessee Health Science Center, 956 Court Avenue, Memphis, TN 38163, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lu</LastName>
                    <ForeName>Lu</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gu</LastName>
                    <ForeName>Weikuan</ForeName>
                    <Initials>W</Initials>
                    <Identifier Source="ORCID">0000-0003-1112-8088</Identifier>
                    <Affiliation>Department of Orthopedic Surgery and BME, University of Tennessee Health Science Center, 956 Court Avenue, Memphis, TN 38163, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiao</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Orthopedic Surgery and BME, University of Tennessee Health Science Center, 956 Court Avenue, Memphis, TN 38163, USA ; Mudanjiang Medical College, Tongxiang Road, Aimin District, Mudanjiang City, Heilongjiang 157001, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>ScientificWorldJournal</MedlineTA>
            <NlmUniqueID>101131163</NlmUniqueID>
            <ISSNLinking>1537-744X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Genet. 2007 May;121(3-4):491-500</RefSource>
                <PMID Version="1">17216495</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Pharmacol. 2005 Nov;68(5):1225-38</RefSource>
                <PMID Version="1">16079270</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Bioinformatics. 2008 Apr 1;24(7):1011-3</RefSource>
                <PMID Version="1">18204061</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Bone Miner Res. 2008 Jul;23(7):1140-9</RefSource>
                <PMID Version="1">18333755</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brief Bioinform. 2010 Mar;11(2):244-52</RefSource>
                <PMID Version="1">19939941</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Lipids. 2010 Apr;45(4):345-55</RefSource>
                <PMID Version="1">20213531</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Calcif Tissue Int. 2010 Jun;86(6):470-83</RefSource>
                <PMID Version="1">20405109</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Circ J. 2010 Nov;74(12):2693-701</RefSource>
                <PMID Version="1">20966593</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Phys Anthropol. 2012 Aug;148(4):512-24</RefSource>
                <PMID Version="1">22460661</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell. 2012 Sep 14;150(6):1287-99</RefSource>
                <PMID Version="1">22939713</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arthritis Rheum. 2013 Mar;65(3):743-52</RefSource>
                <PMID Version="1">23233348</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013;8(5):e63952</RefSource>
                <PMID Version="1">23667691</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Genomics. 2005 Jul;86(1):76-85</RefSource>
                <PMID Version="1">15953542</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Bone. 2000 Nov;27(5):619-26</RefSource>
                <PMID Version="1">11062347</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9842-6</RefSource>
                <PMID Version="1">11504949</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Circulation. 2002 Jun 25;105(25):2968-73</RefSource>
                <PMID Version="1">12081989</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nutr Sci Vitaminol (Tokyo). 2004 Feb;50(1):1-8</RefSource>
                <PMID Version="1">15228210</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nutr. 2004 Sep;134(9):2216-21</RefSource>
                <PMID Version="1">15333707</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann N Y Acad Sci. 1975 Sep 30;258:264-77</RefSource>
                <PMID Version="1">173224</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Gerontol. 1984;19(2):95-100</RefSource>
                <PMID Version="1">6734770</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann N Y Acad Sci. 1987;498:13-27</RefSource>
                <PMID Version="1">3304059</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Bone. 1996 May;18(5):397-403</RefSource>
                <PMID Version="1">8739896</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mamm Genome. 2005 Jan;16(1):20-31</RefSource>
                <PMID Version="1">15674730</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hepatology. 2007 Aug;46(2):548-57</RefSource>
                <PMID Version="1">17542012</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4123512</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/584910</ArticleId>
            <ArticleId IdType="pubmed">25133246</ArticleId>
            <ArticleId IdType="pmc">PMC4123512</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133201</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">2333-6692</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>2</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>4</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of endocrinology, diabetes &amp; obesity</Title>
                <ISOAbbreviation>J Endocrinol Diabetes Obes</ISOAbbreviation>
            </Journal>
            <ArticleTitle>TRANSCRIPTION FACTOR GLI-SIMILAR 3 (GLIS3): IMPLICATIONS FOR THE DEVELOPMENT OF CONGENITAL HYPOTHYROIDISM.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1024</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Congenital hypothyroidism (CH) is the most frequent endocrine disorder in neonates. While several genetic mutations have been identified that result in developmental defects of the thyroid gland or thyroid hormone synthesis, genetic factors have yet to be identified in many CH patients along with the mechanisms underlying their pathophysiology. Mutations in the gene encoding the Kr??ppel-like transcription factor, GLI-similar 3 (GLIS3) have been associated with the development of a syndrome characterized by congenital hypothyroidism and neonatal diabetes and similar phenotypes were observed in mouse knockout models of Glis3. Patients with GLIS3-mediated CH exhibit diminished serum levels of thyroxine (T4) and triiodothyronine (T3) and elevated thyroid stimulating hormone (TSH) and thyroglobulin (TG). However, the inconsistent presentation of clinical features associated with this CH has made it difficult to ascertain a causative mechanism. Future elucidation of the biological functions of GLIS3 in the thyroid will be crucial to the discovery of new therapeutic opportunities for the treatment of CH.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lichti-Kaiser</LastName>
                    <ForeName>Kristin</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Cell Biology Section, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>ZeRuth</LastName>
                    <ForeName>Gary</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Cell Biology Section, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jetten</LastName>
                    <ForeName>Anton M</ForeName>
                    <Initials>AM</Initials>
                    <Affiliation>Cell Biology Section, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>Z01 ES100485-07</GrantID>
                    <Acronym>ES</Acronym>
                    <Agency>NIEHS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Endocrinol Diabetes Obes</MedlineTA>
            <NlmUniqueID>101636673</NlmUniqueID>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Congenital Hypothyroidism</Keyword>
            <Keyword MajorTopicYN="N">Gli-similar 3</Keyword>
            <Keyword MajorTopicYN="N">Neonatal Diabetes</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25133201</ArticleId>
            <ArticleId IdType="pmc">PMC4131692</ArticleId>
            <ArticleId IdType="mid">NIHMS610593</ArticleId>
        </ArticleIdList>
        <?nihms?>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133200</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">2329-423X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>1</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>7</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Neurophotonics</Title>
                <ISOAbbreviation>Neurophotonics</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Optical imaging in an Alzheimer's mouse model reveals amyloid-??-dependent vascular impairment.</ArticleTitle>
            <Pagination>
                <MedlinePgn>011005</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Alzheimer's disease (AD) and cerebrovascular disease are often comorbid conditions, but the relationship between amyloid-?? and in vivo vascular pathophysiology is poorly understood. We utilized a multimodal, multiscale optical imaging approach, including spatial frequency domain imaging, Doppler optical coherence tomography, and confocal microscopy, to quantify AD-dependent changes in a triple transgenic mouse model (3xTg-AD) and age-matched controls. From three months of age (na??ve) to 20 months (severe AD), the brain tissue concentration of total and oxy-hemoglobin (Total Hb, ctO2Hb) decreased 50 and 70%, respectively, in 3xTg-AD mice. Compared to age-matched controls, significant differences in brain hemoglobin concentrations occurred as early as eight months (Total Hb: 126 ?? 5 ??M versus 108 ?? 4 ??M; ctO2Hb: 86 ?? 5 ??M versus 70 ?? 3 ??M; for control and AD, respectively). These changes were linked to a 29% vascular volume fraction decrease and 35% vessel density reduction in the 20-month-old 3xTg-AD versus age-matched controls. Vascular reduction coincided with increased brain concentration of amyloid-?? protein, vascular endothelial growth factor (VEGF), and endothelial nitric oxide synthase (eNOS) at eight and 20 months compared to the three-month baseline. Our results suggest that amyloid-?? blocks the normally reparative effects of upregulated VEGF and eNOS, and may accelerate in vivo vascular pathophysiology in AD.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lin</LastName>
                    <ForeName>Alexander J</ForeName>
                    <Initials>AJ</Initials>
                    <Affiliation>Beckman Laser Institute and Medical Clinic, Laser Microbeam and Medical Program, 1002 Health Sciences Road, Irvine, California 92612 ; University of California Irvine, Department of Biomedical Engineering, 3120 Natural Sciences II, Irvine, California 92697-2715.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Gangjun</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Beckman Laser Institute and Medical Clinic, Laser Microbeam and Medical Program, 1002 Health Sciences Road, Irvine, California 92612.</Affiliation>
                </Author>
                <Author>
                    <LastName>Castello</LastName>
                    <ForeName>Nicholas A</ForeName>
                    <Initials>NA</Initials>
                    <Affiliation>University of California Irvine, Institute for Memory Impairments and Neurological Disorders, 2642 Biological Sciences III Irvine, California 92697-4545 ; University of California Irvine, Department of Neurobiology and Behavior, 2205 McGaugh Hall, Irvine, California 92697-4550.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yeh</LastName>
                    <ForeName>James J</ForeName>
                    <Initials>JJ</Initials>
                    <Affiliation>Beckman Laser Institute and Medical Clinic, Laser Microbeam and Medical Program, 1002 Health Sciences Road, Irvine, California 92612.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rahimian</LastName>
                    <ForeName>Rombod</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Beckman Laser Institute and Medical Clinic, Laser Microbeam and Medical Program, 1002 Health Sciences Road, Irvine, California 92612.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Grace</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Beckman Laser Institute and Medical Clinic, Laser Microbeam and Medical Program, 1002 Health Sciences Road, Irvine, California 92612.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tsay</LastName>
                    <ForeName>Victoria</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Beckman Laser Institute and Medical Clinic, Laser Microbeam and Medical Program, 1002 Health Sciences Road, Irvine, California 92612.</Affiliation>
                </Author>
                <Author>
                    <LastName>Durkin</LastName>
                    <ForeName>Anthony J</ForeName>
                    <Initials>AJ</Initials>
                    <Affiliation>Beckman Laser Institute and Medical Clinic, Laser Microbeam and Medical Program, 1002 Health Sciences Road, Irvine, California 92612.</Affiliation>
                </Author>
                <Author>
                    <LastName>Choi</LastName>
                    <ForeName>Bernard</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Beckman Laser Institute and Medical Clinic, Laser Microbeam and Medical Program, 1002 Health Sciences Road, Irvine, California 92612 ; University of California Irvine, Department of Biomedical Engineering, 3120 Natural Sciences II, Irvine, California 92697-2715.</Affiliation>
                </Author>
                <Author>
                    <LastName>LaFerla</LastName>
                    <ForeName>Frank M</ForeName>
                    <Initials>FM</Initials>
                    <Affiliation>University of California Irvine, Institute for Memory Impairments and Neurological Disorders, 2642 Biological Sciences III Irvine, California 92697-4545 ; University of California Irvine, Department of Neurobiology and Behavior, 2205 McGaugh Hall, Irvine, California 92697-4550.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Zhongping</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Beckman Laser Institute and Medical Clinic, Laser Microbeam and Medical Program, 1002 Health Sciences Road, Irvine, California 92612 ; University of California Irvine, Department of Biomedical Engineering, 3120 Natural Sciences II, Irvine, California 92697-2715.</Affiliation>
                </Author>
                <Author>
                    <LastName>Green</LastName>
                    <ForeName>Kim N</ForeName>
                    <Initials>KN</Initials>
                    <Affiliation>University of California Irvine, Institute for Memory Impairments and Neurological Disorders, 2642 Biological Sciences III Irvine, California 92697-4545 ; University of California Irvine, Department of Neurobiology and Behavior, 2205 McGaugh Hall, Irvine, California 92697-4550.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tromberg</LastName>
                    <ForeName>Bruce J</ForeName>
                    <Initials>BJ</Initials>
                    <Affiliation>Beckman Laser Institute and Medical Clinic, Laser Microbeam and Medical Program, 1002 Health Sciences Road, Irvine, California 92612 ; University of California Irvine, Department of Biomedical Engineering, 3120 Natural Sciences II, Irvine, California 92697-2715.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>P41 EB015890</GrantID>
                    <Acronym>EB</Acronym>
                    <Agency>NIBIB NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neurophotonics</MedlineTA>
            <NlmUniqueID>101632875</NlmUniqueID>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Doppler optical coherence tomography</Keyword>
            <Keyword MajorTopicYN="N">absorption</Keyword>
            <Keyword MajorTopicYN="N">diffuse optical spectroscopy</Keyword>
            <Keyword MajorTopicYN="N">hypercapnia</Keyword>
            <Keyword MajorTopicYN="N">microvascular perfusion</Keyword>
            <Keyword MajorTopicYN="N">neuroimaging</Keyword>
            <Keyword MajorTopicYN="N">scattering</Keyword>
            <Keyword MajorTopicYN="N">spatial frequency domain imaging</Keyword>
            <Keyword MajorTopicYN="N">vascular reactivity</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2015</Year>
                <Month>7</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1117/1.NPh.1.1.011005</ArticleId>
            <ArticleId IdType="pubmed">25133200</ArticleId>
            <ArticleId IdType="pmc">PMC4132842</ArticleId>
            <ArticleId IdType="mid">NIHMS609479</ArticleId>
        </ArticleIdList>
        <?nihms?>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133194</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-7156</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of immunology research</Title>
                <ISOAbbreviation>J Immunol Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Activation Effects of Polysaccharides of Flammulina velutipes Mycorrhizae on the T Lymphocyte Immune Function.</ArticleTitle>
            <Pagination>
                <MedlinePgn>285421</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/285421</ELocationID>
            <Abstract>
                <AbstractText>Flammulina velutipes mycorrhizae have increasingly been produced with increasing of F. velutipes production. A mouse model was thus used to examine potential effect of F. velutipes mycorrhizae on the immune function. Fifty female Wistar mice (5-weeks-old) weighed 15-20???g were randomly allocated into five groups. Polysaccharide of F. velutipes mycorrhizae were treated with mice and mice spleen lymphocytes. The levels of CD3(+), CD4(+), and CD8(+) T lymphocyte, interleukin-2 (IL-2), and tumor necrosis factor-a (TNF-??) were determined. The results showed that the proportions of CD3(+), and CD4(+) T lymphocyte, the ratio of CD4(+)/CD8(+), and the levels of IL-2 and TNF-a were significantly increased in polysaccharide of F. velutipes mycorrhizae, while the proportion of CD8(+) T lymphocyte was decreased in polysaccharide of F. velutipes mycorrhizae-dose dependent manner. Our findings indicated that a long term exposure of polysaccharide of F. velutipes mycorrhizae could activate the T lymphocyte immune function. Polysaccharide of F. velutipes mycorrhizae was expected to develop into the immune health products.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yan</LastName>
                    <ForeName>Zheng-Fei</ForeName>
                    <Initials>ZF</Initials>
                    <Affiliation>College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Nai-Xu</ForeName>
                    <Initials>NX</Initials>
                    <Identifier Source="ORCID">0000-0002-2762-6885</Identifier>
                    <Affiliation>Engineering Research Center of Edible and Medicinal Fungi, Ministry of Education, Jilin Agricultural University, Changchun 130118, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mao</LastName>
                    <ForeName>Xin-Xin</ForeName>
                    <Initials>XX</Initials>
                    <Affiliation>College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">0000-0002-8937-0416</Identifier>
                    <Affiliation>Engineering Research Center of Edible and Medicinal Fungi, Ministry of Education, Jilin Agricultural University, Changchun 130118, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Chang-Tian</ForeName>
                    <Initials>CT</Initials>
                    <Identifier Source="ORCID">0000-0001-6498-8642</Identifier>
                    <Affiliation>Engineering Research Center of Edible and Medicinal Fungi, Ministry of Education, Jilin Agricultural University, Changchun 130118, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Immunol Res</MedlineTA>
            <NlmUniqueID>101627166</NlmUniqueID>
            <ISSNLinking>2314-7156</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol Methods. 2000 Oct 20;244(1-2):29-40</RefSource>
                <PMID Version="1">11033016</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Phytochemistry. 2002 Jan;59(2):175-81</RefSource>
                <PMID Version="1">11809453</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Chem Pharm Bull (Tokyo). 2002 May;50(5):623-9</RefSource>
                <PMID Version="1">12036016</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Endocrinology. 1990 Jan;126(1):88-94</RefSource>
                <PMID Version="1">2294012</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Anal Biochem. 1993 Feb 1;208(2):387-92</RefSource>
                <PMID Version="1">8452237</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunopharmacology. 1997 Jan;35(3):255-63</RefSource>
                <PMID Version="1">9043939</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Anal Biochem. 1962 Oct;4:330-4</RefSource>
                <PMID Version="1">13971270</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Acta Pharmacol Sin. 2004 Nov;25(11):1387-95</RefSource>
                <PMID Version="1">15525457</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Exp Allergy. 2007 Oct;37(10):1566-73</RefSource>
                <PMID Version="1">17850381</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):221-7</RefSource>
                <PMID Version="1">20302932</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2011 Oct 11;137(3):1183-8</RefSource>
                <PMID Version="1">21810462</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Reprod Immunol. 2012 Mar;67(3):198-205</RefSource>
                <PMID Version="1">22151521</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Food Chem Toxicol. 2012 Mar;50(3-4):532-5</RefSource>
                <PMID Version="1">22198605</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pol J Vet Sci. 2012;15(2):305-13</RefSource>
                <PMID Version="1">22844709</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int Immunopharmacol. 2013 Feb;15(2):357-63</RefSource>
                <PMID Version="1">23246255</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biochem Biophys Res Commun. 2014 Jan 3;443(1):1-6</RefSource>
                <PMID Version="1">24269590</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4122143</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/285421</ArticleId>
            <ArticleId IdType="pubmed">25133194</ArticleId>
            <ArticleId IdType="pmc">PMC4122143</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133193</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-7156</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of immunology research</Title>
                <ISOAbbreviation>J Immunol Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Tribbles 3 Regulates the Fibrosis Cytokine TGF- ?? 1 through ERK1/2-MAPK Signaling Pathway in Diabetic Nephropathy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>240396</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/240396</ELocationID>
            <Abstract>
                <AbstractText>To reveal the expression and possible role of tribbles homolog 3 (TRB3) in the incidence of type 2 diabetic nephropathy, we used immunohistochemistry, real-time quantitative PCR, western blot analysis, and enzyme-linked immunosorbent assay (ELISA) to study the expression of TRB3, extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase (ERK1/2 MAPK), transforming growth factor ??1 (TGF-??1), and collagen type IV in kidneys of db/db diabetic mice and in murine renal mesangial cells stimulated with high glucose. The expression of TRB3, TGF-??1, and collagen type IV was increased in kidneys of db/db diabetic mice. TGF-??1 and collagen type IV regulated by high glucose through ERK1/2 MAPK were downregulated by silencing TRB3 in renal mesangial cells. TRB3 may be involved in diabetic nephropathy by regulating the fibrosis cytokine TGF-??1 and collagen type IV through the ERK1/2 MAPK signaling pathway.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Luwei</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Hemodialysis, Qilu Hospital, Shandong University, Jinan 250012, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Jinhang</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Hemodialysis, Qilu Hospital, Shandong University, Jinan 250012, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Xinnong</ForeName>
                    <Initials>X</Initials>
                    <Identifier Source="ORCID">0000-0001-7137-6257</Identifier>
                    <Affiliation>General Department, Qilu Hospital, Shandong University, Jinan 250012, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Shengli</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Hemodialysis, Qilu Hospital, Shandong University, Jinan 250012, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tian</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Hemodialysis, Qilu Hospital, Shandong University, Jinan 250012, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Immunol Res</MedlineTA>
            <NlmUniqueID>101627166</NlmUniqueID>
            <ISSNLinking>2314-7156</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol. 1999 Nov;277(5 Pt 2):F742-9</RefSource>
                <PMID Version="1">10564237</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Kidney Int. 2000 Jun;57(6):2308-18</RefSource>
                <PMID Version="1">10844601</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Med Electron Microsc. 2002 Jun;35(2):68-80</RefSource>
                <PMID Version="1">12181648</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2003 Jun 6;300(5625):1574-7</RefSource>
                <PMID Version="1">12791994</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S241-5</RefSource>
                <PMID Version="1">12874439</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FASEB J. 2003 Aug;17(11):1576-8</RefSource>
                <PMID Version="1">12824291</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Pathol. 2003 Dec;163(6):2565-74</RefSource>
                <PMID Version="1">14633628</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2004 Oct 8;279(41):42703-8</RefSource>
                <PMID Version="1">15299019</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes. 1992 Jun;41(6):679-84</RefSource>
                <PMID Version="1">1587395</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Diabetes. 1997 May;46(5):847-53</RefSource>
                <PMID Version="1">9133554</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Am Soc Nephrol. 1998 Nov;9(11):2157-69</RefSource>
                <PMID Version="1">9808106</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Contrib Nephrol. 2005;148:57-69</RefSource>
                <PMID Version="1">15912027</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Signal. 2006 Jun;18(6):899-909</RefSource>
                <PMID Version="1">16129579</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Lett. 2006 Apr 15;104(1-2):171-7</RefSource>
                <PMID Version="1">16364454</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2006 Apr 21;281(16):11126-34</RefSource>
                <PMID Version="1">16452480</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Oncogene. 2008 Jul 31;27(33):4532-43</RefSource>
                <PMID Version="1">18408768</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cell Mol Life Sci. 2008 Sep;65(18):2924-32</RefSource>
                <PMID Version="1">18726071</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pharmazie. 2009 Oct;64(10):680-4</RefSource>
                <PMID Version="1">19947172</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biol Chem. 2010 Jul 16;285(29):22426-36</RefSource>
                <PMID Version="1">20421299</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Renal Physiol. 2010 Nov;299(5):F965-72</RefSource>
                <PMID Version="1">20660016</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Opin Nephrol Hypertens. 2011 May;20(3):285-9</RefSource>
                <PMID Version="1">21422920</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Sci. 2011 Oct 1;124(Pt 19):3235-46</RefSource>
                <PMID Version="1">21896644</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Lett. 2012 Sep 1;322(1):35-44</RefSource>
                <PMID Version="1">22343223</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4124808</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/240396</ArticleId>
            <ArticleId IdType="pubmed">25133193</ArticleId>
            <ArticleId IdType="pmc">PMC4124808</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25133181</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-6141</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BioMed research international</Title>
                <ISOAbbreviation>Biomed Res Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Erratum to &quot;Biodistribution and SPECT Imaging Study of (99m)Tc Labeling NGR Peptide in Nude Mice Bearing Human HepG2 Hepatoma&quot;</ArticleTitle>
            <Pagination>
                <MedlinePgn>798474</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">[This corrects the article , PMID: 24977153.].</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ma</LastName>
                    <ForeName>Wenhui</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, Shaanxi Province 710032, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Zhe</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, Shaanxi Province 710032, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Weidong</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, Shaanxi Province 710032, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ma</LastName>
                    <ForeName>Xiaowei</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, Shaanxi Province 710032, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kang</LastName>
                    <ForeName>Fei</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, Shaanxi Province 710032, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, Shaanxi Province 710032, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>PUBLISHED ERRATUM</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biomed Res Int</MedlineTA>
            <NlmUniqueID>101600173</NlmUniqueID>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/798474</ArticleId>
            <ArticleId IdType="pubmed">25133181</ArticleId>
            <ArticleId IdType="pmc">PMC4123511</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25133171</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2314-6141</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>BioMed research international</Title>
                <ISOAbbreviation>Biomed Res Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>UVA-UVB Photoprotective Activity of Topical Formulations Containing Morinda citrifolia Extract.</ArticleTitle>
            <Pagination>
                <MedlinePgn>587819</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/587819</ELocationID>
            <Abstract>
                <AbstractText>Exposure to solar radiation, particularly its ultraviolet (UV) component, has a variety of harmful effects on human health. Some of these effects include sunburn cell formations, basal and squamous cell cancers, melanoma, cataracts, photoaging of the skin, and immune suppression. The beneficial photoprotective effects of topical formulations with the extract, Morinda citrifolia, have not been investigated. This present study aims to investigate the potential benefits of M. citrifolia topical application on the dorsal skin of mice, exposed to UVA-UVB light. Using 7 days of treatment, [before (baseline values) and 20???h after UV exposure], the thickness, skin barrier damage (TEWL), erythema, and histological alterations were evaluated. The results showed that the formulations containing the extract protected the skin against UV-induced damage.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Serafini</LastName>
                    <ForeName>Mairim Russo</ForeName>
                    <Initials>MR</Initials>
                    <Affiliation>Departamento de Fisiologia, Universidade Federal de Sergipe (UFS), S??o Crist??v??o, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Detoni</LastName>
                    <ForeName>Cassia Britto</ForeName>
                    <Initials>CB</Initials>
                    <Affiliation>Programa de P??s-Gradua????o em Ci??ncias Farmac??uticas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Menezes</LastName>
                    <ForeName>Paula Dos Passos</ForeName>
                    <Initials>Pdos P</Initials>
                    <Affiliation>Departamento de Fisiologia, Universidade Federal de Sergipe (UFS), S??o Crist??v??o, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pereira Filho</LastName>
                    <ForeName>Rose Nely</ForeName>
                    <Initials>RN</Initials>
                    <Affiliation>Instituto de Tecnologia e Pesquisa (ITP), Aracaju, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fortes</LastName>
                    <ForeName>Vanessa Silveira</ForeName>
                    <Initials>VS</Initials>
                    <Affiliation>Faculdade de Ci??ncias Farmac??uticas de Ribeir??o Preto (FCFRP), Ribeir??o Preto, SP, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vieira</LastName>
                    <ForeName>Maria Jos?? Fonseca</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>Faculdade de Ci??ncias Farmac??uticas de Ribeir??o Preto (FCFRP), Ribeir??o Preto, SP, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guterres</LastName>
                    <ForeName>S??lvia Stanis??uaski</ForeName>
                    <Initials>SS</Initials>
                    <Affiliation>Programa de P??s-Gradua????o em Ci??ncias Farmac??uticas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Albuquerque Junior</LastName>
                    <ForeName>Ricardo Luiz Cavalcanti</ForeName>
                    <Initials>RL</Initials>
                    <Affiliation>Instituto de Tecnologia e Pesquisa (ITP), Aracaju, SE, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ara??jo</LastName>
                    <ForeName>Adriano Antunes de Souza</ForeName>
                    <Initials>AA</Initials>
                    <Affiliation>Departamento de Fisiologia, Universidade Federal de Sergipe (UFS), S??o Crist??v??o, SE, Brazil.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biomed Res Int</MedlineTA>
            <NlmUniqueID>101600173</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Cancer. 2000 Jun;36(10):1292-7</RefSource>
                <PMID Version="1">10882869</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2000 Sep;106(5):663-70</RefSource>
                <PMID Version="1">10974019</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Pharm. 2002 Mar 2;234(1-2):149-57</RefSource>
                <PMID Version="1">11839446</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Dermatol. 2002 Nov;138(11):1462-70</RefSource>
                <PMID Version="1">12437452</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Invest Dermatol. 2003 Jan;120(1):128-34</RefSource>
                <PMID Version="1">12535209</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biosci Bioeng. 2010 Mar;109(3):291-6</RefSource>
                <PMID Version="1">20159580</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2010 Oct 28;132(1):109-14</RefSource>
                <PMID Version="1">20688142</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Toxicol In Vitro. 2011 Mar;25(2):462-8</RefSource>
                <PMID Version="1">21111802</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Photochem Photobiol B. 2011 May 3;103(2):93-7</RefSource>
                <PMID Version="1">21356598</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Pharm Sci. 2011 Jun;100(6):2182-93</RefSource>
                <PMID Version="1">21491442</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Med Food. 2011 Oct;14(10):1159-66</RefSource>
                <PMID Version="1">21548805</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Phytother Res. 2011 Dec;25(12):1854-60</RefSource>
                <PMID Version="1">21520309</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Carcinogenesis. 2003 May;24(5):927-36</RefSource>
                <PMID Version="1">12771038</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Photodermatol Photoimmunol Photomed. 2003 Apr;19(2):56-72</RefSource>
                <PMID Version="1">12945805</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Invest Dermatol. 2003 Oct;121(4):862-8</RefSource>
                <PMID Version="1">14632206</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Am Coll Nutr. 2004 Apr;23(2):157-62</RefSource>
                <PMID Version="1">15047682</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol Methods. 1983 Dec 16;65(1-2):55-63</RefSource>
                <PMID Version="1">6606682</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Photochem Photobiol B. 1992 Jun 30;14(1-2):105-24</RefSource>
                <PMID Version="1">1331386</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 1995 May;95(5):2281-90</RefSource>
                <PMID Version="1">7738193</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc West Pharmacol Soc. 1996;39:7-9</RefSource>
                <PMID Version="1">8895953</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mutat Res. 2005 Apr 1;571(1-2):153-73</RefSource>
                <PMID Version="1">15748645</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Exp Dermatol. 2005 May;30(3):272-6</RefSource>
                <PMID Version="1">15807688</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Photochem Photobiol Sci. 2005 Sep;4(9):715-20</RefSource>
                <PMID Version="1">16121282</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Photochem Photobiol B. 2006 Jul 3;84(1):21-7</RefSource>
                <PMID Version="1">16495072</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nutr Biochem. 2006 Aug;17(8):531-40</RefSource>
                <PMID Version="1">16443355</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Invest Dermatol. 2007 Jan;127(1):222-32</RefSource>
                <PMID Version="1">16902416</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Pathol. 2008 Jan;172(1):86-97</RefSource>
                <PMID Version="1">18156206</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Food Chem Toxicol. 2008 Apr;46(4):1298-307</RefSource>
                <PMID Version="1">18226437</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Photochem Photobiol. 2008 Mar-Apr;84(2):489-500</RefSource>
                <PMID Version="1">18266816</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biomed Opt. 2009 Jan-Feb;14(1):014011</RefSource>
                <PMID Version="1">19256699</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Nat Med. 2009 Jul;63(3):351-4</RefSource>
                <PMID Version="1">19283442</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biomed Nanotechnol. 2009 Jun;5(3):240-6</RefSource>
                <PMID Version="1">20055005</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4123522</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/587819</ArticleId>
            <ArticleId IdType="pubmed">25133171</ArticleId>
            <ArticleId IdType="pmc">PMC4123522</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25132955</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2045-3329</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>4</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical sarcoma research</Title>
                <ISOAbbreviation>Clin Sarcoma Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors.</ArticleTitle>
            <Pagination>
                <MedlinePgn>10</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/2045-3329-4-10</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acquired resistance to tyrosine kinase inhibitors (TKIs) in gastrointestinal stromal tumours (GISTs) is most commonly caused by secondary KIT or PDGFRA mutations. In this study we characterize a newly established GIST xenograft model, UZLX-GIST9, and evaluate the in vivo response of the model to standard TKIs (imatinib, sunitinib, and regorafenib).</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Tumour fragments from a metastatic lesion of a GIST patient clinically progressing after treatment with imatinib, sunitinib and regorafenib were engrafted in a nude, immunodeficient mouse. Upon sequential passaging from mouse to mouse, tumour fragments were collected for histopathological and molecular characterization. The sensitivity of the model to treatment with TKIs was evaluated in 28 mice [passage 2 (n???=???8), passage 4 (n???=???20), 41 tumours]. Mice were grouped as follows: control (untreated), imatinib (50??mg/kg/BID), imatinib (100??mg/kg/BID), sunitinib (40??mg/kg/QD), and regorafenib (30??mg/kg/QD). After three weeks of oral treatment, tumours were collected for subsequent analysis. The efficacy of treatment was assessed by tumour volume, histopathology and Western immunoblotting.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">UZLX-GIST9 maintains the same typical morphological features and immunohistochemical characteristics as the original patient biopsy and expresses CD117 and DOG1. The KIT mutational profile (p.P577del + W557LfsX5+ D820G) remains the same as the original tissue sample originating from an intraspinal metastatic site. Three week treatment with different TKIs showed that the model is resistant to imatinib. Sunitinib induces tumour growth delay and regorafenib reduces the tumour burden by 30% as compared to control animals. While none of the TKIs had a significant effect on cell proliferation or cell survival, a remarkable increase of necrosis and significant reduction of microvessel density was observed under sunitinib and regorafenib. Western immunoblotting showed a mild reduction in KIT and AKT activation only in regorafenib treated tumours.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We established a novel human GIST xenograft, UZLX-GIST9, harbouring KIT exon 11 and 17 mutations and maintaining the pheno-and genotype of the original tumour. UZLX-GIST9 shows different levels of response to standard TKIs. This model will help to study TKI resistance and to explore novel treatment approaches for patients with TKI-resistant GIST.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Van Looy</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gebreyohannes</LastName>
                    <ForeName>Yemarshet Kelemework</ForeName>
                    <Initials>YK</Initials>
                    <Affiliation>Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wozniak</LastName>
                    <ForeName>Agnieszka</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cornillie</LastName>
                    <ForeName>Jasmien</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium ; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wellens</LastName>
                    <ForeName>Jasmien</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Haifu</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vanleeuw</LastName>
                    <ForeName>Ulla</ForeName>
                    <Initials>U</Initials>
                    <Affiliation>Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Floris</LastName>
                    <ForeName>Giuseppe</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Pathology, KU Leuven and University Hospitals Leuven, Herestraat 49, Leuven, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Debiec-Rychter</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Human Genetics, KU Leuven and University Hospitals Leuven, Herestraat 49, Leuven, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sciot</LastName>
                    <ForeName>Raf</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Pathology, KU Leuven and University Hospitals Leuven, Herestraat 49, Leuven, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sch??ffski</LastName>
                    <ForeName>Patrick</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium ; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Clin Sarcoma Res</MedlineTA>
            <NlmUniqueID>101577890</NlmUniqueID>
            <ISSNLinking>2045-3329</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4134663</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Gastrointestinal stromal tumour</Keyword>
            <Keyword MajorTopicYN="N">Imatinib</Keyword>
            <Keyword MajorTopicYN="N">Regorafenib</Keyword>
            <Keyword MajorTopicYN="N">Resistance</Keyword>
            <Keyword MajorTopicYN="N">Sunitinib</Keyword>
            <Keyword MajorTopicYN="N">Tyrosine kinase inhibitor</Keyword>
            <Keyword MajorTopicYN="N">Xenograft</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1186/2045-3329-4-10</ArticleId>
            <ArticleId IdType="pii">2045-3329-4-10</ArticleId>
            <ArticleId IdType="pubmed">25132955</ArticleId>
            <ArticleId IdType="pmc">PMC4134663</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25132860</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1741-427X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Evidence-based complementary and alternative medicine : eCAM</Title>
                <ISOAbbreviation>Evid Based Complement Alternat Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>IKK ?? -Targeted Anti-Inflammatory Activities of a Butanol Fraction of Artificially Cultivated Cordyceps pruinosa Fruit Bodies.</ArticleTitle>
            <Pagination>
                <MedlinePgn>562467</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/562467</ELocationID>
            <Abstract>
                <AbstractText>The inhibitory activities of the Cordyceps pruinosa butanol fraction (Cp-BF) were investigated by determining inflammatory responses of lipopolysaccharide (LPS)-treated RAW264.7 macrophage cells and by evaluating HCl/ethanol (EtOH)-triggered gastric ulcers in mice. The molecular mechanisms of the inhibitory effects of Cp-BF were investigated by identifying target enzymes using biochemical and molecular biological approaches. Cp-BF strongly inhibited the production of NO and TNF-??, release of reactive oxygen species (ROS), phagocytic uptake of FITC-dextran, and mRNA expression levels of interleukin (IL)-6, inducible NO synthase (iNOS), and tumour necrosis factor-alpha (TNF)-?? in activated RAW264.7 cells. Cp-BF also strongly downregulated the NF-??B pathway by suppressing IKK?? according to luciferase reporter assays and immunoblot analysis. Furthermore, Cp-BF blocked both increased levels of NF-??B-mediated luciferase activities and phosphorylation of p65/p50 observed by IKK?? overexpression. Finally, orally administered Cp-BF was found to attenuate gastric ulcer and block the phosphorylation of I??B?? induced by HCl/EtOH. Therefore, these results suggest that the anti-inflammatory activity of Cp-BF may be mediated by suppression of IKK?? and its downstream NF-??B activation. Since our group has established the mass cultivation conditions by developing culture conditions for Cordyceps pruinosa, the information presented in this study may be useful for developing new anti-inflammatory agents.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Han Gyung</ForeName>
                    <Initials>HG</Initials>
                    <Affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Woo Seok</ForeName>
                    <Initials>WS</Initials>
                    <Affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sung</LastName>
                    <ForeName>Gi-Ho</ForeName>
                    <Initials>GH</Initials>
                    <Affiliation>Mushroom Research Division, National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong 369-873, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Ji Hye</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baek</LastName>
                    <ForeName>Gwang-Soo</ForeName>
                    <Initials>GS</Initials>
                    <Identifier Source="ORCID">0000-0003-3164-7379</Identifier>
                    <Affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Eunji</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Sungjae</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Yung Chul</ForeName>
                    <Initials>YC</Initials>
                    <Affiliation>Department of Forest Environment Protection, Kangwon National University, Chuncheon 200-701, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sung</LastName>
                    <ForeName>Jae Mo</ForeName>
                    <Initials>JM</Initials>
                    <Affiliation>Institute of Mushroom, Mushtech, Chuncheon 200-180, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoon</LastName>
                    <ForeName>Deok Hyo</ForeName>
                    <Initials>DH</Initials>
                    <Affiliation>Department of Biochemistry, Kangwon National University, Chuncheon 200-701, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Tae Woong</ForeName>
                    <Initials>TW</Initials>
                    <Affiliation>Department of Biochemistry, Kangwon National University, Chuncheon 200-701, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hong</LastName>
                    <ForeName>Sungyoul</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Jong-Hoon</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Department of Veterinary Physiology, College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University, Jeonju 561-756, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cho</LastName>
                    <ForeName>Jae Youl</ForeName>
                    <Initials>JY</Initials>
                    <Identifier Source="ORCID">0000-0001-8141-9927</Identifier>
                    <Affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Evid Based Complement Alternat Med</MedlineTA>
            <NlmUniqueID>101215021</NlmUniqueID>
            <ISSNLinking>1741-427X</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4123572</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/562467</ArticleId>
            <ArticleId IdType="pubmed">25132860</ArticleId>
            <ArticleId IdType="pmc">PMC4123572</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25132823</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1664-0640</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in psychiatry</Title>
                <ISOAbbreviation>Front Psychiatry</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future.</ArticleTitle>
            <Pagination>
                <MedlinePgn>92</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fpsyt.2014.00092</ELocationID>
            <Abstract>
                <AbstractText>Over the last decades, the endocannabinoid system has been implicated in a large variety of functions, including a crucial modulation of brain-reward circuits and the regulation of motivational processes. Importantly, behavioral studies have shown that cannabinoid compounds activate brain reward mechanisms and circuits in a similar manner to other drugs of abuse, such as nicotine, alcohol, cocaine, and heroin, although the conditions under which cannabinoids exert their rewarding effects may be more limited. Furthermore, there is evidence on the involvement of the endocannabinoid system in the regulation of cue- and drug-induced relapsing phenomena in animal models. The aim of this review is to briefly present the available data obtained using diverse behavioral experimental approaches in experimental animals, namely, the intracranial self-stimulation paradigm, the self-administration procedure, the conditioned place preference procedure, and the reinstatement of drug-seeking behavior procedure, to provide a comprehensive picture of the current status of what is known about the endocannabinoid system mechanisms that underlie modification of brain-reward processes. Emphasis is placed on the effects of cannabinoid 1 (CB1) receptor agonists, antagonists, and endocannabinoid modulators. Further, the role of CB1 receptors in reward processes is investigated through presentation of respective genetic ablation studies in mice. The vast majority of studies in the existing literature suggest that the endocannabinoid system plays a major role in modulating motivation and reward processes. However, much remains to be done before we fully understand these interactions. Further research in the future will shed more light on these processes and, thus, could lead to the development of potential pharmacotherapies designed to treat reward-dysfunction-related disorders.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Panagis</LastName>
                    <ForeName>George</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Laboratory of Behavioral Neuroscience, Department of Psychology, School of Social Sciences, University of Crete , Rethymno , Greece.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mackey</LastName>
                    <ForeName>Brian</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Laboratory of Behavioural Neuroscience, School of Nursing and Human Sciences, Faculty of Science and Health, Dublin City University , Dublin , Ireland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vlachou</LastName>
                    <ForeName>Styliani</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Laboratory of Behavioural Neuroscience, School of Nursing and Human Sciences, Faculty of Science and Health, Dublin City University , Dublin , Ireland.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
                <PublicationType>Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Psychiatry</MedlineTA>
            <NlmUniqueID>101545006</NlmUniqueID>
            <ISSNLinking>1664-0640</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4117180</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CB1 receptors</Keyword>
            <Keyword MajorTopicYN="N">brain-reward system</Keyword>
            <Keyword MajorTopicYN="N">cannabinoids</Keyword>
            <Keyword MajorTopicYN="N">conditioned place preference</Keyword>
            <Keyword MajorTopicYN="N">endocannabinoid system</Keyword>
            <Keyword MajorTopicYN="N">intracranial self-stimulation</Keyword>
            <Keyword MajorTopicYN="N">reinstatement of drug-seeking behavior</Keyword>
            <Keyword MajorTopicYN="N">self-administration</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fpsyt.2014.00092</ArticleId>
            <ArticleId IdType="pubmed">25132823</ArticleId>
            <ArticleId IdType="pmc">PMC4117180</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25132819</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1663-9812</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in pharmacology</Title>
                <ISOAbbreviation>Front Pharmacol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>179</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2014.00179</ELocationID>
            <Abstract>
                <AbstractText>Asthma is characterized by airway inflammation. Inflammation is associated with oxidant stress. Airway epithelial cells are shielded from this stress by a thin layer of lung lining fluid (LLF) which contains an abundance of the antioxidant glutathione. LLF glutathione metabolism is regulated by ??-glutamyl transferase (GGT). Loss of LLF GGT activity in the mutant GGT(enu1) mouse causes an increase in baseline LLF glutathione content which is magnified in an IL-13 model of allergic airway inflammation and protective against asthma. Normal mice are susceptible to asthma in this model but can be protected with acivicin, a GGT inhibitor. GGT is a target to treat asthma but acivicin toxicity limits clinical use. GGsTop is a novel GGT inhibitor. GGsTop inhibits LLF GGT activity only when delivered through the airway. In the IL-13 model, mice treated with IL-13 and GGsTop exhibit a lung inflammatory response similar to that of mice treated with IL-13 alone. But mice treated with IL-13 and GGsTop show attenuation of methacholine-stimulated airway hyper-reactivity, inhibition of Muc5ac and Muc5b gene induction, decreased airway epithelial cell mucous accumulation and a fourfold increase in LLF glutathione content compared to mice treated with IL-13 alone. Mice treated with GGsTop alone are no different from that of mice treated with saline alone, and show no signs of toxicity. GGsTop could represent a valuable pharmacological tool to inhibit LLF GGT activity in pulmonary disease models. The associated increase in LLF glutathione can protect lung airway epithelial cells against oxidant injury associated with inflammation in asthma.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tuzova</LastName>
                    <ForeName>Marina</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>The Pulmonary Center, Boston University School of Medicine Boston, MA, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jean</LastName>
                    <ForeName>Jyh-Chang</ForeName>
                    <Initials>JC</Initials>
                    <Affiliation>The Pulmonary Center, Boston University School of Medicine Boston, MA, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hughey</LastName>
                    <ForeName>Rebecca P</ForeName>
                    <Initials>RP</Initials>
                    <Affiliation>Department of Medicine, University of Pittsburgh Pittsburgh, PA, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brown</LastName>
                    <ForeName>Lou Ann S</ForeName>
                    <Initials>LA</Initials>
                    <Affiliation>Department of Pediatrics, Emory University School of Medicine Atlanta, GA, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cruikshank</LastName>
                    <ForeName>William W</ForeName>
                    <Initials>WW</Initials>
                    <Affiliation>The Pulmonary Center, Boston University School of Medicine Boston, MA, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hiratake</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Institute for Chemical Research, Kyoto University Kyoto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joyce-Brady</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>The Pulmonary Center, Boston University School of Medicine Boston, MA, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Pharmacol</MedlineTA>
            <NlmUniqueID>101548923</NlmUniqueID>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4116799</OtherID>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">GGsTop</Keyword>
            <Keyword MajorTopicYN="N">IL-13</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">glutathione</Keyword>
            <Keyword MajorTopicYN="N">lung lining fluid</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2014.00179</ArticleId>
            <ArticleId IdType="pubmed">25132819</ArticleId>
            <ArticleId IdType="pmc">PMC4116799</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25132735</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1466-1861</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Mediators of inflammation</Title>
                <ISOAbbreviation>Mediators Inflamm.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Circumsporozoite Protein-Specific K(d)-Restricted CD8+ T Cells Mediate Protective Antimalaria Immunity in Sporozoite-Immunized MHC-I-K(d) Transgenic Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>728939</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/728939</ELocationID>
            <Abstract>
                <AbstractText>Although the roles of CD8+ T cells and a major preerythrocytic antigen, the circumsporozoite (CS) protein, in contributing protective antimalaria immunity induced by radiation-attenuated sporozoites, have been shown by a number of studies, the extent to which these players contribute to antimalaria immunity is still unknown. To address this question, we have generated C57BL/6 (B6) transgenic (Tg) mice, expressing K(d) molecules under the MHC-I promoter, called MHC-I-K(d)-Tg mice. In this study, we first determined that a single immunizing dose of IrPySpz induced a significant level of antimalaria protective immunity in MHC-I-K(d)-Tg mice but not in B6 mice. Then, by depleting various T-cell subsets in vivo, we determined that CD8+ T cells are the main mediator of the protective immunity induced by IrPySpz. Furthermore, when we immunized (MHC-I-K(d)-Tg ?? CS-Tg) F1 mice with IrPySpz after crossing MHC-I-K(d)-Tg mice with PyCS-transgenic mice (CS-Tg), which are unable to mount PyCS-specific immunity, we found that IrPySpz immunization failed to induce protective antimalaria immunity in (MHC-I-K(d)-Tg ?? CS-Tg) F1 mice, thus indicating the absence of PyCS antigen-dependent immunity in these mice. These results indicate that protective antimalaria immunity induced by IrPySpz in MHC-I-K(d)-Tg mice is mediated by CS protein-specific, K(d)-restricted CD8+ T cells.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>HIV and Malaria Vaccine Program, Aaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, 455 First Avenue, New York, NY 10016, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsao</LastName>
                    <ForeName>Tiffany</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>HIV and Malaria Vaccine Program, Aaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, 455 First Avenue, New York, NY 10016, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Min</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Pathology, New York University School of Medicine, 545 First Avenue, New York, NY 10016, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsuji</LastName>
                    <ForeName>Moriya</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">0000-0001-8587-277X</Identifier>
                    <Affiliation>HIV and Malaria Vaccine Program, Aaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, 455 First Avenue, New York, NY 10016, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mediators Inflamm</MedlineTA>
            <NlmUniqueID>9209001</NlmUniqueID>
            <ISSNLinking>0962-9351</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2001 Jul 16;194(2):173-80</RefSource>
                <PMID Version="1">11457892</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2013 Sep 20;341(6152):1359-65</RefSource>
                <PMID Version="1">23929949</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Trends Parasitol. 2003 Feb;19(2):88-93</RefSource>
                <PMID Version="1">12586477</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 1967 Oct 14;216(5111):160-2</RefSource>
                <PMID Version="1">6057225</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Med Sci. 1973 Dec;266(6):398-403</RefSource>
                <PMID Version="1">4590095</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Bull World Health Organ. 1979;57 Suppl 1:165-73</RefSource>
                <PMID Version="1">120766</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 1987 Dec 17-23;330(6149):664-6</RefSource>
                <PMID Version="1">3120015</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1988 Jan;85(2):573-6</RefSource>
                <PMID Version="1">2963334</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int Immunol. 1991 Jun;3(6):579-85</RefSource>
                <PMID Version="1">1716146</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Trop Med Hyg. 1991 Nov;45(5):539-47</RefSource>
                <PMID Version="1">1951863</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 1992 Sep 15;149(6):2103-9</RefSource>
                <PMID Version="1">1517574</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2006 Dec 14;444(7121):937-40</RefSource>
                <PMID Version="1">17151604</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Exp Parasitol. 2010 Nov;126(3):421-5</RefSource>
                <PMID Version="1">19944099</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2010 Dec;120(12):4168-78</RefSource>
                <PMID Version="1">21123952</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 2011 Oct 28;334(6055):475-80</RefSource>
                <PMID Version="1">21903775</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol Methods. 2013 Jan 31;387(1-2):254-61</RefSource>
                <PMID Version="1">23142461</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Infect Dis. 2002 Apr 15;185(8):1155-64</RefSource>
                <PMID Version="1">11930326</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4124204</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/728939</ArticleId>
            <ArticleId IdType="pubmed">25132735</ArticleId>
            <ArticleId IdType="pmc">PMC4124204</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25132731</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1466-1861</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Mediators of inflammation</Title>
                <ISOAbbreviation>Mediators Inflamm.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Oral administration of herbal mixture extract inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis in BALB/c mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>319438</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/319438</ELocationID>
            <Abstract>
                <AbstractText>CP001 is four traditional herbal medicine mixtures with anti-inflammatory properties. In this study, we investigated the effect of oral administration of CP001 ethanol extract on the 2,4-dinitrochlorobenzene- (DNCB-) induced AD mouse models. For that purpose, we observed the effects of oral administration of CP001 on skin inflammatory cell infiltration, skin mast cells, production of serum IgE, and expression of Th2 cytokine mRNA in the AD skin lesions of DNCB treated BALB/c mice. Histological analyses demonstrated that CP001 decreased dermis and epidermis thickening as well as dermal infiltration induced by inflammatory cells. In addition, CP001 decreased mast cell infiltration in count as well as dermal infiltration induced by inflammatory cells. In the skin lesions, mRNA expression of interleukin- (IL-) 4 and IL-13 was inhibited by CP001. CP001 also reduced the production of IgE level in mouse plasma. In addition, we investigated the effect of CP001 on the inflammatory allergic reaction using human mast cells (HMC-1). In HMC-1, cytokine production and mRNA levels of IL-4, IL-13, IL-6, and IL-8 were suppressed by CP001. Taken together, our results showed that oral administration of CP001 exerts beneficial effects in AD symptoms, suggesting that CP001 might be a useful candidate for the treatment of AD.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Soon Re</ForeName>
                    <Initials>SR</Initials>
                    <Affiliation>Laboratory of Clinical Biology and Pharmacogenomics, Department of Preventive Medicine, College of Oriental Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Choi</LastName>
                    <ForeName>Han-Seok</ForeName>
                    <Initials>HS</Initials>
                    <Affiliation>Laboratory of Clinical Biology and Pharmacogenomics, Department of Preventive Medicine, College of Oriental Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Seo</LastName>
                    <ForeName>Hye Sook</ForeName>
                    <Initials>HS</Initials>
                    <Affiliation>Laboratory of Clinical Biology and Pharmacogenomics, Department of Preventive Medicine, College of Oriental Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ku</LastName>
                    <ForeName>Jin Mo</ForeName>
                    <Initials>JM</Initials>
                    <Affiliation>Laboratory of Clinical Biology and Pharmacogenomics, Department of Preventive Medicine, College of Oriental Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hong</LastName>
                    <ForeName>Se Hyang</ForeName>
                    <Initials>SH</Initials>
                    <Affiliation>Laboratory of Clinical Biology and Pharmacogenomics, Department of Preventive Medicine, College of Oriental Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoo</LastName>
                    <ForeName>Hye Hyun</ForeName>
                    <Initials>HH</Initials>
                    <Identifier Source="ORCID">0000-0001-8282-852X</Identifier>
                    <Affiliation>Department of Pharmacy, College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 426-791, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shin</LastName>
                    <ForeName>Yong Cheol</ForeName>
                    <Initials>YC</Initials>
                    <Affiliation>Laboratory of Clinical Biology and Pharmacogenomics, Department of Preventive Medicine, College of Oriental Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ko</LastName>
                    <ForeName>Seong-Gyu</ForeName>
                    <Initials>SG</Initials>
                    <Affiliation>Laboratory of Clinical Biology and Pharmacogenomics, Department of Preventive Medicine, College of Oriental Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mediators Inflamm</MedlineTA>
            <NlmUniqueID>9209001</NlmUniqueID>
            <ISSNLinking>0962-9351</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Invest Dermatol. 2001 Oct;117(4):977-83</RefSource>
                <PMID Version="1">11676841</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Med. 2012 May;18(5):693-704</RefSource>
                <PMID Version="1">22561833</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Dermatol. 1976 Sep;112(9):1254-5</RefSource>
                <PMID Version="1">1032900</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1991 May 15;88(10):4220-4</RefSource>
                <PMID Version="1">1709737</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 1992 Feb 15;148(4):1086-92</RefSource>
                <PMID Version="1">1371130</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Allergy Clin Immunol. 1992 Nov;90(5):815-24</RefSource>
                <PMID Version="1">1430707</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 1993 Sep 15;151(6):3261-6</RefSource>
                <PMID Version="1">8376778</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 1993 Oct 1;151(7):3853-65</RefSource>
                <PMID Version="1">8376806</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Blood. 1994 Sep 15;84(6):1913-21</RefSource>
                <PMID Version="1">7521694</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int Immunol. 1997 Mar;9(3):461-6</RefSource>
                <PMID Version="1">9088984</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Postgrad Med. 1998 May;103(5):199-200, 207-8, 212-3</RefSource>
                <PMID Version="1">9590995</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int J Immunopharmacol. 1998 Apr-May;20(4-5):231-40</RefSource>
                <PMID Version="1">9730258</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pharmacol Res. 1999 Aug;40(2):171-6</RefSource>
                <PMID Version="1">10433877</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Allergy. 2005 Oct;60(10):1316-9</RefSource>
                <PMID Version="1">16135000</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Allergy Clin Immunol. 2006 Jul;118(1):152-69</RefSource>
                <PMID Version="1">16815151</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2008 Mar 5;116(2):270-8</RefSource>
                <PMID Version="1">18191513</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2008 May 8;117(2):199-214</RefSource>
                <PMID Version="1">18407446</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Chin Med. 2009;37(1):143-58</RefSource>
                <PMID Version="1">19222118</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Oncol Rep. 2009 Nov;22(5):1051-6</RefSource>
                <PMID Version="1">19787220</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Vet Dermatol. 2010 Apr;21(2):184-91</RefSource>
                <PMID Version="1">20141605</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2010 Oct 28;132(1):143-9</RefSource>
                <PMID Version="1">20699114</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2011 Jan 27;133(2):810-7</RefSource>
                <PMID Version="1">21094681</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2011 Mar 8;134(1):37-44</RefSource>
                <PMID Version="1">21129471</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Ethnopharmacol. 2011 Apr 26;135(1):126-34</RefSource>
                <PMID Version="1">21396437</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Chin Med. 2011;39(6):1173-91</RefSource>
                <PMID Version="1">22083989</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2004 Mar;113(5):651-7</RefSource>
                <PMID Version="1">14991059</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4124654</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/319438</ArticleId>
            <ArticleId IdType="pubmed">25132731</ArticleId>
            <ArticleId IdType="pmc">PMC4124654</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25132730</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1466-1861</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Mediators of inflammation</Title>
                <ISOAbbreviation>Mediators Inflamm.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Macrophage trafficking as key mediator of adenine-induced kidney injury.</ArticleTitle>
            <Pagination>
                <MedlinePgn>291024</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/291024</ELocationID>
            <Abstract>
                <AbstractText>Macrophages play a special role in the onset of several diseases, including acute and chronic kidney injuries. In this sense, tubule interstitial nephritis (TIN) represents an underestimated insult, which can be triggered by different stimuli and, in the absence of a proper regulation, can lead to fibrosis deposition. Based on this perception, we evaluated the participation of macrophage recruitment in the development of TIN. Initially, we provided adenine-enriched food to WT and searched for macrophage presence and action in the kidney. Also, a group of animals were depleted of macrophages with the clodronate liposome while receiving adenine-enriched diet. We collected blood and renal tissue from these animals and renal function, inflammation, and fibrosis were evaluated. We observed higher expression of chemokines in the kidneys of adenine-fed mice and a substantial protection when macrophages were depleted. Then, we specifically investigated the role of some key chemokines, CCR5 and CCL3, in this TIN experimental model. Interestingly, CCR5 KO and CCL3 KO animals showed less renal dysfunction and a decreased proinflammatory profile. Furthermore, in those animals, there was less profibrotic signaling. In conclusion, we can suggest that macrophage infiltration is important for the onset of renal injury in the adenine-induced TIN.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Correa-Costa</LastName>
                    <ForeName>Matheus</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">0000-0003-3364-4390</Identifier>
                    <Affiliation>Laboratory of Transplantation Immunobiology, Department of Immunology, University of S??o Paulo, Institute of Biomedical Sciences, 05508-900 S??o Paulo, SP, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Braga</LastName>
                    <ForeName>T??rcio Teodoro</ForeName>
                    <Initials>TT</Initials>
                    <Affiliation>Laboratory of Transplantation Immunobiology, Department of Immunology, University of S??o Paulo, Institute of Biomedical Sciences, 05508-900 S??o Paulo, SP, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Felizardo</LastName>
                    <ForeName>Raphael Jos?? Ferreira</ForeName>
                    <Initials>RJ</Initials>
                    <Affiliation>Laboratory of Clinical and Experimental Immunology, Nephrology Division, Federal University of S??o Paulo, 04023-900 S??o Paulo, SP, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andrade-Oliveira</LastName>
                    <ForeName>Vin??cius</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Laboratory of Transplantation Immunobiology, Department of Immunology, University of S??o Paulo, Institute of Biomedical Sciences, 05508-900 S??o Paulo, SP, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perez</LastName>
                    <ForeName>Katia Regina</ForeName>
                    <Initials>KR</Initials>
                    <Identifier Source="ORCID">0000-0001-9612-1816</Identifier>
                    <Affiliation>Department of Biophysics, Federal University of S??o Paulo, 04023-062 S??o Paulo, SP, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cuccovia</LastName>
                    <ForeName>Iolanda Midea</ForeName>
                    <Initials>IM</Initials>
                    <Identifier Source="ORCID">0000-0001-8285-7419</Identifier>
                    <Affiliation>Institute of Chemistry, Department of Biochemistry, University of S??o Paulo, 05508-000 S??o Paulo, SP, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hiyane</LastName>
                    <ForeName>Meire Ioshie</ForeName>
                    <Initials>MI</Initials>
                    <Affiliation>Laboratory of Transplantation Immunobiology, Department of Immunology, University of S??o Paulo, Institute of Biomedical Sciences, 05508-900 S??o Paulo, SP, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>da Silva</LastName>
                    <ForeName>Jo??o Santana</ForeName>
                    <Initials>JS</Initials>
                    <Affiliation>Department of Biochemistry and Immunology, School of Medicine of Ribeir??o Preto, University of S??o Paulo, 14049-900 Ribeir??o Preto, SP, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>C??mara</LastName>
                    <ForeName>Niels Olsen Saraiva</ForeName>
                    <Initials>NO</Initials>
                    <Affiliation>Laboratory of Transplantation Immunobiology, Department of Immunology, University of S??o Paulo, Institute of Biomedical Sciences, 05508-900 S??o Paulo, SP, Brazil ; Laboratory of Clinical and Experimental Immunology, Nephrology Division, Federal University of S??o Paulo, 04023-900 S??o Paulo, SP, Brazil.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mediators Inflamm</MedlineTA>
            <NlmUniqueID>9209001</NlmUniqueID>
            <ISSNLinking>0962-9351</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2000 Feb 15;164(4):2110-9</RefSource>
                <PMID Version="1">10657665</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Kidney Dis. 2000 Mar;35(3):433-47</RefSource>
                <PMID Version="1">10692269</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2000 Mar 15;164(6):3392-401</RefSource>
                <PMID Version="1">10706735</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2000 Feb;12(2):121-7</RefSource>
                <PMID Version="1">10714678</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Invest. 2003 Dec;112(12):1776-84</RefSource>
                <PMID Version="1">14679171</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 1996 May 28;93(11):5307-12</RefSource>
                <PMID Version="1">8643571</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 1998 Jul 6;188(1):193-8</RefSource>
                <PMID Version="1">9653095</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Renal Physiol. 2005 Feb;288(2):F406-11</RefSource>
                <PMID Version="1">15507546</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 2006 Feb 9;354(6):610-21</RefSource>
                <PMID Version="1">16467548</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nephron Exp Nephrol. 2007;105(1):e1-9</RefSource>
                <PMID Version="1">17106213</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Pathol. 2007 Mar;170(3):843-54</RefSource>
                <PMID Version="1">17322370</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ann N Y Acad Sci. 2007 Apr;1100:162-72</RefSource>
                <PMID Version="1">17460174</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Pharmacol Toxicol. 2008;48:171-97</RefSource>
                <PMID Version="1">17883327</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Semin Liver Dis. 2010 Aug;30(3):245-57</RefSource>
                <PMID Version="1">20665377</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Am Soc Nephrol. 2010 Aug;21(8):1270-4</RefSource>
                <PMID Version="1">20651159</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Mol Med. 2012;18:1231-9</RefSource>
                <PMID Version="1">22777483</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Oncogene. 2013 Feb 14;32(7):849-60</RefSource>
                <PMID Version="1">22469976</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Physiol Renal Physiol. 2013 Jul 15;305(2):F155-63</RefSource>
                <PMID Version="1">23657853</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nephrol Dial Transplant. 2013 Aug;28(8):2038-45</RefSource>
                <PMID Version="1">23512109</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2008 Nov 1;181(9):6384-93</RefSource>
                <PMID Version="1">18941229</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Exp Nephrol. 2009 Feb;13(1):9-14</RefSource>
                <PMID Version="1">19085040</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Histochem Cell Biol. 2009 Apr;131(4):483-90</RefSource>
                <PMID Version="1">19159945</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Pharmacol Sci. 2009 Nov;111(3):285-92</RefSource>
                <PMID Version="1">19893275</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Kidney Int. 2010 Jun;77(11):956-61</RefSource>
                <PMID Version="1">20336051</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2010 Aug 15;185(4):2044-50</RefSource>
                <PMID Version="1">20660352</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Kidney Int. 2011 Jan;79(2):189-98</RefSource>
                <PMID Version="1">20962742</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Cell Biol. 2011 Jan;89(1):130-42</RefSource>
                <PMID Version="1">20514074</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Kidney Int. 2011 Nov;80(9):915-25</RefSource>
                <PMID Version="1">21814171</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Immunol. 2011 Nov;11(11):723-37</RefSource>
                <PMID Version="1">21997792</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2011;6(12):e29004</RefSource>
                <PMID Version="1">22194975</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Inflammopharmacology. 2012 Feb;20(1):1-18</RefSource>
                <PMID Version="1">22205271</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4124723</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/291024</ArticleId>
            <ArticleId IdType="pubmed">25132730</ArticleId>
            <ArticleId IdType="pmc">PMC4124723</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132679</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2326-5205</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>6</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title>
            </Journal>
            <ArticleTitle>The chemokine receptor CXCR6 regulates cytokine polarization and T cell recruitment to inflamed paws in collagen-induced arthritis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/art.38816</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Objective: The chemokine receptor CXCR6 is highly expressed on lymphocytes isolated from the synovium of patients with rheumatoid, psoriatic, or juvenile idiopathic arthritis, suggesting that CXCR6 regulates immune cell activation or infiltration into arthritic joints. We undertook this study to examine the role of CXCR6 in T cell activation and arthritis development. Methods: A collagen-induced arthritis model was used to examine arthritis development in wild-type and CXCR6(-/-) mice. CXCR6 expression, lymphocyte accumulation, and intracellular cytokine production were examined by flow cytometry. Collagen-specific antibodies were measured in serum. Collagen-specific recall responses were examined in vitro via proliferation and cytokine release assays. T cell homing to inflamed joints was examined by competitive adoptive transfer of dye-labeled wild-type and CXCR6(-/-) lymphocytes. Results: CXCR6(+) T cells increased in the paws and draining lymph nodes of arthritic mice. Arthritis incidence, severity, T cell accumulation, and collagen-specific IgG2a antibodies were significantly reduced in CXCR6(-/-) mice compared to wild-type mice. T cells from wild-type mice exhibited Th1 (IFN-??) polarization in the inguinal lymph nodes following immunization. At disease peak, this shifted to a Th17 (IL-17A) response in the popliteal lymph nodes. T cells in CXCR6(-/-) mice exhibited impaired cytokine polarization, resulting in a decreased frequency and number of IL-17A- and IFN- ??-producing cells. Recruitment of activated CXCR6(-/-) T cells to inflamed paws was impaired compared to recruitment of wild-type T cells. Conclusion: Our experiments demonstrate that CXCR6 plays important roles in arthritis pathogenesis through effects on both T cell cytokine polarization and homing to inflamed joints. ?? 2014 American College of Rheumatology.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American College of Rheumatology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Slauenwhite</LastName>
                    <ForeName>Drew</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Microbiology &amp; Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gebremeskel</LastName>
                    <ForeName>Simon</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Doucette</LastName>
                    <ForeName>Carolyn D</ForeName>
                    <Initials>CD</Initials>
                </Author>
                <Author>
                    <LastName>Hoskin</LastName>
                    <ForeName>David W</ForeName>
                    <Initials>DW</Initials>
                </Author>
                <Author>
                    <LastName>Johnston</LastName>
                    <ForeName>Brent</ForeName>
                    <Initials>B</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Arthritis Rheumatol</MedlineTA>
            <NlmUniqueID>101623795</NlmUniqueID>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.38816</ArticleId>
            <ArticleId IdType="pubmed">25132679</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132671</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2326-5205</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>6</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title>
            </Journal>
            <ArticleTitle>P-selectin glycoprotein ligand-1 leukocyte receptor deficiency in mice induces an autoimmune syndrome affecting the skin and internal organs.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/art.38808</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Objectives To define and characterize the progression of the spontaneous autoimmune disease developed in mice in the absence of the leukocyte adhesion receptor PSGL-1. Methods PSGL-1-deficient mice and C57Bl/6 control mice were sacrificed at different ages. Skin-resident immune cells were isolated and analyzed by flow cytometry. Biochemical parameters were analyzed in serum and urine and the presence of serum autoantibodies was investigated. Skin and internal organs were extracted and their structure was analyzed histologically. Results Skin-resident innate and adaptive immune cells of PSGL-1(-/-) mice have a pro-inflammatory phenotype with an imbalanced Teff/Treg ratio. Sera from PSGL-1(-/-) mice present circulating autoantibodies commonly detected in connective tissue-related human autoimmune diseases. Biochemical and histological analysis of skin and internal organs reveal skin fibrosis and structural and functional abnormalities in lungs and kidneys. Furthermore, PSGL-1(-/-) mice exhibit vascular alterations, showing loss of dermal vessels, small vessel medial layer remodeling in lung and kidney and ischemic processes in the kidney that promote renal infarcts. Conclusions Our study demonstrates that immune system over-activation due to PSGL-1 deficiency triggers an autoimmune syndrome with characteristics similar to systemic sclerosis, including skin fibrosis, vascular alterations and systemic organ involvement. These results suggest that PSGL-1 expression contributes to the maintenance of the homeostasis of the immune system and could act as a barrier for autoimmunity in mice. ?? 2014 American College of Rheumatology.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American College of Rheumatology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>P??rez-Fr??as</LastName>
                    <ForeName>Alicia</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Immunology Department, Fundaci??n de Investigaci??n Biom??dica, Instituto de Investigaci??n Sanitaria-Princesa (IIS-Princesa), Hospital de la Princesa, C/DiegodeLe??n62, 28006-Madrid, Spain.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gonz??lez-Tajuelo</LastName>
                    <ForeName>Rafael</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>N????ez-Andrade</LastName>
                    <ForeName>Norman</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Tejedor</LastName>
                    <ForeName>Reyes</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Garc??a-Blanco</LastName>
                    <ForeName>Mar??a J</ForeName>
                    <Initials>MJ</Initials>
                </Author>
                <Author>
                    <LastName>Vicente-Rabaneda</LastName>
                    <ForeName>Esther</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Casta??eda</LastName>
                    <ForeName>Santos</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Gamallo</LastName>
                    <ForeName>Carlos</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Silv??n</LastName>
                    <ForeName>Javier</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Esteban-Villafruela</LastName>
                    <ForeName>Ainhoa</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Cubero-Rueda</LastName>
                    <ForeName>Lara</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Garc??a-Garc??a</LastName>
                    <ForeName>Carmen</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Mu??oz-Calleja</LastName>
                    <ForeName>Cecilia</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Garc??a-Diez</LastName>
                    <ForeName>Amaro</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Urzainqui</LastName>
                    <ForeName>Ana</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Arthritis Rheumatol</MedlineTA>
            <NlmUniqueID>101623795</NlmUniqueID>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.38808</ArticleId>
            <ArticleId IdType="pubmed">25132671</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132657</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2049-632X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                        <Day>29</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pathogens and disease</Title>
                <ISOAbbreviation>Pathog Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Decreased in vivo virulence and altered gene expression by a Brucella melitensis light-sensing histidine kinase mutant.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/2049-632X.12209</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Brucella species utilize diverse virulence factors. Previously, Brucella abortus light sensing histidine kinase was identified as important for cellular infection. Here, we demonstrate that a ??rucella melitensis LOV-HK (BM-LOV-HK) mutant strain has strikingly different gene expression than wild type. General stress response genes including the alternative sigma factor rpoE1 and its anti-anti sigma factor phyR were downregulated, while flagellar, quorum sensing, and type IV secretion system genes were upregulated in the ??BM-LOV-HK strain versus wild type. Contextually, expression results agree with other studies of transcriptional regulators involving ??rpoE1, ??phyR, ??vjbR, and ??blxR (??babR) Brucella strains. Additionally, deletion of BM-LOV-HK decreases virulence in mice. During C57BL/6 mouse infection, the ??BM-LOV-HK strain had 2 logs less CFUs in the spleen 3 days post infection but similar levels 6 days post infection compared to wild type. Infection of IRF-1(-/-) mice more specifically define ??BM-LOV-HK strain attenuation with fewer bacteria in spleens and significantly increased survival of mutant versus wild type infected IRF-1(-/-) mice. Upregulation of flagella, quorum sensing, and VirB genes, along with downregulation of rpoE1 and related sigma factor, rpoH2 (BMEI0280) suggest that BM-LOV-HK modulates both quorum sensing and general stress response regulatory components to control Brucella gene expression on a global level. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Gourley</LastName>
                    <ForeName>Christopher R</ForeName>
                    <Initials>CR</Initials>
                    <Affiliation>Department of Pathobiological Sciences, University of Wisconsin-Madison, 1656 Linden Dr., Madison, WI 53706.</Affiliation>
                </Author>
                <Author>
                    <LastName>Petersen</LastName>
                    <ForeName>Erik</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Harms</LastName>
                    <ForeName>Jerome</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Splitter</LastName>
                    <ForeName>Gary</ForeName>
                    <Initials>G</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>R01 AI073558</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Pathog Dis</MedlineTA>
            <NlmUniqueID>101595366</NlmUniqueID>
            <ISSNLinking>2049-632X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">LOV</Keyword>
            <Keyword MajorTopicYN="N">Brucellosis</Keyword>
            <Keyword MajorTopicYN="N">Flagella</Keyword>
            <Keyword MajorTopicYN="N">PhyR</Keyword>
            <Keyword MajorTopicYN="N">Secretion</Keyword>
            <Keyword MajorTopicYN="N">Stress</Keyword>
            <Keyword MajorTopicYN="N">Virulence</Keyword>
            <Keyword MajorTopicYN="N">virB</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/2049-632X.12209</ArticleId>
            <ArticleId IdType="pubmed">25132657</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132655</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1552-4981</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of biomedical materials research. Part B, Applied biomaterials</Title>
                <ISOAbbreviation>J. Biomed. Mater. Res. Part B Appl. Biomater.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The heat-compression technique for the conversion of platelet-rich fibrin preparation to a barrier membrane with a reduced rate of biodegradation.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jbm.b.33262</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Platelet-rich fibrin (PRF) was developed as an advanced form of platelet-rich plasma to eliminate xenofactors, such as bovine thrombin, and it is mainly used as a source of growth factor for tissue regeneration. Furthermore, although a minor application, PRF in a compressed membrane-like form has also been used as a substitute for commercially available barrier membranes in guided-tissue regeneration (GTR) treatment. However, the PRF membrane is resorbed within 2 weeks or less at implantation sites; therefore, it can barely maintain sufficient space for bone regeneration. In this study, we developed and optimized a heat-compression technique and tested the feasibility of the resulting PRF membrane. Freshly prepared human PRF was first compressed with dry gauze and subsequently with a hot iron. Biodegradability was microscopically examined in vitro by treatment with plasmin at 37??C or in vivo by subcutaneous implantation in nude mice. Compared with the control gauze-compressed PRF, the heat-compressed PRF appeared plasmin-resistant and remained stable for longer than 10 days in vitro. Additionally, in animal implantation studies, the heat-compressed PRF was observed at least for 3 weeks postimplantation in vivo whereas the control PRF was completely resorbed within 2 weeks. Therefore, these findings suggest that the heat-compression technique reduces the rate of biodegradation of the PRF membrane without sacrificing its biocompatibility and that the heat-compressed PRF membrane easily could be prepared at chair-side and applied as a barrier membrane in the GTR treatment. ?? 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2014.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Kawase</LastName>
                    <ForeName>Tomoyuki</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Division of Oral Bioengineering, Institute of Medicine and Dentistry, Niigata University, Niigata, 951-8514, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kamiya</LastName>
                    <ForeName>Mana</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Kobayashi</LastName>
                    <ForeName>Mito</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Tanaka</LastName>
                    <ForeName>Takaaki</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Okuda</LastName>
                    <ForeName>Kazuhiro</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Wolff</LastName>
                    <ForeName>Larry F</ForeName>
                    <Initials>LF</Initials>
                </Author>
                <Author>
                    <LastName>Yoshie</LastName>
                    <ForeName>Hiromasa</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Biomed Mater Res B Appl Biomater</MedlineTA>
            <NlmUniqueID>101234238</NlmUniqueID>
            <ISSNLinking>1552-4973</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">barrier membrane</Keyword>
            <Keyword MajorTopicYN="N">biodegradability</Keyword>
            <Keyword MajorTopicYN="N">guided tissue regeneration</Keyword>
            <Keyword MajorTopicYN="N">plasmin</Keyword>
            <Keyword MajorTopicYN="N">platelet-rich fibrin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbm.b.33262</ArticleId>
            <ArticleId IdType="pubmed">25132655</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132647</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>24</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-8057</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular and cellular endocrinology</Title>
                <ISOAbbreviation>Mol. Cell. Endocrinol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The expression of aminoacyl-tRNA-synthetase-interacting multifunctional protein-1 (Aimp1) is regulated by estrogen in the mouse uterus.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0303-7207(14)00213-5</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.mce.2014.07.009</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Aimp1 is known as a multifunctional cytokine in various cellular events. Recent study showed Aimp1 is localized in glandular epithelial, endothelial, and stromal cells in functionalis and basalis layers of the endometrium. However, the regulatory mechanism of Aimp1 in the uterus remains unknown. In the present study, we found that Aimp1 is expressed in the mouse uterus. Aimp1 transcripts were decreased at diestrus stage. However, the level of Aimp1 protein was significantly increased in the luminal epithelium in the uterine endometrium at estrus stage during the estrous cycle. We found that treatment of estrogen increased the expression of Aimp1 in the uterus in ovarectomized mice. We identified one estrogen receptor binding element (ERE) on mouse Aimp1 promoter. The activity of Aimp1 promoter was increased with estrogen treatment. Our findings indicate that Aimp1 might act as an important regulator to remodel the uterine endometrium and its expression might be regulated by estrogen during the estrous cycle. This will give us better understanding of the dynamic change of uterine remodeling during the estrous cycle.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Jeong</LastName>
                    <ForeName>Ji-Hye</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Department of Biomedical Science, College of Medicine CHA University, Seoul 135-081, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Miree</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Biomedical Science, College of Medicine CHA University, Seoul 135-081, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Miseon</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Fertility Center of CHA Gangnam Medical Center, Seoul 135-081, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lim</LastName>
                    <ForeName>Eun Jin</ForeName>
                    <Initials>EJ</Initials>
                    <Affiliation>Department of Biomedical Science, College of Medicine CHA University, Seoul 135-081, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Hye-Ryun</ForeName>
                    <Initials>HR</Initials>
                    <Affiliation>Department of Biomedical Science, College of Medicine CHA University, Seoul 135-081, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Song</LastName>
                    <ForeName>Haengseok</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Biomedical Science, College of Medicine CHA University, Seoul 135-081, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Sang Gyu</ForeName>
                    <Initials>SG</Initials>
                    <Affiliation>Department of Biomedical Science, College of Medicine CHA University, Seoul 135-081, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Choi</LastName>
                    <ForeName>Seong-Jun</ForeName>
                    <Initials>SJ</Initials>
                    <Affiliation>Department of Nanobiomedical Science &amp; BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 330-714, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hong</LastName>
                    <ForeName>Kwon-Ho</ForeName>
                    <Initials>KH</Initials>
                    <Affiliation>Department of Nanobiomedical Science &amp; BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 330-714, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Dong Ryul</ForeName>
                    <Initials>DR</Initials>
                    <Affiliation>Department of Biomedical Science, College of Medicine CHA University, Seoul 135-081, Korea; Fertility Center of CHA Gangnam Medical Center, Seoul 135-081, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ko</LastName>
                    <ForeName>Jeong-Jae</ForeName>
                    <Initials>JJ</Initials>
                    <Affiliation>Department of Biomedical Science, College of Medicine CHA University, Seoul 135-081, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Choi</LastName>
                    <ForeName>Youngsok</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Biomedical Science, College of Medicine CHA University, Seoul 135-081, Korea; Fertility Center of CHA Gangnam Medical Center, Seoul 135-081, Korea. Electronic address: youngsokchoi@cha.ac.kr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Mol Cell Endocrinol</MedlineTA>
            <NlmUniqueID>7500844</NlmUniqueID>
            <ISSNLinking>0303-7207</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Aimp1</Keyword>
            <Keyword MajorTopicYN="N">Estrogen</Keyword>
            <Keyword MajorTopicYN="N">Estrous cycle</Keyword>
            <Keyword MajorTopicYN="N">Uterus</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132647</ArticleId>
            <ArticleId IdType="pii">S0303-7207(14)00213-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.mce.2014.07.009</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132642</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-0384</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Archives of biochemistry and biophysics</Title>
                <ISOAbbreviation>Arch. Biochem. Biophys.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0003-9861(14)00284-7</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.abb.2014.07.033</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Monobenzyl ether of hydroquinone (MBEH) is cytotoxic towards melanocytes. Its treatment efficacy is limited by an inability to eradicate stem cells. By contrast, 8-hydroxy-N,N-dipropyl-2-aminotetralin (8-DPAT) affects melanocyte stem cell survival. MBEH and 8-DPAT were added to melanocytes and melanoma cells to compare cytotoxicity. Stem cell content among viable cells was determined by fluorocytometry using markers CD34, Pax3, and CD271. Immunostaining was used to identify stem cells in skin explants treated with MBEH or 8-DPAT ex vivo. Mice were exposed to MBEH or 8-DPAT and scanned for depigmentation before harvesting skin. MBEH exposure prompted a relative increase in stem cells among cultured melanocytes and melanoma cells, as treatment preferentially eliminated differentiated cells and spared the stem cells. Viability of this remaining, enriched stem cell population was however rapidly reduced by exposure to 8-DPAT within melanocyte and melanoma cell cultures. In human skin explants, the abundance of melanocyte stem cells was also visibly reduced after 8-DPAT treatment, in contrast to tissue exposed to MBEH. Meanwhile, significant depigmentation of the mouse pelage and loss of differentiated melanocytes was observed in vivo in response to topical application of MBEH, but not 8-DPAT. Prolonged application of the latter agent instead appeared to effectively reduce the abundance of melanocyte stem cells in the dermis. This furthers the idea that MBEH and 8-DPAT target complementary cell populations. Results indicate that combination treatment may demonstrate superior therapeutic activity by eliminating both differentiated and tumor initiating populations.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Bonchak</LastName>
                    <ForeName>Jonathan G</ForeName>
                    <Initials>JG</Initials>
                    <Affiliation>Departments of Medicine and Radiology, Loyola University Medical Center, Maywood, IL, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Eby</LastName>
                    <ForeName>Jonathan M</ForeName>
                    <Initials>JM</Initials>
                    <Affiliation>Oncology Research Institute, Loyola University Medical Center, Maywood, IL, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Willenborg</LastName>
                    <ForeName>Kristin A</ForeName>
                    <Initials>KA</Initials>
                    <Affiliation>Oncology Research Institute, Loyola University Medical Center, Maywood, IL, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chrobak</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Oncology Research Institute, Loyola University Medical Center, Maywood, IL, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Henning</LastName>
                    <ForeName>Steven W</ForeName>
                    <Initials>SW</Initials>
                    <Affiliation>Oncology Research Institute, Loyola University Medical Center, Maywood, IL, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Krzywiec</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Illinois Mathematics and Science Academy, Aurora, IL, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Johnson</LastName>
                    <ForeName>Steven L</ForeName>
                    <Initials>SL</Initials>
                    <Affiliation>Department of Genetics, Washington University School of Medicine, St. Louis, MA, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Le Poole</LastName>
                    <ForeName>I Caroline</ForeName>
                    <Initials>IC</Initials>
                    <Affiliation>Oncology Research Institute, Loyola University Medical Center, Maywood, IL, USA; Departments of Pathology, Microbiology and Immunology, Loyola University Medical Center, Maywood, IL, USA. Electronic address: ilepool@luc.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Arch Biochem Biophys</MedlineTA>
            <NlmUniqueID>0372430</NlmUniqueID>
            <ISSNLinking>0003-9861</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">8-DPAT</Keyword>
            <Keyword MajorTopicYN="N">MBEH</Keyword>
            <Keyword MajorTopicYN="N">Melanocyte</Keyword>
            <Keyword MajorTopicYN="N">Melanoma</Keyword>
            <Keyword MajorTopicYN="N">Pigmentation</Keyword>
            <Keyword MajorTopicYN="N">Stem cells</Keyword>
            <Keyword MajorTopicYN="N">Viability</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132642</ArticleId>
            <ArticleId IdType="pii">S0003-9861(14)00284-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.abb.2014.07.033</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25132605</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>25</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-5905</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>35</Volume>
                    <Issue>34</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomaterials</Title>
                <ISOAbbreviation>Biomaterials</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Enhanced angiogenic effect of adipose-derived stromal cell spheroid with low-level light therapy in hind limb ischemia mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>9280-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biomaterials.2014.07.061</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0142-9612(14)00883-7</ELocationID>
            <Abstract>
                <AbstractText>The aim of this study was to investigate the effects of low-level laser therapy (LLLT) on transplanted human adipose-derived mesenchymal stem cells (hASCs) spheroid in a hind limb ischemia animal model. LLLT, hASCs spheroid and hASCs spheroid transplantation with LLLT (spheroid??+??LLLT) were applied to the ischemic hind limbs in athymic mice. The survival, differentiation and secretion of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (FGF), and hepatocyte growth factor (HGF) of the spheroid ASCs were evaluated by immunohistochemistry and western blots. Spheroid??+??LLLT group had enhanced the tissue regeneration, including angiogenesis, compared with the ASC group. The spheroid ASCs contributed to tissue regeneration via differentiation and secretion of growth factors. In the spheroid??+??LLLT group, the survival of spheroid hASCs increased with a concomitant decrease in apoptosis of spheroid hASCs in the ischemic hind limb. The secretion of growth factors was stimulated in the spheroid??+??LLLT group compared with the ASCs and spheroid group. These data suggested that LLLT is an effective biostimulator of spheroid hASCs in tissue regeneration that enhanced the survival of ASCs and stimulated the secretion of growth factors in the ischemic hind limb.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>In-Su</ForeName>
                    <Initials>IS</Initials>
                    <Affiliation>Beckman Laser Institute Korea, Dankook University, 119 Dandae-ro, Cheonan, Chungnam 330-714, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chung</LastName>
                    <ForeName>Phil-Sang</ForeName>
                    <Initials>PS</Initials>
                    <Affiliation>Beckman Laser Institute Korea, Dankook University, 119 Dandae-ro, Cheonan, Chungnam 330-714, South Korea; Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Dankook University, 119 Dandae-ro, Cheonan, Chungnam 330-714, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ahn</LastName>
                    <ForeName>Jin Chul</ForeName>
                    <Initials>JC</Initials>
                    <Affiliation>Beckman Laser Institute Korea, Dankook University, 119 Dandae-ro, Cheonan, Chungnam 330-714, South Korea; Department of Biomedical Science, Dankook University, Cheonan, Chungnam 330-714, South Korea; Biomedical Translational Research Institute, Dankook University, Cheonan, Chungnam 330-714, South Korea. Electronic address: jcahn@dankook.ac.kr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Biomaterials</MedlineTA>
            <NlmUniqueID>8100316</NlmUniqueID>
            <ISSNLinking>0142-9612</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adipose-derived stromal cell</Keyword>
            <Keyword MajorTopicYN="N">Angiogenesis</Keyword>
            <Keyword MajorTopicYN="N">Endothelial differentiation</Keyword>
            <Keyword MajorTopicYN="N">Low level light</Keyword>
            <Keyword MajorTopicYN="N">Spheroid</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132605</ArticleId>
            <ArticleId IdType="pii">S0142-9612(14)00883-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2014.07.061</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25132602</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>25</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-5905</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>35</Volume>
                    <Issue>34</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomaterials</Title>
                <ISOAbbreviation>Biomaterials</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Nucleotide biosynthesis arrest by silencing SHMT1 function via vitamin B6-coupled vector and effects on tumor growth inhibition.</ArticleTitle>
            <Pagination>
                <MedlinePgn>9332-42</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biomaterials.2014.07.045</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0142-9612(14)00854-0</ELocationID>
            <Abstract>
                <AbstractText>Serine hydroxymethyltransferase isoforms (SHMT1 &amp; SHMT2??), which serve as scaffold protein for the formation of a multi-enzyme complex and generate one-carbon unit for the de novo thymidylate biosynthesis pathway during DNA synthesis, are vitamin B6 (VB6)-dependent enzyme. Cancer cells with high proliferation intensity need increased SHMT activation which enforces the facilitated-diffusion of VB6 for the continuous functioning of thymidylate synthase cycle. Therefore, SHMT knockdown presents an alternative approach to prevent DNA synthesis in cancer cells; however, its potential to inhibit cancer growth remains unknown so far. Here we demonstrated that VB6 coupled to poly(ester amine) (VBPEA) enforces a high level of VTC (VB6-transporting membrane carriers)-mediated endocytosis of the complexed SHMT1 siRNA (siSHMT1) to interrupt the thymidylate biosynthesis pathway of cancer cells. The detrimental effect of SHMT1 knockdown on the disintegration of multi-enzyme complex resulted in cell cycle arrest and a decrease in cell's genomic DNA content, leading to enhanced apoptotic events in cancer cells. A reduction in tumor size was observed with constant SHMT1 suppression in xenograft mice. This study illustrates how silencing the SHMT1 expression inhibits cancer growth and the increased VB6 channeling for sustenance of cancer cells promotes VB6-coupled vector to elicit enhanced delivery of siSHMT1.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pandey</LastName>
                    <ForeName>Shambhavi</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Biosystems &amp; Biomaterials Science and Engineering, Seoul National University, Seoul 151-921, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Garg</LastName>
                    <ForeName>Pankaj</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Biosystems &amp; Biomaterials Science and Engineering, Seoul National University, Seoul 151-921, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Somin</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Laboratory of Toxicology, College of Veterinary Medicine, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Choung</LastName>
                    <ForeName>Han-Wool</ForeName>
                    <Initials>HW</Initials>
                    <Affiliation>Department of Oral and Maxillofacial Surgery and Dental Research Institute, School of Dentistry, Seoul National University, Seoul 110-774, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Choung</LastName>
                    <ForeName>Yun-Hoon</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Department of Otalaryngology, Ajou University School of Medicine, Suwon 443-749, Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Choung</LastName>
                    <ForeName>Pill-Hoon</ForeName>
                    <Initials>PH</Initials>
                    <Affiliation>Department of Oral and Maxillofacial Surgery and Dental Research Institute, School of Dentistry, Seoul National University, Seoul 110-774, Republic of Korea. Electronic address: choungph@snu.ac.kr.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chung</LastName>
                    <ForeName>Jong Hoon</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Department of Biosystems &amp; Biomaterials Science and Engineering, Seoul National University, Seoul 151-921, Republic of Korea; Research Institute for Agriculture and Life Sciences, Seoul National University, Seoul 151-921, Republic of Korea. Electronic address: jchung@snu.ac.kr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Biomaterials</MedlineTA>
            <NlmUniqueID>8100316</NlmUniqueID>
            <ISSNLinking>0142-9612</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Membrane carrier</Keyword>
            <Keyword MajorTopicYN="N">Poly(ester amine)</Keyword>
            <Keyword MajorTopicYN="N">Serine hydroxymethyltransferase</Keyword>
            <Keyword MajorTopicYN="N">Vitamin B(6)</Keyword>
            <Keyword MajorTopicYN="N">siRNA</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132602</ArticleId>
            <ArticleId IdType="pii">S0142-9612(14)00854-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2014.07.045</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132557</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1095-953X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurobiology of disease</Title>
                <ISOAbbreviation>Neurobiol. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0969-9961(14)00238-1</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.nbd.2014.07.016</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The endothelin system is implicated in various human and animal glaucomas. Targeting the endothelin system has great promise as a treatment for human glaucoma, but the cell types involved and the exact mechanisms of action are not clearly elucidated. Here, we report a detailed characterization of the endothelin system in specific cell types of the optic nerve head (ONH) during glaucoma in DBA/2J mice. First, we show that key components of the endothelin system are expressed in multiple cell types. We discover that endothelin 2 (EDN2) is expressed in astrocytes as well as microglia/monocytes in the ONH. The endothelin receptor type A (Ednra) is expressed in vascular endothelial cells, while the endothelin receptor type B (Ednrb) receptor is expressed in ONH astrocytes. Second, we show that Macitentan treatment protects from glaucoma. Macitentan is a novel, orally administered, dual endothelin receptor antagonist with greater affinity, efficacy and safety than previous antagonists. Finally, we test the combinatorial effect of targeting both the endothelin and complement systems as a treatment for glaucoma. Similar to endothelin, the complement system is implicated in a variety of human and animal glaucomas, and has great promise as a treatment target. We discovered that combined targeting of the endothelin (Bosentan) and complement (C1qa mutation) systems is profoundly protective. Remarkably, 80% of DBA/2J eyes subjected to this combined inhibition developed no detectable glaucoma. This opens an exciting new avenue for neuroprotection in glaucoma.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Howell</LastName>
                    <ForeName>Gareth R</ForeName>
                    <Initials>GR</Initials>
                    <Affiliation>The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, USA. Electronic address: gareth.howell@jax.org.</Affiliation>
                </Author>
                <Author>
                    <LastName>MacNicoll</LastName>
                    <ForeName>Katharine H</ForeName>
                    <Initials>KH</Initials>
                    <Affiliation>The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Braine</LastName>
                    <ForeName>Catherine E</ForeName>
                    <Initials>CE</Initials>
                    <Affiliation>The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Soto</LastName>
                    <ForeName>Ileana</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Macalinao</LastName>
                    <ForeName>Danilo G</ForeName>
                    <Initials>DG</Initials>
                    <Affiliation>The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sousa</LastName>
                    <ForeName>Gregory L</ForeName>
                    <Initials>GL</Initials>
                    <Affiliation>The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>John</LastName>
                    <ForeName>Simon W M</ForeName>
                    <Initials>SW</Initials>
                    <Affiliation>The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, USA; The Howard Hughes Medical Institute, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, USA; Department of Ophthalmology, Tufts University School of Medicine, Boston, MA, USA. Electronic address: simon.john@jax.org.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neurobiol Dis</MedlineTA>
            <NlmUniqueID>9500169</NlmUniqueID>
            <ISSNLinking>0969-9961</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Complement</Keyword>
            <Keyword MajorTopicYN="N">DBA/2J</Keyword>
            <Keyword MajorTopicYN="N">Endothelin</Keyword>
            <Keyword MajorTopicYN="N">Glaucoma</Keyword>
            <Keyword MajorTopicYN="N">Optic nerve head</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132557</ArticleId>
            <ArticleId IdType="pii">S0969-9961(14)00238-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nbd.2014.07.016</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132556</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1095-953X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurobiology of disease</Title>
                <ISOAbbreviation>Neurobiol. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effects of diet-induced obesity and voluntary exercise in a tauopathy mouse model: Implications of persistent hyperleptinemia and enhanced astrocytic leptin receptor expression.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0969-9961(14)00246-0</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.nbd.2014.08.015</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The number of patients with Alzheimer's disease (AD) is increasing worldwide, and available drugs have shown limited efficacy. Hence, preventive interventions and treatments for presymptomatic AD are currently considered very important. Obesity rates have also been increasing dramatically and it is an independent risk factor of AD. Therefore, for the prevention of AD, it is important to elucidate the pathomechanism between obesity and AD. We generated high calorie diet (HCD)-induced obese tauopathy model mice (PS19), which showed hyperleptinemia but limited insulin resistance. HCD enhanced tau pathology and glial activation. Conversely, voluntary exercise with a running wheel normalized the serum leptin concentration without reducing body weight, and restored the pathological changes induced by HCD. Thus, we speculated that persistent hyperleptinemia played an important role in accelerating pathological changes in PS19 mice. Leptin primarily regulates food intake and body weight via leptin receptor b (LepRb). Interestingly, the nuclear staining for p-STAT3, which was activated by LepRb, was decreased in hippocampal neurons in HCD PS19 mice, indicating leptin resistance. Meanwhile, astroglial activation and the astrocytic expression of a short LepR isoform, LepRa, were enhanced in the hippocampus of HCD PS19 mice. Real-time PCR analysis demonstrated that leptin increased mRNA levels for pro-inflammatory cytokines including IL-1?? and TNF-?? in primary cultured astrocytes from wild type and LepRb-deficient mice. These observations suggest that persistent hyperleptinemia caused by obesity induces astrocytic activation, astrocytic leptin hypersensitivity with enhanced LepRa expression, and enhanced inflammation, consequently accelerating tau pathology in PS19 mice.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Koga</LastName>
                    <ForeName>Shunsuke</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Neurology, School of Graduate Medicine, Chiba University, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kojima</LastName>
                    <ForeName>Ayako</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratory for Neurodegenerative Disorder Research, Clinical Research Center, Chiba-East National Hospital, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ishikawa</LastName>
                    <ForeName>Chieko</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Laboratory for Neurodegenerative Disorder Research, Clinical Research Center, Chiba-East National Hospital, Japan; Department of Neurology, Chiba-East National Hospital, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kuwabara</LastName>
                    <ForeName>Satoshi</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Neurology, School of Graduate Medicine, Chiba University, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Arai</LastName>
                    <ForeName>Kimihito</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Neurology, Chiba-East National Hospital, Japan; Department of Neurology, School of Graduate Medicine, Chiba University, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yoshiyama</LastName>
                    <ForeName>Yasumasa</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Laboratory for Neurodegenerative Disorder Research, Clinical Research Center, Chiba-East National Hospital, Japan; Department of Neurology, Chiba-East National Hospital, Japan; Department of Neurology, School of Graduate Medicine, Chiba University, Japan. Electronic address: neuroyy@cehpnet.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neurobiol Dis</MedlineTA>
            <NlmUniqueID>9500169</NlmUniqueID>
            <ISSNLinking>0969-9961</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Astrocyte</Keyword>
            <Keyword MajorTopicYN="N">Leptin</Keyword>
            <Keyword MajorTopicYN="N">Neuroinflammation</Keyword>
            <Keyword MajorTopicYN="N">Obesity</Keyword>
            <Keyword MajorTopicYN="N">Tau</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132556</ArticleId>
            <ArticleId IdType="pii">S0969-9961(14)00246-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nbd.2014.08.015</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132555</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1095-953X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurobiology of disease</Title>
                <ISOAbbreviation>Neurobiol. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0969-9961(14)00244-7</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.nbd.2014.08.013</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Adenosine A1 receptor (A1R) stimulation exerts beneficial effects in response to various insults to the brain and, although it was found neuroprotective in a lesional model of Huntington's disease (HD), the features of this receptor in genetic models of HD have never been explored. In the present study we characterized the expression, affinity and functional effects of A1Rs in R6/2 mice (the most widely used transgenic model of HD) and in a cellular model of HD. Binding studies revealed that the density of A1Rs was significantly reduced in the cortex and the striatum of R6/2 mice compared to age-matched wild-type (WT), while receptor affinity was unchanged. The selective A1R agonist cyclopentyladenosine (CPA, 300nM) was significantly more effective in reducing synaptic transmission in corticostriatal slices from symptomatic R6/2 than in age-matched WT mice. Such an effect was due to a stronger inhibition of glutamate release from the pre-synaptic terminal. The different functional activities of A1Rs in HD mice were associated also to a different intracellular signaling pathway involved in the synaptic effect of CPA. In fact, while the PKA pathway was involved in both genotypes, p38 MAPK inhibitor SB203580 partially prevented synaptic effects of CPA in R6/2, but not in WT, mice; moreover, CPA differently modulated the phosphorylation status of p38 in the two genotypes. In vitro studies confirmed a different behavior of A1Rs in HD: CPA (100 nM for 5h) modulated cell viability in STHdh(Q111/Q111) (mhttHD cells), without affecting the viability of STHdh(Q7/Q7) (wthtt cells). This effect was prevented by the application of SB203580. Our results demonstrate that in the presence of the HD mutation A1Rs undergo profound changes in terms of expression, pharmacology and functional activity. These changes have to be taken in due account when considering A1Rs as a potential therapeutic target for this disease.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ferrante</LastName>
                    <ForeName>Antonella</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Istituto Superiore di Sanit??, Department of Therapeutic Research and Medicines Evaluation, Viale Regina Elena 299, 00161 Rome, Italy. Electronic address: mariateresa.tebano@iss.it.</Affiliation>
                </Author>
                <Author>
                    <LastName>Martire</LastName>
                    <ForeName>Alberto</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Istituto Superiore di Sanit??, Department of Therapeutic Research and Medicines Evaluation, Viale Regina Elena 299, 00161 Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pepponi</LastName>
                    <ForeName>Rita</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Istituto Superiore di Sanit??, Department of Therapeutic Research and Medicines Evaluation, Viale Regina Elena 299, 00161 Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Varani</LastName>
                    <ForeName>Katia</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Medical Sciences, Pharmacology Section, University of Ferrara, via Fossato di Mortara 17/19, 44121 Ferrara, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Vincenzi</LastName>
                    <ForeName>Fabrizio</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Medical Sciences, Pharmacology Section, University of Ferrara, via Fossato di Mortara 17/19, 44121 Ferrara, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ferraro</LastName>
                    <ForeName>Luca</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Life Sciences and Biotechnology, University of Ferrara, Via Fossato di Mortara 17, 44121 Ferrara, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Beggiato</LastName>
                    <ForeName>Sarah</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Medical Sciences, Pharmacology Section, University of Ferrara, via Fossato di Mortara 17/19, 44121 Ferrara, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tebano</LastName>
                    <ForeName>Maria Teresa</ForeName>
                    <Initials>MT</Initials>
                    <Affiliation>Istituto Superiore di Sanit??, Department of Therapeutic Research and Medicines Evaluation, Viale Regina Elena 299, 00161 Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Popoli</LastName>
                    <ForeName>Patrizia</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Istituto Superiore di Sanit??, Department of Therapeutic Research and Medicines Evaluation, Viale Regina Elena 299, 00161 Rome, Italy.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neurobiol Dis</MedlineTA>
            <NlmUniqueID>9500169</NlmUniqueID>
            <ISSNLinking>0969-9961</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adenosine A(1) receptors</Keyword>
            <Keyword MajorTopicYN="N">Huntington's disease</Keyword>
            <Keyword MajorTopicYN="N">R6/2 mice</Keyword>
            <Keyword MajorTopicYN="N">Striatum</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132555</ArticleId>
            <ArticleId IdType="pii">S0969-9961(14)00244-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nbd.2014.08.013</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132554</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1095-953X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurobiology of disease</Title>
                <ISOAbbreviation>Neurobiol. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Animal models of absence epilepsies: What do they model and do sex and sex hormones matter?</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0969-9961(14)00245-9</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.nbd.2014.08.014</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">While epidemiological data suggest a female prevalence in human childhood- and adolescence-onset typical absence epilepsy syndromes, the sex difference is less clear in adult-onset syndromes. In addition, although there are more females than males diagnosed with typical absence epilepsy syndromes, there is a paucity of studies on sex differences in seizure frequency and semiology in patients diagnosed with any absence epilepsy syndrome. Moreover, it is unknown if there are sex differences in the prevalence or expression of atypical absence epilepsy syndromes. Surprisingly, most studies of animal models of absence epilepsy either did not investigate sex differences, or failed to find sex-dependent effects. However, various rodent models for atypical syndromes such as the AY9944 model (prepubertal females show a higher incidence than prepubertal males), BN model also with a higher prevalence in males and the Gabra1 deletion mouse in the C57BL/6J strain offer unique possibilities for the investigation of the mechanisms involved in sex differences. Although the mechanistic bases for the sex differences in humans or these three models are not yet known, studies of the effects of sex hormones on seizures have offered some possibilities. The sex hormones progesterone, estradiol and testosterone exert diametrically opposite effects in genetic absence epilepsy and pharmacologically-evoked convulsive types of epilepsy models. In addition, acute pharmacological effects of progesterone on absence seizures during proestrus are opposite to those seen during pregnancy. 17??-Estradiol has anti-absence seizure effects, but it is only active in atypical absence models. It is speculated that the pro-absence action of progesterone, and perhaps also the delayed pro-absence action of testosterone, are mediated through the neurosteroid allopregnanolone and its structural and functional homolog, androstanediol. These two steroids increase extrasynaptic thalamic tonic GABAergic inhibition by selectively targeting neurosteroid-selective subunits of GABAA receptors (GABAARs). Neurosteroids also modulate the expression of GABAAR containing the ??2, ??4, and ?? subunits. It is hypothesized that differences in subunit expression during pregnancy and ovarian cycle contribute to the opposite effects of progesterone in these two hormonal states.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>van Luijtelaar</LastName>
                    <ForeName>Gilles</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Donders Centre of Cognition, Radboud University Nijmegen, Nijmegen, The Netherlands. Electronic address: g.vanluijtelaar@donders.ru.nl.</Affiliation>
                </Author>
                <Author>
                    <LastName>Onat</LastName>
                    <ForeName>Filiz Yilmaz</ForeName>
                    <Initials>FY</Initials>
                    <Affiliation>Department of Pharmacology, School of Medicine, Marmara University, Istanbul, Turkey.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gallagher</LastName>
                    <ForeName>Martin J</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>Department of Neurology, Vanderbilt University, Nashville, TN, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neurobiol Dis</MedlineTA>
            <NlmUniqueID>9500169</NlmUniqueID>
            <ISSNLinking>0969-9961</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">AY 9944</Keyword>
            <Keyword MajorTopicYN="N">Absence epilepsy</Keyword>
            <Keyword MajorTopicYN="N">Alpha subunits</Keyword>
            <Keyword MajorTopicYN="N">Atypical absence models</Keyword>
            <Keyword MajorTopicYN="N">Delta subunits</Keyword>
            <Keyword MajorTopicYN="N">GABA(A) receptors</Keyword>
            <Keyword MajorTopicYN="N">Genetic models</Keyword>
            <Keyword MajorTopicYN="N">Mice</Keyword>
            <Keyword MajorTopicYN="N">Neurosteroids</Keyword>
            <Keyword MajorTopicYN="N">Ovarian cycle</Keyword>
            <Keyword MajorTopicYN="N">Pregnancy</Keyword>
            <Keyword MajorTopicYN="N">Puberty</Keyword>
            <Keyword MajorTopicYN="N">Rats</Keyword>
            <Keyword MajorTopicYN="N">Sex differences</Keyword>
            <Keyword MajorTopicYN="N">Typical absence models</Keyword>
            <Keyword MajorTopicYN="N">WAG/Rij</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132554</ArticleId>
            <ArticleId IdType="pii">S0969-9961(14)00245-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nbd.2014.08.014</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132550</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-4687</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature</Title>
                <ISOAbbreviation>Nature</ISOAbbreviation>
            </Journal>
            <ArticleTitle>RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/nature13608</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Necroptosis has emerged as an important pathway of programmed cell death in embryonic development, tissue homeostasis, immunity and inflammation. RIPK1 is implicated in inflammatory and cell death signalling and its kinase activity is believed to drive RIPK3-mediated necroptosis. Here we show that kinase-independent scaffolding RIPK1 functions regulate homeostasis and prevent inflammation in barrier tissues by inhibiting epithelial cell apoptosis and necroptosis. Intestinal epithelial cell (IEC)-specific RIPK1 knockout caused IEC apoptosis, villus atrophy, loss of goblet and Paneth cells and premature death in mice. This pathology developed independently of the microbiota and of MyD88 signalling but was partly rescued by TNFR1 (also known as TNFRSF1A) deficiency. Epithelial FADD ablation inhibited IEC apoptosis and prevented the premature death of mice with IEC-specific RIPK1 knockout. However, mice lacking both RIPK1 and FADD in IECs displayed RIPK3-dependent IEC necroptosis, Paneth cell loss and focal erosive inflammatory lesions in the colon. Moreover, a RIPK1 kinase inactive knock-in delayed but did not prevent inflammation caused by FADD deficiency in IECs or keratinocytes, showing that RIPK3-dependent necroptosis of FADD-deficient epithelial cells only partly requires RIPK1 kinase activity. Epidermis-specific RIPK1 knockout triggered keratinocyte apoptosis and necroptosis and caused severe skin inflammation that was prevented by RIPK3 but not FADD deficiency. These findings revealed that RIPK1 inhibits RIPK3-mediated necroptosis in keratinocytes in vivo and identified necroptosis as a more potent trigger of inflammation compared with apoptosis. Therefore, RIPK1 is a master regulator of epithelial cell survival, homeostasis and inflammation in the intestine and the skin.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Dannappel</LastName>
                    <ForeName>Marius</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>1] Institute for Genetics, Centre for Molecular Medicine (CMMC), and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Vlantis</LastName>
                    <ForeName>Katerina</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>1] Institute for Genetics, Centre for Molecular Medicine (CMMC), and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Kumari</LastName>
                    <ForeName>Snehlata</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>1] Institute for Genetics, Centre for Molecular Medicine (CMMC), and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Polykratis</LastName>
                    <ForeName>Apostolos</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>1] Institute for Genetics, Centre for Molecular Medicine (CMMC), and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Chun</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Institute for Genetics, Centre for Molecular Medicine (CMMC), and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wachsmuth</LastName>
                    <ForeName>Laurens</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Institute for Genetics, Centre for Molecular Medicine (CMMC), and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Eftychi</LastName>
                    <ForeName>Christina</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Institute for Genetics, Centre for Molecular Medicine (CMMC), and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lin</LastName>
                    <ForeName>Juan</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Institute for Genetics, Centre for Molecular Medicine (CMMC), and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Corona</LastName>
                    <ForeName>Teresa</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Institute for Genetics, Centre for Molecular Medicine (CMMC), and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hermance</LastName>
                    <ForeName>Nicole</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zelic</LastName>
                    <ForeName>Matija</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kirsch</LastName>
                    <ForeName>Petra</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Tierforschungszentrum, University of Ulm, Albert-Einstein-Allee 11, D-89081 Ulm, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Basic</LastName>
                    <ForeName>Marijana</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute for Laboratory Animal Science, Hannover Medical School, D-30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bleich</LastName>
                    <ForeName>Andre</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Institute for Laboratory Animal Science, Hannover Medical School, D-30625 Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kelliher</LastName>
                    <ForeName>Michelle</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>1] Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Pasparakis</LastName>
                    <ForeName>Manolis</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>1] Institute for Genetics, Centre for Molecular Medicine (CMMC), and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany [2].</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Nature</MedlineTA>
            <NlmUniqueID>0410462</NlmUniqueID>
            <ISSNLinking>0028-0836</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">nature13608</ArticleId>
            <ArticleId IdType="doi">10.1038/nature13608</ArticleId>
            <ArticleId IdType="pubmed">25132550</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132527</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1523-6536</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation</Title>
                <ISOAbbreviation>Biol. Blood Marrow Transplant.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Host-derived CD8(+) dendritic cells protect against acute Graft-versus-Host Disease after experimental allogeneic bone marrow transplantation.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1083-8791(14)00504-7</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.bbmt.2014.08.005</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Graft-versus-host disease (GVHD) is a frequent life-threatening complication following allogeneic haematopoietic stem cell transplantation (HSCT) and induced by donor-derived T cells that become activated by host antigen-presenting cells. To address the relevance of host dendritic cell (DC) populations in this disease, we used mouse strains deficient of CD11c(+) or CD8??(+) DC populations in a model of acute GVHD where bone marrow and T cells from BALB/c donors are transplanted into C57BL/6 hosts. Surprisingly a strong increase in GVHD-related mortality was observed in the absence of CD11c(+) cells. Likewise Batf3-deficient (Batf3(-/-)) mice that lack CD8??(+) DCs also displayed a strongly increased GVHD-related mortality. In the absence of CD8??(+) DCs, we detected an increased activation of the remaining DC populations post HSCT, leading to an enhanced priming of allogeneic T cells. Importantly, this was associated with reduced numbers of regulatory T (Treg) cells and TGF-?? levels indicating an aggravated failure of peripheral tolerance mechanisms after HSCT in the absence of CD8??(+) DCs. In summary, our results indicate for a critical role of CD8??(+) DCs as important inducers of Treg mediated tolerance to control DC activation and T-cell priming in the initiation phase of GVHD.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Weber</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute of Immunology, Johannes Gutenberg-University Medical Center, Mainz, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rudolph</LastName>
                    <ForeName>Berenice</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Dept. of Dermatology, Johannes Gutenberg-University Medical Center, Mainz, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Stein</LastName>
                    <ForeName>Pamela</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Institute of Immunology, Johannes Gutenberg-University Medical Center, Mainz, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yogev</LastName>
                    <ForeName>Nir</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Institute of Molecular Medicine, Johannes Gutenberg-University Medical Center, Mainz, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bosmann</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>IIIrd Dept. of Medicine, Johannes Gutenberg-University Medical Center, Mainz, Germany; Center for Thrombosis and Hemostasis, Johannes Gutenberg-University Medical Center, Mainz, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Schild</LastName>
                    <ForeName>Hansj??rg</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Institute of Immunology, Johannes Gutenberg-University Medical Center, Mainz, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Radsak</LastName>
                    <ForeName>Markus P</ForeName>
                    <Initials>MP</Initials>
                    <Affiliation>IIIrd Dept. of Medicine, Johannes Gutenberg-University Medical Center, Mainz, Germany. Electronic address: radsak@uni-mainz.de.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biol Blood Marrow Transplant</MedlineTA>
            <NlmUniqueID>9600628</NlmUniqueID>
            <ISSNLinking>1083-8791</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1083-8791(14)00504-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbmt.2014.08.005</ArticleId>
            <ArticleId IdType="pubmed">25132527</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132514</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1539-3429</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology</Title>
                <ISOAbbreviation>Biochem Mol Biol Educ</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Oxidative damage in diabetics: Insights from a graduate study in La Reunion University.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/bmb.20818</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Due to the growing incidence of diabetes in developed nations, there is a compelling case to be made for teaching graduate students more deeply about mechanisms underlying this disease. Diabetes is associated with enhanced oxidative stress and protein glycation via the covalent binding of glucose molecules. Albumin represents the major plasmatic protein and undergoes enhanced glycoxidative modifications in diabetic condition. La R??union Island, a French department located in the Indian Ocean exhibit a growing incidence of diabetes. At the University of La R??union, our research group named GEICO (Groupe d'Etude sur l'Inflammation Chronique et l'Ob??sit??) participated to foster research and training in diabetes context and focuses on the impact of glycated albumin mediated oxidative stress on cell physiopathology. A laboratory course was designed by our group to introduce graduate students to cutting edge techniques in redox biology while providing insights into scientific processes and methods. This two weeks research laboratory training took place at CYROI, a local biotechnology center that provides advanced facilities for research, business, and education. Using histochemistry, molecular biology, biochemical techniques, student investigated oxidative damages in liver from leptin receptor deficient diabetic mice compared to control littermates. In addition, they used an in vitro model by assaying oxidative impact of glycated albumin on hepatoma carcinoma HepG2 cells. This article gives an overview of the organization and protocol used by the students during their two weeks training in the laboratory. Therefore, it may be helpful for teaching graduate students techniques used in research laboratory working on redox biology. ?? 2014 by The International Union of Biochemistry and Molecular Biology, 2014.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Girard</LastName>
                    <ForeName>Doroth??e</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Groupe d'??tude sur l'inflammation chronique et l'ob??sit?? (GEICO), Plateforme CYROI, Universit?? de La R??union, Saint Denis de La R??union, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rondeau</LastName>
                    <ForeName>Philippe</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Catan</LastName>
                    <ForeName>Aur??lie</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Planesse</LastName>
                    <ForeName>Cynthia</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Giraud</LastName>
                    <ForeName>Pierre</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Bourdon</LastName>
                    <ForeName>Emmanuel</ForeName>
                    <Initials>E</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biochem Mol Biol Educ</MedlineTA>
            <NlmUniqueID>100970605</NlmUniqueID>
            <ISSNLinking>1470-8175</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">University of La R??union</Keyword>
            <Keyword MajorTopicYN="N">diabetes</Keyword>
            <Keyword MajorTopicYN="N">glycated albumin</Keyword>
            <Keyword MajorTopicYN="N">oxidation</Keyword>
            <Keyword MajorTopicYN="N">oxidative stress</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/bmb.20818</ArticleId>
            <ArticleId IdType="pubmed">25132514</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132513</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1742-481X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>6</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International wound journal</Title>
                <ISOAbbreviation>Int Wound J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>17??-Estradiol administration promotes delayed cutaneous wound healing in 40-week ovariectomised female mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/iwj.12336</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">This study investigated the effect of 17??-estradiol on wound healing in 40-week ovariectomised female mice. Thirty-six-week-old female mice were divided into three groups: medication with 17??-estradiol after ovariectomy (OVX???+???17??-estradiol), ovariectomy (OVX) and sham (SHAM). The mice received two full-thickness wounds, and the OVX???+???17??-estradiol group was administered 17??-estradiol at 0??01 g/day until healing. In the OVX???+???17??-estradiol group, the ratio of wound area was significantly smaller than those of the OVX and SHAM groups on days 1-3, 5, 6, 8-12 and 9-12, respectively, the numbers of neutrophils and macrophages were significantly smaller than those on days 3 and 7, the ratio of re-epithelialisation was significantly higher than those on days 3 and 11, the ratio of myofibroblasts was significantly higher than those on day 11 and smaller on day 14, and the ratio of collagen fibres was significantly larger than that of the OVX group on days 7-14. We found that 17??-estradiol administration promotes cutaneous wound healing in 40-week female mice by reducing wound area, shortening inflammatory response, and promoting re-epithelialisation, collagen deposition and wound contraction. Our results suggest that cutaneous wound healing that is delayed because of ageing is promoted by exogenous and continuous 17??-estradiol administration.</AbstractText>
                <CopyrightInformation>?? 2014 The Authors. International Wound Journal ?? 2014 Medicalhelplines.com Inc and John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Mukai</LastName>
                    <ForeName>Kanae</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Clinical Nursing, Graduate Course of Nursing Science, Division of Health Sciences, Graduate School of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nakajima</LastName>
                    <ForeName>Yukari</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Urai</LastName>
                    <ForeName>Tamae</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Komatsu</LastName>
                    <ForeName>Emi</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Nasruddin</LastName>
                </Author>
                <Author>
                    <LastName>Sugama</LastName>
                    <ForeName>Junko</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Nakatani</LastName>
                    <ForeName>Toshio</ForeName>
                    <Initials>T</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Int Wound J</MedlineTA>
            <NlmUniqueID>101230907</NlmUniqueID>
            <ISSNLinking>1742-4801</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">17??-Estradiol</Keyword>
            <Keyword MajorTopicYN="N">Ageing</Keyword>
            <Keyword MajorTopicYN="N">Cutaneous wound healing</Keyword>
            <Keyword MajorTopicYN="N">Female mice</Keyword>
            <Keyword MajorTopicYN="N">Ovariectomy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/iwj.12336</ArticleId>
            <ArticleId IdType="pubmed">25132513</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132500</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1473-4230</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cerebellum (London, England)</Title>
                <ISOAbbreviation>Cerebellum</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Impaired Hypercarbic and Hypoxic Responses from Developmental Loss of Cerebellar Purkinje Neurons: Implications for Sudden Infant Death Syndrome.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Impaired responsivity to hypercapnia or hypoxia is commonly considered a mechanism of failure in sudden infant death syndrome (SIDS). The search for deficient brain structures mediating flawed chemosensitivity typically focuses on medullary regions; however, a network that includes Purkinje cells of the cerebellar cortex and its associated cerebellar nuclei also helps mediate responses to carbon dioxide (CO2) and oxygen (O2) challenges and assists integration of cardiovascular and respiratory interactions. Although cerebellar nuclei contributions to chemoreceptor challenges in adult models are well described, Purkinje cell roles in developing models are unclear. We used a model of developmental cerebellar Purkinje cell loss to determine if such loss influenced compensatory ventilatory responses to hypercapnic and hypoxic challenges. Twenty-four Lurcher mutant mice and wild-type controls were sequentially exposed to 2??% increases in CO2 (0-8??%) or 2??% reductions in O2 (21-13??%) over 4??min, with return to room air (21??% O2/79??%??N2/0??% CO2) between each exposure. Whole body plethysmography was used to continuously monitor tidal volume (TV) and breath frequency (f). Increased f to hypercapnia was significantly lower in mutants, slower to initiate, and markedly lower in compensatory periods, except for very high (8??%) CO2 levels. The magnitude of TV changes to increasing CO2 appeared smaller in mutants but only approached significance. Smaller but significant differences emerged in response to hypoxia, with mutants showing smaller TV when initially exposed to reduced O2 and lower f following exposure to 17??% O2. Since cerebellar neuropathology appears in SIDS victims, developmental cerebellar neuropathology may contribute to SIDS vulnerability.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Calton</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Psychology, The University of Memphis, 400 Innovation Drive, Memphis, TN, 38152, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dickson</LastName>
                    <ForeName>P</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Harper</LastName>
                    <ForeName>R M</ForeName>
                    <Initials>RM</Initials>
                </Author>
                <Author>
                    <LastName>Goldowitz</LastName>
                    <ForeName>D</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Mittleman</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cerebellum</MedlineTA>
            <NlmUniqueID>101089443</NlmUniqueID>
            <ISSNLinking>1473-4222</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12311-014-0592-1</ArticleId>
            <ArticleId IdType="pubmed">25132500</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
